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CommentaryThe Centers for Disease Control and Prevention 
(CDC) collects, analyzes, and disseminates surveil-
lance data on HIV infection and AIDS; these data are 
the nation’s source of information on the HIV epi-
demic. The annual surveillance report, published by 
the Division of HIV/AIDS Prevention, summarizes 
information about HIV infection and AIDS in the 
United States and 5 U.S. dependent areas (this report, 
formerly known as the HIV/AIDS Surveillance 
Report, has been renamed the HIV Surveillance 
Report). HIV surveillance data are used by CDC’s 
public health partners in other federal agencies, health 
departments, nonprofit organizations, academic insti-
tutions, and the general public to help target preven-
tion efforts, plan for services, develop policy, and 
monitor the HIV epidemic. In accord with CDC’s rec-
ognition of the changing needs for data and its com-
mitment to meeting those needs, the presentation of 
2008 data emphasizes the date of diagnosis of HIV 
infection or AIDS (diagnosis as of December 31, 
2008; reported to CDC as of June 30, 2009). The term 
HIV/AIDS—previously used to refer to a diagnosis of 
HIV infection regardless of the person’s AIDS status 
at the time of diagnosis—has been replaced with the 
term diagnosis of HIV infection. The new title of the 
report—HIV Surveillance Report—reflects this 
change in terminology.
Data on HIV infection in the tables presented in the 
2008 report reflect the date of diagnosis of HIV infec-
tion, not the date of report to CDC. Historically, the 
date of report has reflected reporting practices; that is, 
the information may have been reported months or 
years after the date of diagnosis. HIV data displayed 
by year of diagnosis more closely approximate the 
date of infection and are thus the best marker of 
trends in the epidemic; however, HIV diagnoses do 
not necessarily represent new infections: some per-
sons were infected recently, and others were infected 
at some time in the past. Because of reporting delays, 
the actual numbers of cases diagnosed in a given year 
may be higher than the numbers of diagnoses of 
HIV infection (unweighted) presented in this report 
for recent years; however the numbers of diagnoses 
for a calendar year typically stabilize after 2 to 3 years 
of reporting.The 2008 HIV Surveillance Report is organized 
into 4 sections:
1. Diagnoses of HIV infection and AIDS
2. Deaths and survival of persons with a diagnosis 
of HIV infection or AIDS
3. Persons living with a diagnosis of HIV infection 
or AIDS
4. HIV infection and AIDS data, by state and met-
ropolitan statistical area (MSA)
Sections 1–3 (Tables 1a/b–18a/b) present trends in 
numbers (statistically adjusted and unadjusted) and 
rates (adjusted) of diagnoses of HIV infection and 
AIDS, deaths of persons with a diagnosis of HIV 
infection or AIDS, and persons living with a diagnosis 
of HIV infection or AIDS. Section 4 (Tables 19–24) 
presents trends in numbers (adjusted and unadjusted) 
and rates (adjusted) of diagnoses of HIV infection and 
AIDS and persons living with a diagnosis of HIV 
infection or AIDS, by state and MSA. Numerical 
rankings, based on rates of diagnoses of HIV infection 
and AIDS, are provided by MSA. All 50 states, the 
District of Columbia, and 5 U.S. dependent areas had 
implemented confidential name-based HIV infection 
reporting by April 2008. Numbers (unadjusted) of 
diagnoses of HIV infection are presented (Table 19) 
for all 56 areas for 2008. These numbers should be 
viewed as minimums, as they have not been adjusted 
for reporting delays.
The tables in the 2008 report present data in two 
formats. Tables in the first format—labeled “a”—
exclude data from the dependent areas (American 
Samoa, Guam, Northern Mariana Islands, Puerto 
Rico, and the U.S. Virgin Islands). Tables in the sec-
ond format—labeled “b”—include data from the 
dependent areas. 
Where indicated, counts of diagnoses and deaths 
have been statistically adjusted to correct for delays in 
reporting. Because states implemented confidential 
name-based reporting at different times, the areas 
included in estimates (adjusted) of numbers and rates 
of diagnoses of HIV infection are based on the date of 
implementation of confidential name-based HIV 
infection reporting. Although all states had success-
fully implemented confidential name-based HIV 5
infection reporting by April 2008, a national compari-
son of HIV infection rates will not be possible until 
the 2012 HIV Surveillance Report, when all states will 
have mature HIV reporting systems.
The estimated numbers and rates of diagnoses of 
HIV infection are based on data from the 42 areas (37 
states and 5 U.S. dependent areas) that have had con-
fidential name-based HIV infection reporting for a 
sufficient length of time (i.e., since at least January 
2005) to allow for stabilization of data collection and 
for adjustment of the data in order to monitor trends. 
This report marks the first time that HIV diagnosis 
reports from Connecticut, Kentucky, and New 
Hampshire have been included in the estimates of 
diagnoses of HIV infection. According to the number 
of AIDS diagnoses reported to CDC through 2008, 
these 37 states represent approximately 68% of AIDS 
diagnoses in the 50 states and the District of 
Columbia. From 2005 through 2008, the annual esti-
mated number of diagnoses of HIV infection 
increased 8% in the 37 states; however, the overall 
annual estimated rate of diagnosis of HIV infection 
during this period remained stable. Estimated num-
bers and rates of diagnoses of HIV infection increased 
in some subgroups. Increases are likely due to 
increases in HIV testing because estimates of new 
infections (incidence) through 2006 do not suggest an 
increase in recent years. However, it is not possible to 
rule out an increase in HIV infections because the 
estimation models include a degree of uncertainty. 
Updated HIV incidence surveillance data will provide 
the best indication of changes in trends in new HIV 
infections. The figure on the cover depicts the esti-
mated rates (per 100,000 population) of diagnoses of 
HIV infection in 2008, by race/ethnicity and sex, for 
persons residing in the 37 states with confidential 
name-based HIV infection reporting since at least 
January 2005. As shown in the figure, the highest 
rates of diagnoses of HIV infection were among 
black/African American males and females residing 
in the 37 states.
The analyses of AIDS diagnoses were based on data 
from the 50 states, the District of Columbia, and 
5 U.S. dependent areas. For trends in AIDS diagnoses, 
tables of data for the most recent 4-year period include 
the cumulative totals through 2008 for all 50 states, the 
District of Columbia, and 5 U.S. dependent areas.
6 CommHIGHLIGHTS OF ANALYSES
All statements in this section are based on estimated 
data. All rates are per 100,000 population. Our stan-
dard for determining trends in numbers and rates is 
based on an increase or a decrease of 5% or more. 
Exceptions to this standard were made for populations 
with small numbers.
Diagnoses of HIV Infection and AIDS
Diagnoses of HIV infection
From 2005 through 2008, the estimated numbers of 
annual diagnoses of HIV infection in the 37 states 
with confidential name-based HIV infection reporting 
increased 8% (Table 1a). However, the estimated 
rates of annual diagnoses of HIV infection during this 
period remained stable. In 2008, the estimated rate of 
diagnoses of HIV infection in the 37 states was 19.4 
per 100,000 population.
• Age group: From 2005 through 2008, the rates 
remained stable among children (less than 13 
years of age) and persons aged 13–14, 30–34, 40–
44, 60–64, and 65 years and older. The rate for 
persons aged 35–39 decreased. The rates for 
persons aged 15–19, 20–24, 25–29, 45–49, 50–54 
and 55–59 increased. In 2008, the largest 
percentage—14% of all diagnoses— and the 
highest rate—38.7 per 100,000 population—were 
those for persons aged 40–44 years.
• Race/ethnicity: From 2005 through 2008, rates 
among American Indians/Alaska Natives, 
Asians, and blacks/African Americans increased 
(Table 1a). The rates among Native Hawaiians/
other Pacific Islanders and persons reporting 
multiple races decreased. The rate among whites 
remained stable. Among Hispanics/Latinos, the 
rate decreased, although the number increased. In 
2008, blacks/African Americans accounted for 
52% of all diagnoses of HIV infection. The rates 
by race/ethnicity in 2008 were 73.7 in the black/
African American population, 25.0 in the 
Hispanic/Latino population, 22.8 in the Native 
Hawaiian/other Pacific Islander population, 14.1 
in the population of persons reporting multiple 
races, 11.9 in the American Indian/Alaska Native 
population, 8.2 in the white population, and 7.2 in 
the Asian population (Table 1a).entary
• Sex: In 2008, males accounted for 75% of all 
diagnoses of HIV infection among adults and 
adolescents. The rate among adult and adolescent 
males was 35.9, and the rate among females was 
11.5. During 2005–2008, the rate among males 
increased 7%, but the rate among females 
remained stable (Table 1a).
• Transmission category: During 2005–2008, the 
number of annual diagnoses of HIV infection 
among men who have sex with men (MSM) 
increased. Among male and female adults and 
adolescents exposed through heterosexual 
contact, the numbers of diagnoses increased. 
Among male and female adult and adolescent 
injection drug users (IDUs), MSM who were also 
IDUs, and children, the numbers of diagnoses 
decreased. In 2008, MSM (54%) and persons 
exposed through heterosexual contact (32%) 
accounted for 86% of all diagnoses of HIV 
infection in the 37 states.
AIDS diagnoses
From 2005 through 2008, the estimated numbers and 
the estimated rates of annual AIDS diagnoses in the 
United States remained stable (Table 2a). In 2008, the 
estimated rate of AIDS diagnoses in the United States 
was 12.2 per 100,000 population.
• Age: From 2005 through 2008, the numbers and 
the rates decreased for persons aged 30–34, 35–
39, and 40–44. The numbers and the rates 
increased among persons aged 20–24, 25–29, 55–
59, and 60–64. The rates remained stable for 
children (less than 13 years old) and persons aged 
13–14, 15–19, 45–49, 50–54, and 65 and older. In 
2008, the highest rate was that for persons aged 
40–44 years: 31.1 per 100,000 population.
• Race/ethnicity: From 2005 through 2008, the 
rates among American Indians/Alaska Natives 
and Asians increased. The rates decreased among 
Hispanics/Latinos and persons reporting multiple 
races. The rates remained stable among blacks/
African Americans, Native Hawaiians/other 
Pacific Islanders, and whites. In 2008, the rates 
were 49.3 in the black/African American 
population, 15.0 in the Hispanic/Latino 
population, 11.8 in the Native Hawaiian/other 
Pacific Islander population, 9.8 in the population 
of persons reporting multiple races, 8.5 in the CommAmerican Indian/Alaska Native population, 5.3 
in the white population, and 4.0 in the Asian 
population (Table 2a).
• Sex: From 2005 through 2008, the rates among 
adult and adolescent males remained stable; 
among females, the rates decreased (Table 2a). 
Adult and adolescent males accounted for 74% of 
all AIDS diagnoses made during 2008. The rates 
among adults and adolescents in 2008 were 22.4 
among males and 7.5 among females.
• Transmission category: Among male adults and 
adolescents, the numbers of annual AIDS 
diagnoses decreased among IDUs and among 
MSM who were also IDUs (Table 2a). The 
numbers among males exposed through male-to-
male sexual contact and through heterosexual 
contact increased. Among female adults and 
adolescents, the number of AIDS diagnoses 
among those exposed through heterosexual 
contact remained stable; the number among those 
exposed through injection drug use decreased.
• Region: From 2005 through 2008, the rates 
decreased in the Northeast, increased in the West, 
and remained stable in the Midwest and the South.
Deaths
Deaths of persons with a diagnosis of HIV 
infection
From 2005 through 2007, the estimated number of 
deaths of persons with a diagnosis of HIV infection 
in the 37 states with confidential name-based HIV 
infection reporting increased 17% (Table 11a). The 
estimated rate of deaths increased 14%, from 6.9 per 
100,000 population in 2005 to 7.9 per 100,000 popu-
lation in 2007. The increase in the estimated number 
of deaths of persons with a diagnosis of HIV infection 
may be influenced by significant efforts to improve 
death reporting. It is not possible, however, to rule out 
an actual increase in deaths of persons with a diagno-
sis of HIV infection because the estimation models 
include a degree of uncertainty. Readers should use 
caution when interpreting trend data on the estimated 
number of deaths because the estimates for the most 
recent year are most subject to uncertainty. Deaths 
of persons with a diagnosis of HIV infection may be 
due to any cause (i.e., may or may not be related to 
HIV infection).entary 7
• Age group: The rates of deaths increased among 
all age groups, except among children (less than 
13 years of age) and persons aged 30–34 and 35–
39. The rate decreased among persons aged 30–
34. The rates among children and persons aged 
35–39 remained stable.
• Race/ethnicity: The rates of deaths increased 
among American Indians/Alaska Natives, blacks/
African Americans, Hispanics/Latinos, Native 
Hawaiians/other Pacific Islanders, whites, and 
persons reporting multiple races. The number 
of deaths in these populations increased as well. 
Among Asians, the number of deaths increased; 
however, the rate of deaths remained stable. 
In 2007, the highest rate of deaths was that for 
blacks/African Americans: 31.3 per 100,000 
population.
• Sex and transmission category: The numbers of 
deaths of males in all transmission categories 
increased, except for males exposed through 
injection drug use in which the number of deaths 
remained stable. Among females, the number of 
deaths increased among those exposed through 
heterosexual contact and injection drug use.
Deaths of persons with an AIDS diagnosis
During 2005–2007 in the United States, the annual 
estimated number of deaths among persons with an 
AIDS diagnosis increased. The annual estimated rate 
of deaths per 100,000 population remained stable 
(Table 12a). The increase in the estimated number of 
deaths of persons with an AIDS diagnosis may be 
influenced by significant efforts to improve death 
reporting. It is not possible, however, to rule out an 
actual increase in deaths of persons with an AIDS 
diagnosis because the estimation models include a 
degree of uncertainty. Readers should use caution 
when interpreting trend data on the estimated number 
of deaths because the estimates for the most recent 
year are most subject to uncertainty. Deaths of persons 
with an AIDS diagnosis may be due to any cause.
• Age group: From 2005 through 2007, the rates of 
deaths increased among persons aged 25–29, 50–
54, 55–59, 60–64, and 65 and older. Rates 
remained stable among children (less than 13 
years old) and among persons aged 13–14, 15–
19, 20–24, 40–44, and 45–49. Rates decreased 
among persons aged 30–34 and 35–39. In 2007, 
8 Commthe highest rate was that for persons aged 45–49: 
15.7 per 100,000 population.
• Race/ethnicity: The annual rates of deaths 
increased among American Indians/Alaska 
Natives and among persons reporting multiple 
races. Rates remained stable among Asians, 
blacks/African Americans, Hispanics/Latinos, 
and whites. The number and the rate decreased 
among Native Hawaiians/other Pacific Islanders.
• Sex and transmission category: The number of 
deaths among adult and adolescent males 
increased among persons exposed through male-
to-male sexual contact and those exposed through 
heterosexual contact. The number of deaths 
decreased among IDUs and remained stable 
among MSM who were also IDUs. Among 
female adults and adolescents, the number of 
deaths increased among those exposed through 
heterosexual contact; among those who were 
IDUs, the number remained stable. During 2005–
2007, the rate among males remained stable, and 
the rate among females increased.
• Region: The rates of deaths increased in the 
Midwest and the South, decreased in the West, 
and remained stable in the Northeast.
Survival
Survival after a diagnosis of HIV infection
Data from diagnoses of HIV infection made during 
2000–2004 in the 37 states with confidential name-
based HIV reporting were used to describe persons 
surviving 12, 24, and 36 months after a diagnosis of 
HIV infection.
• Survival increased with the year of diagnosis for 
diagnoses made during 2000–2004, although 
year-to-year differences were small (Table 13a).
• Survival decreased as age at diagnosis increased 
among persons aged 35 and older at time of 
diagnosis.
• Survival was greatest among MSM, female adults 
and adolescents exposed through heterosexual 
contact, and children regardless of transmission 
category. Survival was intermediate among male 
adults and adolescents exposed through 
heterosexual contact and among MSM who were 
also IDUs. Survival was lowest among male and 
female adults and adolescents who were IDUs.entary
• By race/ethnicity, survival was greater among 
Asians, whites, Hispanics/Latinos, and persons 
reporting multiple races than among American 
Indians/Alaska Natives and blacks/African 
Americans. Data for Native Hawaiians/other 
Pacific Islanders should be interpreted with 
caution because the estimated number of persons 
in this category is small and the data are therefore 
unstable.
Survival after AIDS diagnosis
Data from AIDS diagnoses made during 2000–2004 
in the United States were used to describe persons sur-
viving 12, 24, and 36 months after an AIDS diagnosis.
• Survival increased with the year of diagnosis for 
diagnoses made during 2000–2004, although 
year-to-year differences were small (Table 14a).
• Survival decreased as age increased, particularly 
among persons aged 35 and older. Survival was 
greatest for persons in the age groups 13–14 and 
15–19.
• Survival was greatest among MSM and among 
children exposed perinatally. Survival was 
intermediate among male and female adults and 
adolescents exposed through heterosexual 
contact, as well as MSM who were also IDUs. 
Survival was lowest among male and female 
adults and adolescents who were IDUs.
• Survival was greater among Asians, Hispanics/
Latinos, whites, and persons reporting multiple 
races than among American Indians/Alaska 
Natives and blacks/African Americans. Data for 
Native Hawaiians/other Pacific Islanders should 
be interpreted with caution because the number of 
persons in this category is small and the data are 
therefore unstable.
Persons Living with a Diagnosis of HIV 
Infection or AIDS (Prevalence)
Persons living with a diagnosis of 
HIV infection
From 2005 through 2007, the estimated number of 
persons living with a diagnosis of HIV infection (HIV 
prevalence) increased steadily in the 37 states with 
confidential name-based HIV infection reporting 
(Table 15a). At the end of 2007, an estimated 580,371 
persons in these states were living with a diagnosis of 
HIV infection.Comm• By age group, the largest percentage of persons 
living with a diagnosis of HIV infection were 
persons aged 40–44 during 2007.
• By race/ethnicity, the largest percentage of 
persons living with a diagnosis of HIV 
infection—48%—were blacks/African 
Americans. The remaining race/ethnicity 
percentages were whites, 33% of diagnoses; 
Hispanics/Latinos, 17%; and less than 1% each, 
American Indians/Alaska Natives, Asians, 
Native Hawaiians/other Pacific Islanders, and 
persons reporting multiple races.
• By sex, 73% of adults and adolescents living with 
a diagnosis of HIV infection were male.
• Among male adults and adolescents living with a 
diagnosis of HIV infection, 64% had been 
exposed through male-to-male sexual contact, 
16% through injection drug use, 12% through 
heterosexual contact, and 7% through both male-
to-male sexual contact and injection drug use. 
Among female adults and adolescents living with 
a diagnosis of HIV infection, 73% had been 
exposed through heterosexual contact and 26% 
through injection drug use. Among children 
living with a diagnosis of HIV infection, 89% had 
been exposed perinatally.
Prevalence rates of diagnoses of HIV infection
At the end of 2007, in the 37 states with confidential 
name-based HIV reporting, the estimated prevalence 
rate of diagnoses of HIV infection was 275.4 per 
100,000 population (Table 15a). The estimated rates 
per 100,000 population were 492.8 among male 
adults and adolescents, 173.0 among female adults 
and adolescents, and 23.6 among children (aged less 
than 13 years at the time of diagnosis). Among all 
racial/ethnic groups, the highest estimated prevalence 
rate was that for blacks/African Americans: 967.5 per 
100,000 population.
Persons living with an AIDS diagnosis
From 2005 through 2007, the estimated number of 
persons living with an AIDS diagnosis steadily 
increased (Table 16a). At the end of 2007, an estimated 
459,594 persons in the United States were living with 
an AIDS diagnosis.
• By age group, the number was highest 
among persons aged 45–49, followed by persons entary 9
aged 40–44. The largest percentage increase in 
prevalence from 2005 through 2007 was among 
persons aged 60–64.
• By race/ethnicity, blacks/African Americans 
accounted for the largest percentage: 44% of all 
persons living with an AIDS diagnosis. The 
remaining race/ethnicity percentages were 
whites, 35%; Hispanics/Latinos, 19%; Asians, 
1%; and less than 1% each, American Indians/
Alaska Natives, Native Hawaiians/other Pacific 
Islanders, and persons reporting multiple races.
• Of the 350,491 male adults and adolescents living 
with an AIDS diagnosis in 2007, 62% had been 
exposed through male-to-male sexual contact, 
18% through injection drug use, 11% through 
heterosexual contact, and 8% through male-to-
male sexual contact and injection drug use. Of the 
105,260 female adults and adolescents living 
with an AIDS diagnosis in 2007, 65% had been 
exposed through heterosexual contact, and 32% 
had been exposed through injection drug use. Of 
the 3,842 children living with an AIDS diagnosis, 
95% had been exposed perinatally.
Prevalence rates of AIDS diagnoses
At the end of 2007, the prevalence rate of AIDS diag-
noses among adults and adolescents in the United 
States was estimated at 152.5 per 100,000 population 
(Table 16a). The estimated prevalence rates per 
100,000 population were 288.3 for adult and adoles-
cent males, 82.8 for adult and adolescent females, and 
7.3 for children (aged less than 13 years at the time of 
diagnosis). By race/ethnicity, the highest estimated 
prevalence rate for persons living with an AIDS diag-
nosis was that for blacks/African Americans: 546.7 
per 100,000 population.
ADDITIONAL RESOURCES
The following were prepared by using HIV surveil-
lance data:
• MMWR articles (selected): http://www.cdc.gov/
hiv/resources/reports/mmwr/
• Other surveillance reports: http://www.cdc.gov/
hiv/topics/surveillance/resources/reports/
• Public-use slides updated annually: http://www.
cdc.gov/hiv/topics/surveillance/resources/slides/
10 Comm• Public-use version of the AIDS surveillance data 
set (AIDS Public Information Data Set [APIDS]): 
http://www.cdc.gov/hiv/software/apids.htm
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Technical NotesSURVEILLANCE OF HIV INFECTION
This report includes data from case reports from 56 
areas (all 50 states, the District of Columbia, 
American Samoa, Guam, the Northern Mariana 
Islands, Puerto Rico, and the U.S. Virgin Islands) that 
had laws or regulations requiring confidential report-
ing by name for adults, adolescents, and children with 
confirmed diagnoses of HIV infection (including 
AIDS) as of December 31, 2008. After the removal of 
personal identifying information, data from these 
reports were submitted to CDC. The implementation 
of HIV infection reporting has differed from state to 
state. Before 1991, the surveillance of HIV infection 
was not standardized, and reporting was based pri-
marily on passive surveillance. The information on 
many of the cases reported before 1991 is not com-
plete. Since then, CDC has assisted states in conduct-
ing active surveillance of HIV infection by the use of 
standardized report forms and software.
Data on diagnoses of HIV infection should be inter-
preted with caution. HIV surveillance reports may not 
be representative of all persons infected with HIV 
because not all infected persons have been tested. Many 
HIV-reporting states offer anonymous HIV testing; the 
results of anonymous tests are not reported to the confi-
dential name-based HIV registries of state and local 
health departments. Therefore, reports of confidential 
test results may not represent all persons who tested 
positive for HIV infection. Furthermore, many factors, 
including the extent to which testing is routinely 
offered to specific groups and the availability of, and 
access to, medical care and testing services, may influ-
ence testing patterns. These data provide a minimum 
estimate of persons known to be HIV infected. In addi-
tion, because surveillance practices differ, the reporting 
and the updating of a person’s clinical and vital status 
differ among states. The completeness of reporting of 
HIV infection is estimated at more than 80% [1]. 
Because states initiated confidential name-based 
HIV infection reporting on different dates, the length 
of time that reporting has been in place influences the 
number of diagnoses of HIV infection reported to 
CDC. For example, data presented for the first year a 
state initiated reporting may include cases diagnosed 
12during only part of the year if case reporting began in 
the middle of the year.
For this report, we used the 2008 revised HIV case 
definition to classify HIV infection among adults and 
adolescents and among children [2]. The revised defi-
nition increases the specificity of the case definition 
by requiring laboratory-confirmed evidence of HIV 
infection. Increased specificity results in more accu-
rate data on the number of diagnoses of HIV infec-
tion; these data, in turn, can be used to refine public 
health policies and determine the most appropriate 
use of HIV resources.
TABULATION AND PRESENTATION OF DATA
The data in this report are provisional. This report 
includes information received by CDC through June 
30, 2009. The data are organized into 4 sections.
• Section 1 (Tables 1a/b–10a/b): numbers 
(statistically adjusted and unadjusted) and rates 
(adjusted) of diagnoses of HIV infection and AIDS
• Section 2 (Tables 11a/b–14a/b): numbers 
(statistically adjusted and unadjusted) and rates 
(adjusted) of deaths and proportions (unadjusted) 
of survival among persons with a diagnosis of 
HIV infection or AIDS
• Section 3 (Tables 15a/b–18a/b): numbers 
(statistically adjusted and unadjusted) and rates 
(adjusted) of persons living with a diagnosis of 
HIV infection or AIDS
• Section 4 (Tables 19–24): numbers (statistically 
adjusted and unadjusted) and rates (adjusted) of 
diagnoses of HIV infection and AIDS, presented 
by state and metropolitan statistical area (MSA)
For the assessment of trends in diagnoses, deaths, 
or prevalence, it is preferable to use statistically 
adjusted (estimated) data to eliminate artifacts of 
reporting in the surveillance system.
Areas with Mature HIV Infection 
Reporting Systems
An area’s confidential name-based HIV infection 
reporting is considered mature after 4 years—long 
enough for the calculation of reporting delay estimates  
and the determination of reliable trends [3]. To esti-
mate the number of diagnoses of HIV infection, we 
used data from 42 areas (i.e., 37 states and 5 U.S. 
dependent areas) with laws or regulations requiring 
confidential name-based HIV infection reporting since 
at least January 2005. The 42 areas comprise 37 states 
(Alabama, Alaska, Arizona, Arkansas, Colorado, 
Connecticut, Florida, Georgia, Idaho, Indiana, Iowa, 
Kansas, Kentucky, Louisiana, Michigan, Minnesota, 
Mississippi, Missouri, Nebraska, New Hampshire, 
New Jersey, New Mexico, New York, Nevada, North 
Carolina, North Dakota, Ohio, Oklahoma, South 
Carolina, South Dakota, Tennessee, Texas, Utah, 
Virginia, West Virginia, Wisconsin, Wyoming) and 5 
U.S. dependent areas (American Samoa, Guam, the 
Northern Mariana Islands, Puerto Rico, and the U.S. 
Virgin Islands). For Tables 1a/b, 3a/b, 5a/b, 8, 10a/b, 
19, and 23, we used data from these 42 areas to tabu-
late numbers (unadjusted), and estimated numbers and 
rates of diagnoses of HIV infection. These data were 
also used to tabulate the numbers and the estimated 
numbers and rates of persons living with HIV infec-
tion (Tables 15a/b, 17a/b, 21, and 23).
Areas with Confidential Name-Based HIV 
Infection Reporting as of December 31, 2008
Areas were included in tabulations of numbers (unad-
justed) of diagnoses of HIV infection by state and 
MSA if confidential name-based HIV infection 
reporting had been implemented by December 31, 
2008. For Tables 19, 21, and 23, we used data from all 
50 states, the District of Columbia, and 5 U.S. depen-
dent areas to describe numbers (unadjusted) of diag-
noses of HIV infection.
Deaths
Persons reported to the national HIV surveillance sys-
tem are assumed alive unless their deaths have been 
reported to CDC. Death data (Tables 11a/b–12a/b) 
include all deaths of persons with a diagnosis of HIV 
infection or AIDS regardless of the cause of death. 
Because of delays in the reporting of deaths, 3 years 
(2005–2007) of death data are displayed. The exclusion 
of data from the most recent year allowed at least 18 
months for deaths to be reported to CDC. The estimated 
numbers and rates of deaths resulted from statistical 
adjustment for delays in reporting.TechnicSurvival Analyses
For the survival analyses presented in Section 3 
(Tables 13a/b–14a/b), we used the Kaplan-Meier 
method to estimate the probability of survival for 12, 
24, and 36 months for persons with a diagnosis of 
HIV infection or AIDS whose case data were reported 
by June 30, 2009. Tables were limited to persons 
whose diagnosis was made during 2000–2004 to 
allow at least 3 years from the time of diagnosis to 
deaths occurring through December 31, 2007. Data 
for each HIV reporting area were included in the sur-
vival tables beginning with the first full calendar year 
after implementation of code-based or name-based 
HIV reporting (e.g., New York implemented HIV 
reporting in June 2000, so in this report, the New 
York data on diagnoses of HIV infection are for the 
period 2001–2004).
Persons Living with a Diagnosis of HIV 
Infection or AIDS
Because of delays in the reporting of deaths, 3 years 
of prevalence data are displayed. The data reflect the 
persons living with HIV infection or AIDS at the end 
of each year during 2005–2007. The exclusion of data 
from the most recent year allowed at least 18 months 
for deaths to be reported and for these persons to be 
removed from calculations of prevalence (persons liv-
ing with HIV infection or AIDS).
Age
The designation “adults and adolescents” refers to 
persons aged 13 years and older; the designation 
“children” refers to persons aged less than 13 years. 
For presentations of data on persons living with HIV 
infection or AIDS (Tables 15a/b–18a/b and 21–24), 
the age-group assignment is based on the person’s age 
as of December 31, 2007. In Tables 11a/b and 12a/b, 
which concern deaths of persons with a diagnosis of 
HIV infection or AIDS, age-group assignment is 
determined by the person’s age at the time of death. 
For all other tables, the age designation (for example, 
“adults and adolescents”) or the specific age-group 
assignment (for example, 20–24 years) is based on the 
person’s age at the time of diagnosis (HIV infection 
or AIDS).
Race and Ethnicity
In the Federal Register for October 30, 1997 [4], the 
Office of Management and Budget (OMB) announced al Notes 13
the Revisions to the Standards for the Classification 
of Federal Data on Race and Ethnicity. Implementa-
tion by January 1, 2003, was mandated. At a mini-
mum, data on the following racial categories should 
be collected:
• American Indian or Alaska Native
• Asian
• black or African American
• Native Hawaiian or Other Pacific Islander
• white
Additionally, systems must be able to retain infor-
mation when multiple racial categories are reported. 
In addition to data on race, data on 2 categories of eth-
nicity should be collected:
• Hispanic or Latino
• not Hispanic or Latino
The Asian or Pacific Islander category displayed in 
previous surveillance reports has been split into 2 cate-
gories: (1) Asian and (2) Native Hawaiian or other 
Pacific Islander. The Asian category (in tables where 
footnoted) includes the cases in Asians/Pacific Island-
ers (referred to as legacy cases) that were reported 
before the implementation of the new racial categories
in 2003 (e.g., cases of HIV infection that were diag-
nosed and reported to CDC before 2003 but that pro-
gressed to AIDS after 2003) and a small percentage of 
cases that were reported after 2003 but that were 
reported according to the old racial category (Asian/
Pacific Islander). In tables of diagnoses of HIV infec-
tion during 2005–2008, the Asian category does not 
include Asian/Pacific Islander cases because these 
cases were diagnosed after 2003 and were reported to 
CDC in accordance with OMB’s Revisions to the 
Standards for the Classification of Federal Data on 
Race and Ethnicity [4].
This report is the first annual report of HIV infection 
and AIDS surveillance data in which we present data 
for persons who reported multiple racial categories. 
Persons whose race was unknown are included in the 
total numbers in Tables 1a/b–6a/b and 10a/b–18a/b. 
The number of persons reported in each race category 
may include persons whose ethnicity was not reported. 
In this report, persons categorized by race were not 
Hispanic or Latino.
 
14 TechnicGeographic Designations
The areas of residence included in the report are 
defined as follows:
Northeast: Connecticut, Maine, Massachusetts, 
New Hampshire, New Jersey, New York, Pennsylvania, 
Rhode Island, and Vermont
Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, 
Minnesota, Missouri, Nebraska, North Dakota, Ohio, 
South Dakota, and Wisconsin
South: Alabama, Arkansas, Delaware, District of 
Columbia, Florida, Georgia, Kentucky, Louisiana, 
Maryland, Mississippi, North Carolina, Oklahoma, 
South Carolina, Tennessee, Texas, Virginia, and West 
Virginia
West: Alaska, Arizona, California, Colorado, 
Hawaii, Idaho, Montana, Nevada, New Mexico, 
Oregon, Utah, Washington, and Wyoming
U.S. dependent areas: American Samoa, Guam, 
the Northern Mariana Islands, Puerto Rico, and the 
U.S. Virgin Islands
Metropolitan Statistical Areas
In the Federal Register for December 27, 2000, the 
OMB published revised standards for defining MSAs 
in federal statistical activities [5]. These standards, 
which provided for the identification of MSAs in the 
United States and Puerto Rico, replaced the 1990 stan-
dards. The adoption of the new standards was effective 
as of December 27, 2000. On June 6, 2003, the OMB 
announced new MSA definitions based on the new 
standards and Census 2000 data [6]. Tables 23 (HIV 
diagnosis data) and 24 (AIDS data) present numbers 
and rates of diagnoses, by MSA, for areas with popula-
tions of more than 500,000. The MSAs listed in Tables 
23 and 24 are defined according to the OMB’s most 
recent update (November 2008) of statistical areas [7].
Transmission Categories
Transmission category is the term for the classifica-
tion of cases that summarizes a person’s possible HIV 
risk factors; the summary classification results from 
selecting, from the presumed hierarchical order of 
probability, the one risk factor most likely to have 
been responsible for transmission. For surveillance 
purposes, a diagnosis of HIV infection or AIDS is 
counted only once in the hierarchy of transmission cat-
egories. Persons with more than one reported risk fac-
tor for HIV infection are classified in the transmission 
category listed first in the hierarchy. The exception is al Notes
men who report sexual contact with other men and 
injection drug use; this group makes up a separate 
transmission category.
Persons whose transmission category is classified as 
male-to-male sexual contact include men who report 
sexual contact with other men (i.e., homosexual con-
tact) and men who report sexual contact with both men 
and women (i.e., bisexual contact). Persons whose 
transmission category is classified as heterosexual 
contact are persons who report specific heterosexual 
contact with a person known to have, or to be at high 
risk for, HIV infection (e.g., an injection drug user). 
The term high-risk has been removed from the cate-
gory formerly labeled “high-risk heterosexual con-
tact.” The table footnote regarding this category has 
not been changed because it clarifies how the data are 
defined: “Heterosexual contact with a person known 
to have, or to be at high risk for, HIV infection.”
Adults and adolescents born in, or who had sex with 
someone born in, a country where heterosexual trans-
mission was believed to be the predominant mode of 
HIV transmission (formerly classified as Pattern II 
countries by the World Health Organization) are no lon-
ger classified as having heterosexually acquired HIV 
infection unless they meet the criteria stated in the pre-
ceding paragraph. Similar to other cases in persons who 
were reported without information about a behavioral or 
a transfusion risk factor for HIV infection, these cases 
are classified (in the absence of other risk factor infor-
mation that would classify them in another transmission 
category) as “no risk factor reported or identified” [8]. 
Cases in children whose mother was born in, or whose 
mother had sex with someone born in, a Pattern II coun-
try are now classified (in the absence of other risk factor 
information that would classify them in another trans-
mission category) as “mother with documented HIV 
infection, a risk factor for HIV infection, or HIV infec-
tion without a specified risk factor.”
Cases in persons with no reported exposure to HIV 
through any of the routes listed in the hierarchy of 
transmission categories are classified as “no risk fac-
tor reported or identified.” No identified risk factor 
(NIR) cases include cases that have been followed up 
by local health department officials; cases in persons 
whose exposure history is missing because they died, 
declined to be interviewed, or were lost to follow-up; 
and cases in persons who were interviewed or for 
whom other follow-up information was available but 
for whom no mode of exposure was identified.TechnicBecause a substantial proportion of cases of HIV 
infection and AIDS are reported to CDC without an 
identified risk factor, multiple imputation is used to 
assign a risk factor for these cases [9]. Multiple impu-
tation is a statistical approach in which each missing 
risk factor is replaced with a set of plausible values that 
represent the uncertainty about the true, but missing, 
value [10]. The plausible values are analyzed by using 
standard procedures, and the results from these analy-
ses are then combined to produce the final results. In 
this report, multiple imputation has been used in tables 
showing estimated values for diagnoses among adults 
and adolescents, but not in tables concerning diagnoses 
among children (because the number of cases in chil-
dren is small, missing risk factors were not imputed).
Reporting Delays
Reporting delays (time between diagnosis or death and 
the reporting of diagnosis or death to CDC) may differ 
among demographic and geographic categories; for 
some, delays in reporting have been as long as several 
years. The statistical adjustment of the data on diagno-
ses and deaths is based on estimates of reporting-delay 
distributions, which are calculated by using a modified 
semiparametric life-table statistical procedure. This 
procedure takes into account differences in reporting 
delays due to sex, race/ethnicity, and HIV transmis-
sion categories; reporting city, state, or territory; geo-
graphic region; the size of the MSA; and the type of 
facility where the diagnosis was made or death 
occurred. In addition, the method used in this report 
takes into account, for the first time, changes in the 
patterns of reporting delays over time as well as 
reporting delays of more than 5 years [3].
Rates
Rates per 100,000 population were calculated for the 
numbers of diagnoses of HIV infection and AIDS, the 
deaths of persons with a diagnosis of HIV infection or 
AIDS, and persons living with a diagnosis of HIV 
infection or AIDS. The population denominators used 
to compute these rates for the 50 states, the District of 
Columbia, and Puerto Rico were based on official 
postcensus estimates for 2008 from the U.S. Census 
Bureau [11]. The population denominators for 
American Samoa, Guam, the Northern Mariana 
Islands, and the U.S. Virgin Islands were based on 
estimates and projections from the U.S. Census 
Bureau’s International Database [12]. Each rate was al Notes 15
calculated by dividing the total number of estimated 
diagnoses (or deaths, or persons living with a diagno-
sis of HIV infection or AIDS) for the calendar year by 
the population for that calendar year and then multi-
plying the number by 100,000. The denominators used 
for calculating age-, sex-, and race/ethnicity-specific 
rates were computed by applying the age, sex, and 
race/ethnicity estimates from the 2008 postcensus 
Census file for the 50 states, the District of Columbia, 
and Puerto Rico. When population denominators for 
the U.S. dependent areas were not available, propor-
tions from the U.S. Census Bureau’s International 
Database were used to estimate the age- and sex-
specific subpopulations [13].
CDC currently does not provide subpopulation 
rates by race/ethnicity for the 5 U.S. dependent areas 
because the U.S. Census Bureau does not collect 
information from all U.S. dependent areas. Similarly, 
rates for transmission categories are not provided 
because of the absence of denominator data (i.e., the 
denominator data used in this report come from the 
U.S. Census Bureau, but the U.S. Census Bureau does 
not collect data on transmission categories).
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07 2008
stimateda
No.
Estimateda
o. Rate No. Rate
180 0.5 150 182 0.5
34 0.6 26 31 0.5
712 11.5 1,559 1,870 12.6
778 32.9 4,499 5,427 37.2
478 37.3 4,690 5,646 37.9
859 36.0 4,216 5,096 37.4
764 39.4 4,483 5,418 37.1
125 40.1 4,792 5,788 38.7
893 30.7 4,146 5,023 31.5
267 22.3 2,694 3,254 21.7
775 13.9 1,565 1,883 14.5 
872 8.5 775 935 8.8 
743 2.8 593 716 2.6 
204 11.2 181 220 11.9 
430 7.2 362 444 7.2 
147 70.5 17,517 21,289 73.7 
278 26.4 5,897 7,121 25.0 
39 27.8 27 33 22.8 
962 8.3 9,886 11,778 8.2 
418 15.9 318 384 14.1 
425 — 13,775 22,469 —
844 — 976 2,539 —
218 — 600 1,141 —
343 — 2,016 4,496 —
84 — 8,129 110 —
914 35.3 25,496 30,755 35.9 
D
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able 1a. Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2005–2008—37 states with
reporting   
2005 2006 20
No.
Estimateda
No.
Estimateda
No.
E
No. Rate No. Rate N
Age at diagnosis (yr)
<13 201 215 0.6 164 179 0.5 160
13–14 39 42 0.7 43 47 0.8 30
15–19 1,184 1,267 8.7 1,321 1,440 9.8 1,523 1,
20–24 3,795 4,059 27.9 3,937 4,301 29.6 4,241 4,
25–29 4,494 4,814 34.8 4,531 4,953 34.6 4,858 5,
30–34 4,904 5,258 38.1 4,323 4,723 34.9 4,312 4,
35–39 5,732 6,148 42.6 5,232 5,717 39.3 5,111 5,
40–44 5,750 6,162 38.9 5,531 6,051 38.8 5,430 6,
45–49 4,176 4,476 28.7 4,042 4,412 27.8 4,339 4,
50–54 2,630 2,819 20.3 2,619 2,866 20.1 2,898 3,
55–59 1,488 1,594 13.1 1,368 1,493 11.7 1,575 1,
60–64 705 756 8.2 660 723 7.7 771 
65 629 675 2.6 579 631 2.4 659 
Race/ethnicity
American Indian/Alaska Native 170 183 10.3 153 168 9.4 182 
Asian 314 340 6.1 301 332 5.7 374 
Black/African American 17,799 19,037 68.2 17,269 18,839 66.8 17,856 20,
Hispanic/Latinob 6,282 6,772 26.6 6,168 6,793 25.6 6,417 7,
Native Hawaiian/Other Pacific Islander 42 45 34.8 40 43 32.0 35 
White 10,674 11,428 8.0 10,099 11,010 7.7 10,677 11,
Multiple races 446 481 19.7 320 351 13.9 366 
Transmission category
Male adult or adolescent
Male-to-male sexual contact 14,140 19,174 — 13,880 19,231 — 14,481 21,
Injection drug use 1,782 3,092 — 1,510 2,784 — 1,411 2,
Male-to-male sexual contact and injection drug use 1,006 1,419 — 852 1,255 — 742 1,
Heterosexual contactc 2,377 4,064 — 2,317 4,051 — 2,192 4,
Otherd 6,700 125 — 6,557 130 — 7,701 
Subtotal 26,005 27,875 33.7 25,116 27,451 32.8 26,527 29,
18
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2008
mateda
No.
Estimateda
Rate No. Rate
 — 606 1,571 —
 — 3,321 8,684 —
 — 4,615 77 —
 11.7 8,542 10,332 11.5 
 — 118 141 —
 — 32 41 —
 0.5 150 182 0.5 
 19.2 34,188 41,269 19.4 
uary 2005.
e reporting. Rates are per 100,000 population. 
ot sum to the column total. Table 1a. Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2005–2008—37 states with co
reporting (cont) 
2005 2006 2007
No.
Estimateda
No.
Estimateda
No.
Esti
No. Rate No. Rate No.
Female adult or adolescent
Injection drug use 988 1,883 — 820 1,675 — 725 1,634
Heterosexual contactc 4,376 8,201 — 4,012 8,140 — 3,859 8,657
Otherd 4,157 111 — 4,238 90 — 4,636 93
Subtotal 9,521 10,196 11.7 9,070 9,905 11.3 9,220 10,385
 Child (<13 yrs at diagnosis)
Perinatal 172 184 — 135 148 — 135 151
Othere 29 32 — 29 32 — 25 29
Subtotal 201 215 0.6 164 179 0.5 160 180
Totalf 35,727 38,286 18.6 34,350 37,536 18.0 35,907 40,478
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least Jan
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplet
Rates are not calculated by transmission category because of the lack of denominator data.
b Hispanics/Latinos can be of any race.
c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
f Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may n
5 U.S. dependent areas with confidential 
07 2008
stimateda
No.
Estimateda
o. Rate No. Rate
192 0.5 150 182 0.5
35 0.6 27 33 0.6
741 11.5 1,578 1,895 12.4 
883 32.9 4,569 5,518 37.0 
630 37.5 4,797 5,784 38.0 
000 36.3 4,318 5,228 37.6 
921 39.6 4,607 5,578 37.5 
299 40.5 4,955 6,000 39.4 
061 31.2 4,268 5,182 31.9 
377 22.6 2,775 3,358 22.0 
831 14.0 1,610 1,942 14.6 
910 8.7 810 981 9.0 
782 2.9 627 760 2.7
204 — 181 220 —
434 — 362 444 — 
179 — 17,534 21,312 — 
420 — 6,777 8,260 — 
42 — 29 36 — 
965 — 9,890 11,783 — 
418 — 318 384 — 
,711 — 14,004 22,810 —
142 — 1,151 2,825 —
251 — 620 1,173 —
535 — 2,130 4,677 —
84 — 8,239 111 —
724 35.5 26,144 31,595 36.2
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Table 1b. Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2005–2008—37 states and 
name-based HIV infection reporting   
2005 2006 20
No.
Estimateda
No.
Estimateda
No.
E
No. Rate No. Rate N
Age at diagnosis (yr)
<13 202 217 0.6 169 185 0.5 170
13–14 41 44 0.7 46 50 0.8 31
15–19 1,213 1,299 8.7 1,343 1,465 9.7 1,548 1,
20–24 3,893 4,167 28.0 4,005 4,377 29.5 4,332 4,
25–29 4,646 4,981 35.2 4,680 5,120 35.0 4,990 5,
30–34 5,064 5,433 38.5 4,483 4,902 35.5 4,434 5,
35–39 5,926 6,361 43.2 5,412 5,919 39.8 5,246 5,
40–44 5,945 6,376 39.5 5,692 6,231 39.3 5,580 6,
45–49 4,321 4,635 29.2 4,182 4,569 28.3 4,484 5,
50–54 2,743 2,943 20.8 2,734 2,995 20.6 2,992 3,
55–59 1,572 1,686 13.6 1,425 1,557 12.0 1,623 1,
60–64 745 800 8.5 689 756 7.8 804 
65 676 727 2.8 620 677 2.5 692 
Race/ethnicity
American Indian/Alaska Native 170 183 — 153 168 — 182 
Asian 315 341 — 303 334 — 377
Black/African American 17,817 19,057 — 17,291 18,864 — 17,883 20,
Hispanic/Latinob 7,520 8,130 — 7,272 8,030 — 7,402 8,
Native Hawaiian/Other Pacific Islander 43 46 — 41 44 — 37
White 10,676 11,430 — 10,100 11,011 — 10,679 11,
Multiple races 446 481 — 320 351 — 366 
Transmission category
Male adult or adolescent
Male-to-male sexual contact 14,357 19,449 — 14,080 19,497 — 14,677 21
Injection drug use 2,112 3,503 — 1,769 3,133 — 1,602 3,
Male-to-male sexual contact and injection drug use 1,044 1,468 — 880 1,291 — 764 1,
Heterosexual contactc 2,564 4,300 — 2,489 4,281 — 2,311 4,
Otherd 6,814 127 — 6,686 131 — 7,871 
Subtotal 26,891 28,846 34.2 25,904 28,334 33.2 27,225 30,
20
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2008
mateda
No.
Estimateda
Rate No. Rate
 — 635 1,619 —
 — 3,488 8,963 —
 — 4,674 80 —
 11.8 8,797 10,662 11.6 
 — 118 141 —
— 32 41 —
0.5 150 182 0.5 
19.4 35,091 42,439 19.5
uary 2005.
e reporting. Rates are per 100,000 population. 
ion category because of the lack of denominator 
ot sum to the column total. Table 1b. Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2005–2008—37 states and 5 U
name-based HIV infection reporting (cont) 
2005 2006 2007
No.
Estimateda
No.
Estimateda
No.
Esti
No. Rate No. Rate No.
Female adult or adolescent
Injection drug use 1,056 1,970 — 885 1,758 — 761 1,688
Heterosexual contactc 4,611 8,521 — 4,225 8,435 — 4,063 8,964
Otherd 4,227 113 — 4,297 90 — 4,707 94
Subtotal 9,894 10,605 11.9 9,407 10,283 11.5 9,531 10,746
 Child (<13 yrs at diagnosis)
Perinatal 173 185 — 139 152 — 140 157
Othere 29 32 — 30 33 — 30 35
Subtotal 202 217 0.6 169 185 0.5 170 192
Totalf 36,987 39,668 18.8 35,480 38,803 18.2 36,926 41,661
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least Jan
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplet
Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas. Rates are not calculated by transmiss
data.
b Hispanics/Latinos can be of any race.
c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
f Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may n
tates   
2008
CumulativebEstimateda
No. Rate No. Est. No.a
41 0.1 9,270 9,349 
48 0.6 1,179 1,220 
497 2.3 6,407 6,685 
1,976 9.4 39,498 40,735 
3,616 16.9 123,139 125,755 
4,461 22.8 205,658 209,554 
5,719 27.2 224,034 229,111 
6,683 31.1 182,192 187,421 
5,920 25.9 117,002 121,111 
3,946 18.4 66,034 68,560 
2,242 12.1 35,633 36,987 
1,140 7.5 18,999 19,669 
862 2.2 16,412 16,972 
199 8.5 3,629 3,741 
525 4.0 7,891 8,253 
18,328 49.3 439,415 452,916 
7,043 15.0 174,819 180,061 
51 11.8 799 830 
10,570 5.3 411,756 419,905 
435 9.8 6,784 7,054 
17,758 — 458,731 513,138 
3,555 — 157,879 183,052 
1,704 — 67,811 74,155 
4,301 — 53,124 68,546 
225 — 93,595 13,083 
27,543 22.4 831,140 851,974 
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Table 2a. AIDS diagnoses, by year of diagnosis and selected characteristics, 2005–2008 and cumulative—United S
2005 2006 2007
No.
Estimateda
No.
Estimateda
No.
Estimateda
No.No. Rate No. Rate No. Rate
Age at diagnosis (yr)
<13 52 55 0.1 37 40 0.1 27 30 0.1 31 
13–14 69 73 0.9 69 75 0.9 66 73 0.9 40
15–19 397 420 2.0 367 398 1.9 395 447 2.1 397 
20–24 1,627 1,719 8.2 1,523 1,647 7.9 1,709 1,935 9.2 1,563 
25–29 2,998 3,166 15.9 3,118 3,368 16.4 3,021 3,423 16.3 2,856 
30–34 4,535 4,789 24.0 3,989 4,319 22.1 3,719 4,214 21.7 3,543 
35–39 6,242 6,591 31.5 5,812 6,295 29.9 5,201 5,899 27.9 4,525 
40–44 7,132 7,537 33.1 6,674 7,225 32.2 6,050 6,857 31.2 5,276 
45–49 5,535 5,847 26.0 5,168 5,599 24.6 5,187 5,882 25.7 4,639 
50–54 3,382 3,574 17.9 3,369 3,645 17.8 3,263 3,680 17.5 3,102 
55–59 1,810 1,911 11.0 1,877 2,028 11.1 1,837 2,075 11.4 1,782 
60–64 828 873 6.7 891 964 7.2 888 999 6.9 912 
65 696 734 2.0 778 839 2.3 725 818 2.2 680 
Race/ethnicity
American Indian/Alaska 
Native
166 174 7.8 144 156 6.9 141 156 6.8 163 
Asianc 374 398 3.3 402 443 3.5 417 488 3.8 401 
Black/African American 17,260 18,262 50.6 16,257 17,594 48.3 15,657 17,718 48.1 14,474 
Hispanic/Latinod 6,692 7,066 16.6 6,494 7,044 16.0 6,167 7,023 15.4 5,473 
Native Hawaiian/Other 
Pacific Islander
47 50 12.1 50 54 12.9 51 58 13.6 41 
White 10,333 10,886 5.5 9,895 10,688 5.4 9,229 10,413 5.2 8,441 
Multiple races 431 455 11.3 430 463 11.1 426 477 11.1 353 
Transmission category
Male adult or adolescent
Male-to-male sexual 
contact
13,225 16,824 — 12,693 16,696 — 12,157 16,992 — 10,946 
Injection drug use 3,114 4,350 — 2,672 3,921 — 2,326 3,708 — 1,869 
Male-to-male sexual 
contact and injection 
drug use
1,707 2,085 — 1,480 1,889 — 1,271 1,759 — 1,091 
Heterosexual contacte 2,744 3,920 — 2,773 4,005 — 2,472 3,961 — 2,401 
Otherf 5,177 256 — 5,050 231 — 5,214 199 — 5,371 
Subtotal 25,967 27,436 23.1 24,668 26,741 22.2 23,440 26,619 21.9 21,678 
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2008
CumulativebEstimateda
No. Rate No. Est. No.a
2,256 — 68,987 84,339 
7,112 — 91,341 120,039 
199 — 44,718 7,426 
9,567 7.5 205,046 211,804 
34 — 8,504 8,577 
6 — 766 773 
41 0.1 9,270 9,349 
8,386 15.3 320,394 328,748 
4,251 6.4 108,178 111,137 
17,471 15.6 404,732 414,914 
7,042 9.9 212,153 218,331 
37,151 12.2 1,045,457i 1,073,128 
e reporting. Rates are per 100,000 population. 
ot sum to the column total.
 
Table 2a. AIDS diagnoses, by year of diagnosis and selected characteristics, 2005–2008 and cumulative—United Stat
2005 2006 2007
No.
Estimateda
No.
Estimateda
No.
Estimateda
No.No. Rate No. Rate No. Rate
Female adult or 
adolescent
Injection drug use 1,803 2,724 — 1,509 2,406 — 1,387 2,384 — 1,099 
Heterosexual contacte 4,452 6,856 — 4,442 7,029 — 4,141 7,069 — 3,523 
Otherf 3,029 219 — 3,016 226 — 3,092 230 — 3,015 
Subtotal 9,284 9,799 7.9 8,967 9,661 7.7 8,620 9,683 7.6 7,637 
Child (<13 yrs at 
diagnosis)
Perinatal 47 50 — 34 37 — 25 28 — 27 
Otherg 5 5 — 3 3 — 2 2 — 4
Subtotal 52 55 0.1 37 40 0.1 27 30 0.1 31 
Region of residence
Northeast 8,756 9,323 17.1 8,445 9,168 16.8 7,881 9,011 16.5 6,233 
Midwest 4,185 4,427 6.7 3,818 4,126 6.2 3,539 3,993 6.0 3,395 
South 16,406 17,204 16.0 15,623 16,711 15.4 15,164 16,781 15.2 14,648 
West 5,956 6,336 9.3 5,786 6,436 9.3 5,504 6,548 9.4 5,070 
Totalh 35,303 37,290 12.6 33,672 36,442 12.2 32,088 36,333 12.1 29,346 
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplet
Rates are not calculated by transmission category because of the lack of denominator data.
b From the beginning of the epidemic through 2008.
c Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d Hispanics/Latinos can be of any race.
e Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
g Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
h Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may n
i Includes persons of unknown race/ethnicity.
tates and 5 U.S. dependent areas   
2008
CumulativebEstimateda
No. Rate No. Est. No.a
41 0.1 9,694 9,776 
48 0.6 1,233 1,275 
507 2.3 6,614 6,899 
1,997 9.3 40,794 42,052 
3,669 16.9 127,135 129,811 
4,569 23.0 212,211 216,213 
5,849 27.5 230,821 236,037 
6,836 31.4 187,494 192,865 
6,070 26.2 120,365 124,582 
4,051 18.6 67,964 70,564 
2,286 12.1 36,793 38,185 
1,167 7.6 19,649 20,340 
900 2.3 17,205 17,790 
199 — 3,631 3,743 
527 — 7,952 8,315 
18,341 — 439,862 453,369 
7,864 — 206,685 212,665 
55 — 808 840 
10,571 — 411,874 420,024 
435 — 6,788 7,058 
17,940 — 463,999 518,618 
3,818 — 170,414 196,068 
1,729 — 70,190 76,584 
4,420 — 56,538 72,146 
230 — 94,181 13,270 
28,137 22.6 855,322 876,687 
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Table 2b. AIDS diagnoses, by year of diagnosis and selected characteristics, 2005–2008 and cumulative—United S
2005 2006 2007
No.
Estimateda
No.
Estimateda
No.
Estimateda
No.No. Rate No. Rate No. Rate
Age at diagnosis (yr)
<13 52 55 0.1 39 42 0.1 27 30 0.1 31 
13–14 72 76 0.9 71 77 0.9 66 73 0.9 40
15–19 407 431 2.0 377 409 1.9 403 456 2.1 405 
20–24 1,654 1,747 8.2 1,543 1,669 7.9 1,732 1,961 9.2 1,579 
25–29 3,068 3,240 16.1 3,173 3,428 16.5 3,079 3,491 16.4 2,898 
30–34 4,667 4,929 24.3 4,077 4,414 22.3 3,794 4,299 21.8 3,626 
35–39 6,391 6,750 31.8 5,939 6,433 30.1 5,318 6,032 28.2 4,622 
40–44 7,315 7,731 33.5 6,823 7,387 32.5 6,193 7,022 31.5 5,393 
45–49 5,667 5,988 26.3 5,290 5,731 24.9 5,304 6,015 26.0 4,755 
50–54 3,472 3,669 18.1 3,473 3,758 18.1 3,347 3,775 17.7 3,182 
55–59 1,880 1,985 11.3 1,925 2,080 11.3 1,878 2,122 11.5 1,817 
60–64 856 903 6.8 915 990 7.3 922 1,037 7.1 933 
65 732 773 2.1 813 877 2.3 746 842 2.2 710 
Race/ethnicity
American Indian/Alaska 
Native
166 174 — 144 156 — 141 156 — 163 
Asianc 374 398 — 402 443 — 417 488 — 403
Black/African American 17,270 18,272 — 16,277 17,614 — 15,678 17,740 — 14,485 
Hispanic/Latinod 7,610 8,040 — 7,259 7,876 — 6,865 7,819 — 6,101 
Native Hawaiian/Other 
Pacific Islander
49 52 — 50 54 — 53 60 — 44
White 10,333 10,886 — 9,896 10,689 — 9,229 10,413 — 8,442 
Multiple races 431 455 — 430 463 — 426 477 — 353 
Transmission category
Male adult or adolescent
Male-to-male sexual 
contact
13,381 16,997 — 12,818 16,837 — 12,285 17,147 — 11,071 
Injection drug use 3,414 4,682 — 2,907 4,186 — 2,526 3,959 — 2,049 
Male-to-male sexual 
contact and injection 
drug use
1,743 2,125 — 1,513 1,925 — 1,306 1,800 — 1,108 
Heterosexual contacte 2,878 4,071 — 2,882 4,131 — 2,569 4,084 — 2,481 
Otherf 5,211 261 — 5,079 239 — 5,257 201 — 5,424 
Subtotal 26,627 28,136 23.4 25,199 27,318 22.4 23,943 27,191 22.1 22,133 
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2008
CumulativebEstimateda
No. Rate No. Est. No.a
2,311 — 71,792 87,258 
7,303 — 96,131 125,090 
199 — 45,032 7,578 
9,813 7.5 212,955 219,927 
34 — 8,905 8,980 
6 — 789 796 
41 0.1 9,694 9,776 
8,386 15.3 320,394 328,748 
4,251 6.4 108,178 111,137 
17,471 15.6 404,732 414,914 
7,042 9.9 212,153 218,331 
840 19.3 32,515 33,262
37,991 12.3 1,077,972i 1,106,391
e reporting. Rates are per 100,000 population. 
ion category because of the lack of denominator 
ot sum to the column total. Table 2b. AIDS diagnoses, by year of diagnosis and selected characteristics, 2005–2008 and cumulative—United Stat
2005 2006 2007
No.
Estimateda
No.
Estimateda
No.
Estimateda
No.No. Rate No. Rate No. Rate
Female adult or 
adolescent
Injection drug use 1,867 2,797 — 1,579 2,485 — 1,437 2,443 — 1,135 
Heterosexual contacte 4,638 7,066 — 4,604 7,219 — 4,294 7,255 — 3,656 
Otherf 3,049 224 — 3,037 232 — 3,107 233 — 3,036 
Subtotal 9,554 10,086 8.0 9,220 9,936 7.8 8,838 9,931 7.7 7,827 
 Child (<13 yrs at 
diagnosis)
Perinatal 47 50 — 36 39 — 25 28 — 27 
Otherg 5 5 — 3 3 — 2 2 — 4
Subtotal 52 55 0.1 39 42 0.1 27 30 0.1 31 
Region of residence
Northeast 8,756 9,323 17.1 8,445 9,168 16.8 7,881 9,011 16.5 6,233 
Midwest 4,185 4,427 6.7 3,818 4,126 6.2 3,539 3,993 6.0 3,395 
South 16,406 17,204 16.0 15,623 16,711 15.4 15,164 16,781 15.2 14,648 
West 5,956 6,336 9.3 5,786 6,436 9.3 5,504 6,548 9.4 5,070 
U.S. dependent areas 930 987 22.8 786 854 19.7 721 820 18.9 645
Totalh 36,233 38,277 12.8 34,458 37,296 12.3 32,809 37,154 12.2 29,991
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplet
Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas. Rates are not calculated by transmiss
data.
b From the beginning of the epidemic through 2008.
c Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d Hispanics/Latinos can be of any race.
e Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
g Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
h Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may n
i Includes persons of unknown race/ethnicity.
Table 3a. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2008—37 states with confidential 
name-based HIV infection reporting  
No.
Estimateda
No. Rate
American Indian/Alaska Native
Age at diagnosis (yr)
<13 1 1 0.3
13–14 0 0 0.0
15–19 3 3 2.1
20–24 23 27 17.1
25–29 32 41 27.9
30–34 24 28 23.2
35–39 25 30 25.0
40–44 27 33 26.8
45–49 24 30 23.0
50–54 12 14 11.7
55–59 5 6 5.9
60–64 2 2 3.2
65 3 5 3.1
Transmission category
Male adult or adolescent
Male-to-male sexual contact 85 128 —
Injection drug use 8 12 —
Male-to-male sexual contact and injection drug use 6 12 —
Heterosexual contactb 9 15 —
Otherc 30 0 —
Subtotal 138 167 23.4
Female adult or adolescent
Injection drug use 7 14 —
Heterosexual contactb 12 35 —
Otherc 23 3 —
Subtotal 42 52 6.9
Child (<13 yrs at diagnosis)
Perinatal 1 1 —
Otherd 0 0 —
Subtotal 1 1 0.3
Totale 181 220 11.9
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Table 3a. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2008—37 states with confidential 
name-based HIV infection reporting (cont)
No.
Estimateda
No. Rate
Asian
Age at diagnosis (yr)
<13 2 2 0.2
13–14 0 0 0.0
15–19 8 10 2.6
20–24 38 46 12.1
25–29 49 61 11.9
30–34 79 95 15.9
35–39 73 89 14.3
40–44 43 53 10.1
45–49 25 32 6.9
50–54 23 29 7.1
55–59 10 12 3.6
60–64 7 8 3.4
65 5 7 1.4
Transmission category
Male adult or adolescent
Male-to-male sexual contact 156 295 —
Injection drug use 7 16 —
Male-to-male sexual contact and injection drug use 5 10 —
Heterosexual contactb 21 40 —
Otherc 107 2 —
Subtotal 296 363 14.8
Female adult or adolescent
Injection drug use 0 4 —
Heterosexual contactb 29 72 —
Otherc 35 3 —
Subtotal 64 78 3.0
Child (<13 yrs at diagnosis)
Perinatal 2 2 —
Otherd 0 0 —
Subtotal 2 2 0.2
Totale 362 444 7.2
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Table 3a. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2008—37 states with confidential 
name-based HIV infection reporting (cont)
No.
Estimateda
No. Rate
Black/African American
Age at diagnosis (yr)
<13 101 121 2.1
13–14 19 23 2.4
15–19 1,169 1,402 55.0
20–24 2,744 3,315 141.4
25–29 2,388 2,886 127.4
30–34 2,008 2,447 126.3
35–39 2,013 2,456 121.9
40–44 2,163 2,646 129.3
45–49 1,971 2,415 115.7
50–54 1,394 1,700 90.6
55–59 836 1,009 66.4
60–64 398 485 45.0
65 313 382 15.5
Transmission category
Male adult or adolescent
Male-to-male sexual contact 5,132 9,133 —
Injection drug use 404 1,425 —
Male-to-male sexual contact and injection drug use 137 426 —
Heterosexual contactb 1,313 3,236 —
Otherc 4,733 46 —
Subtotal 11,719 14,266 131.9
Female adult or adolescent
Injection drug use 244 878 —
Heterosexual contactb 2,120 5,984 —
Otherc 3,333 40 —
Subtotal 5,697 6,902 56.0
Child (<13 yrs at diagnosis)
Perinatal 74 88 —
Otherd 27 33 —
Subtotal 101 121 2.1
Totale 17,517 21,289 73.7
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Table 3a. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2008—37 states with confidential 
name-based HIV infection reporting (cont)
No.
Estimateda
No. Rate
Hispanic/Latinof
Age at diagnosis (yr)
<13 18 22 0.3
13–14 5 6 0.7
15–19 195 238 10.7
20–24 750 909 42.1
25–29 936 1,132 45.1
30–34 958 1,154 46.7
35–39 875 1,053 46.5
40–44 821 985 49.3
45–49 612 735 42.8
50–54 374 456 33.8
55–59 171 210 20.3
60–64 111 134 17.3
65 71 85 4.9
Transmission category
Male adult or adolescent
Male-to-male sexual contact 2,650 4,201 —
Injection drug use 256 605 —
Male-to-male sexual contact and injection drug use 117 212 —
Heterosexual contactb 399 708 —
Otherc 1,345 17 —
Subtotal 4,767 5,742 52.3
Female adult or adolescent
Injection drug use 93 214 —
Heterosexual contactb 492 1,133 —
Otherc 527 10 —
Subtotal 1,112 1,357 13.3
Child (<13 yrs at diagnosis)
Perinatal 17 21 —
Otherd 1 2 —
Subtotal 18 22 0.3
Totale 5,897 7,121 25.0
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Table 3a. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2008—37 states with confidential 
name-based HIV infection reporting (cont)
No.
Estimateda
No. Rate
Native Hawaiian/Other Pacific Islander
Age at diagnosis (yr)
<13 0 0 0.0
13–14 0 0 0.0
15–19 0 0 0.0
20–24 3 3 29.6
25–29 2 3 23.3
30–34 5 6 42.0
35–39 3 4 31.0
40–44 9 11 111.8
45–49 3 4 39.7
50–54 2 2 30.2
55–59 0 0 0.0
60–64 0 0 0.0
65 0 0 0.0
Transmission category
Male adult or adolescent
Male-to-male sexual contact 16 24 —
Injection drug use 1 1 —
Male-to-male sexual contact and injection drug use 0 0 —
Heterosexual contactb 1 2 —
Otherc 4 0 —
Subtotal 22 27 48.2
Female adult or adolescent
Injection drug use 1 2 —
Heterosexual contactb 2 4 —
Otherc 2 0 —
Subtotal 5 6 10.6
Child (<13 yrs at diagnosis)
Perinatal 0 0 —
Otherd 0 0 —
Subtotal 0 0 0.0
Totale 27 33 22.8
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Table 3a. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2008—37 states with confidential 
name-based HIV infection reporting (cont)
No.
Estimateda
No. Rate
White
Age at diagnosis (yr)
<13 25 32 0.1
13–14 1 1 0.0
15–19 170 201 2.2
20–24 902 1,080 11.6
25–29 1,230 1,460 15.7
30–34 1,098 1,312 15.7
35–39 1,458 1,741 18.5
40–44 1,678 1,996 19.7
45–49 1,480 1,768 15.5
50–54 864 1,022 9.2
55–59 533 635 6.4
60–64 250 296 3.5
65 197 232 1.0
Transmission category
Male adult or adolescent
Male-to-male sexual contact 5,601 8,478 —
Injection drug use 290 458 —
Male-to-male sexual contact and injection drug use 326 464 —
Heterosexual contactb 258 468 —
Otherc 1,851 44 —
Subtotal 8,326 9,913 16.6
Female adult or adolescent
Injection drug use 251 442 —
Heterosexual contactb 626 1,372 —
Otherc 658 19 —
Subtotal 1,535 1,833 2.9
Child (<13 yrs at diagnosis)
Perinatal 21 26 —
Otherd 4 5 —
Subtotal 25 32 0.1
Totale 9,886 11,778 8.2
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Table 3a. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2008—37 states with confidential 
name-based HIV infection reporting (cont)
No.
Estimateda
No. Rate
Multiple races
Age at diagnosis (yr)
<13 3 3 0.3
13–14 1 1 1.1
15–19 14 16 6.4
20–24 39 46 22.1
25–29 53 63 33.2
30–34 44 54 37.9
35–39 36 44 33.8
40–44 51 62 53.0
45–49 31 39 32.6
50–54 25 31 28.1
55–59 10 12 13.2
60–64 7 9 12.9
65 4 5 3.3
Transmission category
Male adult or adolescent
Male-to-male sexual contact 135 211 —
Injection drug use 10 21 —
Male-to-male sexual contact and injection drug use 9 17 —
Heterosexual contactb 15 27 —
Otherc 59 1 —
Subtotal 228 277 33.6
Female adult or adolescent
Injection drug use 10 19 —
Heterosexual contactb 40 84 —
Otherc 37 1 —
Subtotal 87 104 11.9
Child (<13 yrs at diagnosis)
Perinatal 3 3 —
Otherd 0 0 —
Subtotal 3 3 0.3
Totale 318 384 14.1
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Table 3a. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2008—37 states with confidential 
name-based HIV infection reporting (cont)
No.
Estimateda
No.g Rate
Total
Age at diagnosis (yr)
<13 150 182 0.5
13–14 26 31 0.5
15–19 1,559 1,870 12.6
20–24 4,499 5,427 37.2
25–29 4,690 5,646 37.9
30–34 4,216 5,096 37.4
35–39 4,483 5,418 37.1
40–44 4,792 5,788 38.7
45–49 4,146 5,023 31.5
50–54 2,694 3,254 21.7
55–59 1,565 1,883 14.5
60–64 775 935 8.8
65 593 716 2.6
Transmission category
Male adult or adolescent
Male-to-male sexual contact 13,775 22,469 —
Injection drug use 976 2,539 —
Male-to-male sexual contact and injection drug use 600 1,141 —
Heterosexual contactb 2,016 4,496 —
Otherc 8,129 110 —
Subtotal 25,496 30,755 35.9
Female adult or adolescent
Injection drug use 606 1,571 —
Heterosexual contactb 3,321 8,684 —
Otherc 4,615 77 —
Subtotal 8,542 10,332 11.5
Child (<13 yrs at diagnosis)
Perinatal 118 141 —
Otherd 32 41 —
Subtotal 150 182 0.5
Totale 34,188 41,269 19.4
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. 
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least 
January 2005.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete 
reporting. Rates are per 100,000 population. Rates are not calculated by transmission category because of the lack of denominator data.
b Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
c Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
d Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may 
not sum to the column total. 
f Hispanics/Latinos can be of any race.
g Because row totals were calculated independently of the values for the subpopulations, the values in each row may not sum to the row total. 
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Table 3b. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2008—37 states and 5 U.S. 
dependent areas with confidential name-based HIV infection reporting  
No. Est. No.a
American Indian/
Alaska Native
Age at diagnosis (yr)
<13 1 1
13–14 0 0
15–19 3 3
20–24 23 27
25–29 32 41
30–34 24 28
35–39 25 30
40–44 27 33
45–49 24 30
50–54 12 14
55–59 5 6
60–64 2 2
65 3 5
Transmission category
Male adult or adolescent
Male-to-male sexual contact 85 128
Injection drug use 8 12
Male-to-male sexual contact and injection drug use 6 12
Heterosexual contactb 9 15
Otherc 30 0
Subtotal 138 167
Female adult or adolescent
Injection drug use 7 14
Heterosexual contactb 12 35
Otherc 23 3
Subtotal 42 52
Child (<13 yrs at diagnosis)
Perinatal 1 1
Otherd 0 0
Subtotal 1 1
Totale 181 220
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Table 3b. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2008—37 states and 5 U.S. 
dependent areas with confidential name-based HIV infection reporting (cont)
No. Est. No.a
Asian
Age at diagnosis (yr)
<13 2 2
13–14 0 0
15–19 8 10
20–24 38 46
25–29 49 61
30–34 79 95
35–39 73 89
40–44 43 53
45–49 25 32
50–54 23 29
55–59 10 12
60–64 7 8
65 5 7
Transmission category
Male adult or adolescent
Male-to-male sexual contact 156 295
Injection drug use 7 16
Male-to-male sexual contact and injection drug use 5 10
bHeterosexual contact 21 40
Otherc 107 2
Subtotal 296 363
Female adult or adolescent
Injection drug use 0 4
bHeterosexual contact 29 72
Otherc 35 3
Subtotal 64 78
Child (<13 yrs at diagnosis)
Perinatal 2 2
Otherd 0 0
Subtotal 2 2
Totale 362 444
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Table 3b. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2008—37 states and 5 U.S. 
dependent areas with confidential name-based HIV infection reporting (cont)
No. Est. No.a
Black/African American
Age at diagnosis (yr)
<13 101 121
13–14 19 23
15–19 1,169 1,402
20–24 2,745 3,317
25–29 2,391 2,890
30–34 2,011 2,451
35–39 2,014 2,458
40–44 2,166 2,651
45–49 1,974 2,419
50–54 1,395 1,702
55–59 837 1,010
60–64 398 485
65 314 383
Transmission category
Male adult or adolescent
Male-to-male sexual contact 5,133 9,136
Injection drug use 405 1,430
Male-to-male sexual contact and injection drug use 137 426
Heterosexual contactb 1,315 3,245
Otherc 4,742 46
Subtotal 11,732 14,283
Female adult or adolescent
Injection drug use 244 878
Heterosexual contactb 2,122 5,988
Otherc 3,335 40
Subtotal 5,701 6,907
Child (<13 yrs at diagnosis)
Perinatal 74 88
Otherd 27 33
Subtotal 101 121
Totale 17,534 21,312
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Table 3b. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2008—37 states and 5 U.S. 
dependent areas with confidential name-based HIV infection reporting (cont)
No. Est. No.a
Hispanic/Latinof
Age at diagnosis (yr)
<13 18 22
13–14 6 8
15–19 214 262
20–24 819 998
25–29 1,040 1,266
30–34 1,057 1,282
35–39 997 1,211
40–44 978 1,190
45–49 730 889
50–54 454 559
55–59 214 266
60–64 146 179
65 104 128
Transmission category
Male adult or adolescent
Male-to-male sexual contact 2,875 4,533
Injection drug use 430 885
Male-to-male sexual contact and injection drug use 137 243
Heterosexual contactb 511 880
Otherc 1,443 17
Subtotal 5,396 6,557
Female adult or adolescent
Injection drug use 122 260
Heterosexual contactb 657 1,408
Otherc 584 13
Subtotal 1,363 1,681
Child (<13 yrs at diagnosis)
Perinatal 17 21
Otherd 21
Subtotal 18 22
Totale 6,777 8,260
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Table 3b. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2008—37 states and 5 U.S. 
dependent areas with confidential name-based HIV infection reporting (cont)
No. Est. No.a
Native Hawaiian/Other 
Pacific Islander
Age at diagnosis (yr)
<13 0 0
13–14 0 0
15–19 0 0
20–24 3 3
25–29 2 3
30–34 5 6
35–39 3 4
40–44 10 13
45–49 4 5
50–54 2 2
55–59 0 0
60–64 0 0
65 0 0
Transmission category
Male adult or adolescent
Male-to-male sexual contact 16 25
Injection drug use 1 2
Male-to-male sexual contact and injection drug use 0 0
Heterosexual contactb 1 3
Otherc 6 0
Subtotal 24 30
Female adult or adolescent
Injection drug use 1 2
Heterosexual contactb 2 4
Otherc 2 0
Subtotal 5 6
Child (<13 yrs at diagnosis)
Perinatal 0 0
Otherd 0 0
Subtotal 0 0
Totale 29 36
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Table 3b. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2008—37 states and 5 U.S. 
dependent areas with confidential name-based HIV infection reporting (cont)
No. Est. No.a
White
Age at diagnosis (yr)
<13 25 32
13–14 1 1
15–19 170 201
20–24 902 1,080
25–29 1,230 1,460
30–34 1,098 1,312
35–39 1,459 1,743
40–44 1,680 1,999
45–49 1,480 1,768
50–54 864 1,022
55–59 534 636
60–64 250 296
65 197 232
Transmission category
Male adult or adolescent
Male-to-male sexual contact 5,604 8,483
Injection drug use 290 458
Male-to-male sexual contact and injection drug use 326 465
Heterosexual contactb 258 468
Otherc 1,852 44
Subtotal 8,330 9,918
Female adult or adolescent
Injection drug use 251 442
Heterosexual contactb 626 1,372
Otherc 658 19
Subtotal 1,535 1,833
Child (<13 yrs at diagnosis)
Perinatal 21 26
Otherd 4 5
Subtotal 25 32
Totale 9,890 11,783
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Table 3b. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2008—37 states and 5 U.S. 
dependent areas with confidential name-based HIV infection reporting (cont)
No. Est. No.a
Multiple races
Age at diagnosis (yr)
<13 3 3
13–14 1 1
15–19 14 16
20–24 39 46
25–29 53 63
30–34 44 54
35–39 36 44
40–44 51 62
45–49 31 39
50–54 25 31
55–59 10 12
60–64 7 9
65 4 5
Transmission category
Male adult or adolescent
Male-to-male sexual contact 135 211
Injection drug use 10 21
Male-to-male sexual contact and injection drug use 9 17
Heterosexual contactb 15 27
Otherc 59 1
Subtotal 228 277
Female adult or adolescent
Injection drug use 10 19
Heterosexual contactb 40 84
Otherc 37 1
Subtotal 87 104
Child (<13 yrs at diagnosis)
Perinatal 3 3
Otherd 0 0
Subtotal 3 3
Totale 318 384
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Table 3b. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2008—37 states and 5 U.S. 
dependent areas with confidential name-based HIV infection reporting (cont)
No. Est. No.a,g
Total
Age at diagnosis (yr)
<13 150 182
13–14 27 33
15–19 1,578 1,895
20–24 4,569 5,518
25–29 4,797 5,784
30–34 4,318 5,228
35–39 4,607 5,578
40–44 4,955 6,000
45–49 4,268 5,182
50–54 2,775 3,358
55–59 1,610 1,942
60–64 810 981
65 627 760
Transmission category
Male adult or adolescent
Male-to-male sexual contact 14,004 22,810
Injection drug use 1,151 2,825
Male-to-male sexual contact and injection drug use 620 1,173
Heterosexual contactb 2,130 4,677
Otherc 8,239 111
Subtotal 26,144 31,595
Female adult or adolescent
Injection drug use 635 1,619
Heterosexual contactb 3,488 8,963
Otherc 4,674 80
Subtotal 8,797 10,662
Child (<13 yrs at diagnosis)
Perinatal 118 141
Otherd 32 41
Subtotal 150 182
Totale 35,091 42,439
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least 
January 2005.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete 
reporting.
b Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
c Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
d Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may 
not sum to the column total.
f Hispanics/Latinos can be of any race.
g Because row totals were calculated independently of the values for the subpopulations, the values in each row may not sum to the row total.
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Table 4a. AIDS diagnoses, by race/ethnicity and selected characteristics, 2008—United States  
No.
Estimateda
No. Rate
American Indian/Alaska Native
Age at diagnosis (yr)
<13 0 0 0.0
13–14 0 0 0.0
15–19 1 1 0.5
20–24 6 7 3.2
25–29 16 22 12.0
30–34 19 22 14.6
35–39 38 45 29.4
40–44 25 30 19.0
45–49 24 28 17.0
50–54 22 25 16.6
55–59 6 9 6.8
60–64 4 5 4.8
65 2 6 2.9
Transmission category
Male adult or adolescent
Male-to-male sexual contact 70 99      —
Injection drug use 16 21      —
Male-to-male sexual contact and injection drug use 15 22      —
Heterosexual contactb 6 11      —
Otherc 21 2      —
Subtotal 128 155 17.0
Female adult or adolescent
Injection drug use 9 16      —
Heterosexual contactb 9 22      —
Otherc 17 5      —
Subtotal 35 44 4.6
Child (<13 yrs at diagnosis)
Perinatal 0 0      —
Otherd 0 0      —
Subtotal 0 0 0.0
Region of Residence
Northeast 9 13 9.7
Midwest 18 22 5.5
South 49 61 8.4
West 87 103 9.6
Totale 163 199 8.5
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Table 4a. AIDS diagnoses, by race/ethnicity and selected characteristics, 2008—United States (cont)
No.
Estimateda
No. Rate
Asianf
Age at diagnosis (yr)
<13 1 1 0.1
13–14 1 1 0.4
15–19 1 1 0.1
20–24 13 17 2.1
25–29 50 67 6.5
30–34 75 99 8.3
35–39 98 124 9.8
40–44 64 85 7.8
45–49 40 55 5.5
50–54 21 26 2.9
55–59 19 25 3.3
60–64 11 13 2.4
65 7 10 0.8
Transmission category
Male adult or adolescent
Male-to-male sexual contact 202 356   —
Injection drug use 4 9   —
Male-to-male sexual contact and injection drug use 6 10   —
Heterosexual contactb 30 47   —
Otherc 84 4   —
Subtotal 326 427 8.0
Female adult or adolescent
Injection drug use 3 10   —
Heterosexual contactb 41 78   —
Otherc 30 8   —
Subtotal 74 97 1.7
Child (<13 yrs at diagnosis)
Perinatal 1 1   —
Otherd 0 0   —
Subtotal 1 1 0.1
Region of Residence
Northeast 90 115 4.1
Midwest 29 35 2.3
South 88 104 3.8
West 194 270 4.4
Totale 401 525 4.0
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Table 4a. AIDS diagnoses, by race/ethnicity and selected characteristics, 2008—United States (cont)
No.
Estimateda
No. Rate
Black/African American
Age at diagnosis (yr)
<13 19 25 0.3
13–14 29 35 2.9
15–19 284 356 10.9
20–24 965 1,222 40.7
25–29 1,449 1,824 63.2
30–34 1,690 2,104 84.7
35–39 2,004 2,524 96.8
40–44 2,437 3,087 116.1
45–49 2,222 2,854 105.0
50–54 1,656 2,115 87.1
55–59 928 1,177 59.9
60–64 462 583 41.7
65 329 421 13.1
Transmission category
Male adult or adolescent
Male-to-male sexual contact 3,594 6,284 —
Injection drug use 958 2,030 —
Male-to-male sexual contact and injection drug use 347 624 —
bHeterosexual contact 1,520 2,913 —
Otherc 2,989 117 —
Subtotal 9,408 11,968 85.5
Female adult or adolescent
Injection drug use 581 1,350 —
bHeterosexual contact 2,338 4,861 —
Otherc 2,128 124 —
Subtotal 5,047 6,336 39.9
Child (<13 yrs at diagnosis)
Perinatal 17 22 —
Otherd 2 2 —
Subtotal 19 25 0.3
Region of Residence
Northeast 3,074 4,210 69.0
Midwest 1,715 2,166 32.1
South 8,757 10,610 50.4
West 928 1,342 41.1
Totale 14,474 18,328 49.3
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Table 4a. AIDS diagnoses, by race/ethnicity and selected characteristics, 2008—United States (cont)
No.
Estimateda
No. Rate
Hispanic/Latinog
Age at diagnosis (yr)
<13 3 4 0.0
13–14 8 9 0.6
15–19 61 76 2.0
20–24 314 408 11.1
25–29 681 886 21.4
30–34 861 1,114 27.6
35–39 948 1,223 32.8
40–44 934 1,196 36.5
45–49 760 971 34.7
50–54 429 551 25.2
55–59 235 299 18.1
60–64 141 179 14.8
65 98 129 4.8
Transmission category
Male adult or adolescent
Male-to-male sexual contact 2,270 3,779      —
Injection drug use 420 788      —
Male-to-male sexual contact and injection drug use 198 318      —
Heterosexual contactb 450 741      —
Otherc 1,042 34      —
Subtotal 4,380 5,660 31.4
Female adult or adolescent
Injection drug use 167 325      —
Heterosexual contactb 522 1,024      —
Otherc 401 30      —
Subtotal 1,090 1,379 8.2
Child (<13 yrs at diagnosis)
Perinatal 3 4      —
Otherd 0 0      —
Subtotal 3 4 0.0
Region of Residence
Northeast 1,576 2,076 32.3
Midwest 320 405 9.5
South 1,962 2,218 13.4
West 1,615 2,343 11.9
Totale 5,473 7,043 15.0
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Table 4a. AIDS diagnoses, by race/ethnicity and selected characteristics, 2008—United States (cont)
No.
Estimateda
No. Rate
Native Hawaiian/Other Pacific Islander
Age at diagnosis (yr)
<13 0 0 0.0
13–14 0 0 0.0
15–19 0 0 0.0
20–24 3 3 9.9
25–29 4 5 13.4
30–34 4 5 13.8
35–39 9 11 34.2
40–44 5 6 20.4
45–49 7 9 30.5
50–54 6 7 27.8
55–59 0 0 0.0
60–64 0 0 0.0
65 3 4 11.1
Transmission category
Male adult or adolescent
Male-to-male sexual contact 21 32      —
Injection drug use 3 4      —
Male-to-male sexual contact and injection drug use 3 4      —
Heterosexual contactb 3 4      —
Otherc 5 0      —
Subtotal 35 44 25.5
Female adult or adolescent
Injection drug use 1 1      —
Heterosexual contactb 3 5      —
Otherc 2 1      —
Subtotal 6 7 4.1
Child (<13 yrs at diagnosis)
Perinatal 0 0      —
Otherd 0 0      —
Subtotal 0 0 0.0
Region of Residence
Northeast 5 7 30.7
Midwest 2 2 8.6
South 10 12 20.2
West 24 30 9.2
Totale 41 51 11.8
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Table 4a. AIDS diagnoses, by race/ethnicity and selected characteristics, 2008—United States (cont)
No.
Estimateda
No. Rate
White
Age at diagnosis (yr)
<13 5 7 0.0
13–14 2 3 0.1
15–19 44 55 0.4
20–24 243 294 2.3
25–29 628 776 6.1
30–34 849 1,061 9.3
35–39 1,374 1,728 13.3
40–44 1,755 2,209 15.7
45–49 1,531 1,935 12.1
50–54 918 1,162 7.4
55–59 575 710 5.1
60–64 282 345 2.9
65 235 285 0.9
Transmission category
Male adult or adolescent
Male-to-male sexual contact 4,669 7,027   —
Injection drug use 435 653   —
Male-to-male sexual contact and injection drug use 503 698   —
Heterosexual contactb 360 538   —
Otherc 1,184 64   —
Subtotal 7,151 8,980 10.8
Female adult or adolescent
Injection drug use 322 525   —
Heterosexual contactb 555 1,028   —
Otherc 408 30   —
Subtotal 1,285 1,583 1.8
Child (<13 yrs at diagnosis)
Perinatal 3 3   —
Otherd 2 4   —
Subtotal 5 7 0.0
Region of Residence
Northeast 1,374 1,833 4.7
Midwest 1,254 1,551 2.9
South 3,624 4,274 6.2
West 2,189 2,912 7.5
Totale 8,441 10,570 5.3
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Table 4a. AIDS diagnoses, by race/ethnicity and selected characteristics, 2008—United States (cont)
No.
Estimateda
No. Rate
Multiple races
Age at diagnosis (yr)
<13 3 3 0.2
13–14 0 0 0.0
15–19 6 7 1.6
20–24 19 25 6.9
25–29 28 35 11.2
30–34 45 56 23.4
35–39 54 65 29.3
40–44 56 69 34.6
45–49 55 68 33.6
50–54 50 60 33.0
55–59 19 23 15.3
60–64 12 15 13.2
65 6 8 3.4
Transmission category
Male adult or adolescent
Male-to-male sexual contact 120 181 —
Injection drug use 33 50 —
Male-to-male sexual contact and injection drug use 19 28 —
Heterosexual contactb 32 47 —
Otherc 46 4 —
Subtotal 250 310 22.3
Female adult or adolescent
Injection drug use 16 28 —
Heterosexual contactb 55 93 —
Otherc 29 1 —
Subtotal 100 121 8.2
Child (<13 yrs at diagnosis)
Perinatal 3 3 —
Otherd 0 0 —
Subtotal 3 3 0.2
Region of Residence
Northeast 105 133 21.2
Midwest 57 69 8.3
South 158 191 13.8
West 33 42 2.6
Totale 353 435 9.8
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Table 4a. AIDS diagnoses, by race/ethnicity and selected characteristics, 2008—United States (cont)
No.
Estimateda
No.h Rate
Total
Age at diagnosis (yr)
<13 31 41 0.1
13–14 40 48 0.6
15–19 397 497 2.3
20–24 1,563 1,976 9.4
25–29 2,856 3,616 16.9
30–34 3,543 4,461 22.8
35–39 4,525 5,719 27.2
40–44 5,276 6,683 31.1
45–49 4,639 5,920 25.9
50–54 3,102 3,946 18.4
55–59 1,782 2,242 12.1
60–64 912 1,140 7.5
65 680 862 2.2
Transmission category
Male adult or adolescent
Male-to-male sexual contact 10,946 17,758   —
Injection drug use 1,869 3,555   —
Male-to-male sexual contact and injection drug use 1,091 1,704   —
bHeterosexual contact 2,401 4,301   —
Otherc 5,371 225   —
Subtotal 21,678 27,543 22.4
Female adult or adolescent
Injection drug use 1,099 2,256   —
bHeterosexual contact 3,523 7,112   —
Otherc 3,015 199   —
Subtotal 7,637 9,567 7.5
Child (<13 yrs at diagnosis)
Perinatal 27 34   —
Otherd 4 6   —
Subtotal 31 41 0.1
Region of Residence
Northeast 6,233 8,386 15.3
Midwest 3,395 4,251 6.4
South 14,648 17,471 15.6
West 5,070 7,042 9.9
Totale 29,346 37,151 12.2
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete 
reporting. Rates are per 100,000 population. Rates are not calculated by transmission category because of the lack of denominator data.
b Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
c Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
d Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may 
not sum to the column total.
f Includes Asian/Pacific Islander legacy cases (see Technical Notes).
g Hispanics/Latinos can be of any race.
h Because row totals were calculated independently of the values for the subpopulations, the values in each row may not sum to the row total.
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Table 4b. AIDS diagnoses, by race/ethnicity and selected characteristics, 2008—United States and 5 U.S. 
dependent areas  
No. Est. No.a
American Indian/
Alaska Native
Age at diagnosis (yr)
<13 0 0
13–14 0 0
15–19 1 1
20–24 6 7
25–29 16 22
30–34 19 22
35–39 38 45
40–44 25 30
45–49 24 28
50–54 22 25
55–59 6 9
60–64 4 5
65 2 6
Transmission category
Male adult or adolescent
Male-to-male sexual contact 70 99
Injection drug use 16 21
Male-to-male sexual contact and injection drug use 15 22
Heterosexual contactb 6 11
Otherc 21 2
Subtotal 128 155
Female adult or adolescent
Injection drug use 9 16
Heterosexual contactb 9 22
Otherc 17 5
Subtotal 35 44
Child (<13 yrs at diagnosis)
Perinatal 0 0
Otherd 0 0
Subtotal 0 0
Region of Residence
Northeast 9 13
Midwest 18 22
South 49 61
West 87 103
U.S. dependent areas 0 0
Totale 163 199
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Table 4b. AIDS diagnoses, by race/ethnicity and selected characteristics, 2008—United States and 5 U.S. 
dependent areas (cont)
No. Est. No.a
Asianf
Age at diagnosis (yr)
<13 1 1
13–14 1 1
15–19 1 1
20–24 13 17
25–29 50 67
30–34 75 99
35–39 99 125
40–44 65 86
45–49 40 55
50–54 21 26
55–59 19 25
60–64 11 13
65 7 10
Transmission category
Male adult or adolescent
Male-to-male sexual contact 202 356
Injection drug use 4 9
Male-to-male sexual contact and injection drug use 7 12
Heterosexual contactb 31 48
Otherc 84 4
Subtotal 328 430
Female adult or adolescent
Injection drug use 3 10
Heterosexual contactb 41 78
Otherc 30 8
Subtotal 74 97
Child (<13 yrs at diagnosis)
Perinatal 1 1
Otherd 0 0
Subtotal 1 1
Region of Residence
Northeast 90 115
Midwest 29 35
South 88 104
West 194 270
U.S. dependent areas 2 2
Totale 403 527
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Table 4b. AIDS diagnoses, by race/ethnicity and selected characteristics, 2008—United States and 5 U.S. 
dependent areas (cont)
No. Est. No.a
Black/African American
Age at diagnosis (yr)
<13 19 25
13–14 29 35
15–19 284 356
20–24 965 1,222
25–29 1,451 1,826
30–34 1,691 2,106
35–39 2,006 2,526
40–44 2,439 3,090
45–49 2,224 2,856
50–54 1,657 2,116
55–59 928 1,177
60–64 462 583
65 330 422
Transmission category
Male adult or adolescent
Male-to-male sexual contact 3,594 6,285
Injection drug use 959 2,033
Male-to-male sexual contact and injection drug use 347 624
Heterosexual contactb 1,520 2,915
Otherc 2,994 118
Subtotal 9,414 11,974
Female adult or adolescent
Injection drug use 581 1,352
Heterosexual contactb 2,339 4,866
Otherc 2,132 124
Subtotal 5,052 6,341
Child (<13 yrs at diagnosis)
Perinatal 17 22
Otherd 2 2
Subtotal 19 25
Region of Residence
Northeast 3,074 4,210
Midwest 1,715 2,166
South 8,757 10,610
West 928 1,342
U.S. dependent areas 11 12
Totale 14,485 18,341
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Table 4b. AIDS diagnoses, by race/ethnicity and selected characteristics, 2008—United States and 5 U.S. 
dependent areas (cont)
No. Est. No.a
Hispanic/Latinog
Age at diagnosis (yr)
<13 3 4
13–14 8 9
15–19 69 86
20–24 330 428
25–29 721 936
30–34 942 1,220
35–39 1,042 1,350
40–44 1,046 1,344
45–49 873 1,117
50–54 508 654
55–59 270 344
60–64 162 206
65 127 167
Transmission category
Male adult or adolescent
Male-to-male sexual contact 2,393 3,958
Injection drug use 599 1,047
Male-to-male sexual contact and injection drug use 214 342
Heterosexual contactb 529 857
Otherc 1,088 38
Subtotal 4,823 6,240
Female adult or adolescent
Injection drug use 203 378
Heterosexual contactb 654 1,211
Otherc 418 30
Subtotal 1,275 1,619
Child (<13 yrs at diagnosis)
Perinatal 3 4
Otherd 0 0
Subtotal 3 4
Region of Residence
Northeast 1,576 2,076
Midwest 320 405
South 1,962 2,218
West 1,615 2,343
U.S. dependent areas 628 821
Totale 6,101 7,864
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Table 4b. AIDS diagnoses, by race/ethnicity and selected characteristics, 2008—United States and 5 U.S. 
dependent areas (cont)
No. Est. No.a
Native Hawaiian/Other 
Pacific Islander
Age at diagnosis (yr)
<13 0 0
13–14 0 0
15–19 0 0
20–24 3 3
25–29 4 5
30–34 5 6
35–39 9 11
40–44 6 8
45–49 8 10
50–54 6 7
55–59 0 0
60–64 0 0
65 3 4
Transmission category
Male adult or adolescent
Male-to-male sexual contact 22 34
Injection drug use 3 5
Male-to-male sexual contact and injection drug use 3 4
bHeterosexual contact 3 5
Otherc 7 0
Subtotal 38 48
Female adult or adolescent
Injection drug use 1 1
bHeterosexual contact 3 5
Otherc 2 1
Subtotal 6 7
Child (<13 yrs at diagnosis)
Perinatal 0 0
Otherd 0 0
Subtotal 0 0
Region of Residence
Northeast 5 7
Midwest 2 2
South 10 12
West 24 30
U.S. dependent areas 3 3
Totale 44 55
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Table 4b. AIDS diagnoses, by race/ethnicity and selected characteristics, 2008—United States and 5 U.S. 
dependent areas (cont)
No. Est. No.a
White
Age at diagnosis (yr)
<13 5 7
13–14 2 3
15–19 44 55
20–24 243 294
25–29 628 776
30–34 849 1,061
35–39 1,374 1,728
40–44 1,756 2,211
45–49 1,531 1,935
50–54 918 1,162
55–59 575 710
60–64 282 345
65 235 285
Transmission category
Male adult or adolescent
Male-to-male sexual contact 4,670 7,028
Injection drug use 435 653
Male-to-male sexual contact and injection drug use 503 698
Heterosexual contactb 360 538
Otherc 1,184 64
Subtotal 7,152 8,981
Female adult or adolescent
Injection drug use 322 525
Heterosexual contactb 555 1,028
Otherc 408 30
Subtotal 1,285 1,583
Child (<13 yrs at diagnosis)
Perinatal 3 3
Otherd 2 4
Subtotal 5 7
Region of Residence
Northeast 1,374 1,833
Midwest 1,254 1,551
South 3,624 4,274
West 2,189 2,912
U.S. dependent areas 1 1
Totale 8,442 10,571
54 Diagnoses of HIV Infection and AIDS  
Table 4b. AIDS diagnoses, by race/ethnicity and selected characteristics, 2008—United States and 5 U.S. 
dependent areas (cont)
No. Est. No.a
Multiple races
Age at diagnosis (yr)
<13 3 3
13–14 0 0
15–19 6 7
20–24 19 25
25–29 28 35
30–34 45 56
35–39 54 65
40–44 56 69
45–49 55 68
50–54 50 60
55–59 19 23
60–64 12 15
65 6 8
Transmission category
Male adult or adolescent
Male-to-male sexual contact 120 181
Injection drug use 33 50
Male-to-male sexual contact and injection drug use 19 28
Heterosexual contactb 32 47
Otherc 46 4
Subtotal 250 310
Female adult or adolescent
Injection drug use 16 28
Heterosexual contactb 55 93
Otherc 29 1
Subtotal 100 121
Child (<13 yrs at diagnosis)
Perinatal 3 3
Otherd 0 0
Subtotal 3 3
Region of Residence
Northeast 105 133
Midwest 57 69
South 158 191
West 33 42
U.S. dependent areas 0 0
Totale 353 435
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Table 4b. AIDS diagnoses, by race/ethnicity and selected characteristics, 2008—United States and 5 U.S. 
dependent areas (cont)
No. Est. No.a,h
Total
Age at diagnosis (yr)
<13 31 41
13–14 40 48
15–19 405 507
20–24 1,579 1,997
25–29 2,898 3,669
30–34 3,626 4,569
35–39 4,622 5,849
40–44 5,393 6,836
45–49 4,755 6,070
50–54 3,182 4,051
55–59 1,817 2,286
60–64 933 1,167
65 710 900
Transmission category
Male adult or adolescent
Male-to-male sexual contact 11,071 17,940
Injection drug use 2,049 3,818
Male-to-male sexual contact and injection drug use 1,108 1,729
Heterosexual contactb 2,481 4,420
Otherc 5,424 230
Subtotal 22,133 28,137
Female adult or adolescent
Injection drug use 1,135 2,311
Heterosexual contactb 3,656 7,303
Otherc 3,036 199
Subtotal 7,827 9,813
Child (<13 yrs at diagnosis)
Perinatal 27 34
Otherd 4 6
Subtotal 31 41
Region of Residence
Northeast 6,233 8,386
Midwest 3,395 4,251
South 14,648 17,471
West 5,070 7,042
U.S. dependent areas 645 840
Totale 29,991 37,991
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete 
reporting.
b Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
c Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
d Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may 
not sum to the column total.
f Includes Asian/Pacific Islander legacy cases (see Technical Notes).
g Hispanics/Latinos can be of any race.
h Because row totals were calculated independently of the values for the subpopulations, the values in each row may not sum to the row total.
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h confidential name-based HIV infection 
2008
ateda
No.
Estimateda
Rate No. Rate
0.0 1 1 0.3
0.6 2 2 0.2
2.1 101 121 2.1
0.4 18 22 0.3
0.0 0 0 0.0
0.1 25 32 0.1
0.3 3 3 0.3
0.5 150 182 0.5
 January 2005
00 population.
y not sum to the column total.
 5 U.S. dependent areas with 
 January 2005
y not sum to the column total.
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Table 5a. Diagnoses of HIV infection among children <13 years of age, by race/ethnicity, 2005–2008—37 states wit
reporting 
2005 2006 2007
No.
Estimateda
No.
Estimateda
No.
Estim
No. Rate No. Rate No.
Race/ethnicity
American Indian/Alaska Native 0 0 0.0 2 2 0.6 0 0
Asian 5 5 0.5 2 2 0.2 6 7
Black/African American 132 141 2.4 116 127 2.2 108 121
Hispanic/Latinob 32 35 0.5 25 27 0.4 25 28
Native Hawaiian/Other Pacific Islander 0 0 0.0 0 0 0.0 0 0
White 27 29 0.1 17 19 0.1 18 21
Multiple races 5 5 0.6 2 2 0.2 3 3
Totalc 201 215 0.6 164 179 0.5 160 180
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. 
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,0
b Hispanics/Latinos can be of any race.
c Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column ma
Table 5b. Diagnoses of HIV infection among children <13 years of age, by race/ethnicity, 2005–2008—37 states and
confidential name-based HIV infection reporting 
2005 2006 2007 2008
No. Est. No.a No. Est. No.a No. Est. No.a No. Est. No.a
Race/ethnicity
American Indian/Alaska Native 0 0 2 2 0 0 1 1
Asian 5 5 2 2 7 8 2 2
Black/African American 132 141 116 127 109 123 101 121
Hispanic/Latinob 33 36 30 33 33 37 18 22
Native Hawaiian/Other Pacific Islander 0 0 0 0 0 0 0 0
White 27 29 17 19 18 21 25 32
Multiple races 5 5 2 2 3 3 3 3
Totalc 202 217 169 185 170 192 150 182
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. 
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. 
b Hispanics/Latinos can be of any race.
c Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column ma
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2008
Cumulativeb
.
Estimateda
No. Rate No. Est. No.a
0 0.0 33 33
1 0.1 48 49
25 0.3 5,729 5,782
4 0.0 1,785 1,798
0 0.0 7 7
7 0.0 1,601 1,612
3 0.2 65 66
41 0.1 9,270f 9,349
population.
ot sum to the column total.
tes and 5 U.S. dependent areas 
lativeb
Est. No.a
33
49
5,794
2,212
7
1,612
67
9,776
ot sum to the column total.
Table 6a. AIDS diagnoses among children <13 years of age, by race/ethnicity, 2005–2008 and cumulative—United Sta
2005 2006 2007
No.
Estimateda
No.
Estimateda
No.
Estimateda
NoNo. Rate No. Rate No. Rate
Race/ethnicity
American Indian/Alaska Native 0 0 0.0 0 0 0.0 0 0 0.0 0
Asianc 1 1 0.1 1 1 0.1 0 0 0.0 1
Black/African American 38 40 0.5 28 30 0.4 20 22 0.3 19
Hispanic/Latinod 8 8 0.1 4 4 0.0 3 3 0.0 3
Native Hawaiian/Other Pacific Islander 0 0 0.0 0 0 0.0 0 0 0.0 0
White 4 4 0.0 3 3 0.0 4 4 0.0 5
Multiple races 1 1 0.1 1 1 0.1 0 0 0.0 3
Totale 52 55 0.1 37 40 0.1 27 30 0.1 31
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000 
b From the beginning of the epidemic through 2008.
c Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d Hispanics/Latinos can be of any race.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may n
f Includes children of unknown race/ethnicity.
Table 6b. AIDS diagnoses among children <13 years of age, by race/ethnicity, 2005–2008 and cumulative—United Sta
2005 2006 2007 2008 Cumu
No. Est. No.a No. Est. No.a No. Est. No.a No. Est. No.a No.
Race/ethnicity
American Indian/Alaska Native 0 0 0 0 0 0 0 0 33
Asianc 1 1 1 1 0 0 1 1 48
Black/African American 38 40 28 30 20 22 19 25 5,741
Hispanic/Latinod 8 8 6 7 3 3 3 4 2,196
Native Hawaiian/Other Pacific Islander 0 0 0 0 0 0 0 0 7
White 4 4 3 3 4 4 5 7 1,601
Multiple races 1 1 1 1 0 0 3 3 66
Totale 52 55 39 42 27 30 31 41 9,694f
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.
b From the beginning of the epidemic through 2008.
c Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d Hispanics/Latinos can be of any race.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may n
f Includes children of unknown race/ethnicity.
Table 7. AIDS diagnoses among children <13 years of age, by year of diagnosis, 1992–2008—United States and 
5 U.S. dependent areas  
United States
United States and 
dependent areas
No. Est. No.a No. Est. No.a
Year of diagnosis
1992 901 905 949 954
1993 883 888 921 926
1994 807 812 832 837
1995 673 679 695 701
1996 515 520 529 534
1997 337 341 349 353
1998 250 254 257 261
1999 197 200 203 206
2000 134 137 137 140
2001 131 134 132 135
2002 107 110 114 117
2003 72 75 74 77
2004 54 56 55 57
2005 52 55 52 55
2006 37 40 39 42
2007 27 30 27 30
2008 31 41 31 41
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.
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and place of birth, 2008—37 states 
Puerto Rico Total
No.
Est. 
No.a % No.b
Est. 
No.a,b %
286 429 43.4 2,875 4,533 69.1
205 322 32.5 430 885 13.5
28 40 4.1 137 243 3.7
119 197 19.9 511 880 13.4
132 0 0.0 1,443 17 0.3
770 989 100 5,396 6,557 100
36 60 15.1 122 260 15.5
183 337 84.2 657 1,408 83.7
94 3 0.7 584 13 0.8
313 400 100 1,363 1,681 100
1,083 1,389 100 6,759 8,238 100
uary 2005.
e reporting.
ot sum to the column total.
Table 8. Diagnoses of HIV infection among adult and adolescent Hispanics/Latinos, by transmission category 
and 5 U.S. dependent areas with confidential name-based HIV infection reporting
Transmission category
Place of birth
United States Central America South America Cuba Mexico
No.
Est. 
No.a % No.
Est. 
No.a % No.
Est. 
No.a % No.
Est. 
No.a % No.
Est. 
No.a %
Male adult or adolescent
Male-to-male sexual contact 1,175 1,712 77.1 130 249 67.1 188 253 79.7 155 191 75.6 391 618 73.3
Injection drug use 104 232 10.5 6 23 6.2 2 14 4.3 6 10 4.0 29 61 7.2
Male-to-male sexual contact 
and injection drug use
52 92 4.1 3 8 2.1 5 7 2.3 5 6 2.5 20 33 3.9
Heterosexual contactc 113 180 8.1 49 89 23.9 22 43 13.5 27 42 16.8 70 130 15.4
Otherd 408 4 0.2 121 3 0.8 45 0 0.1 28 3 1.0 201 2 0.3
Subtotal 1,852 2,220 100 309 372 100 262 317 100 221 253 100 711 843 100
Female adult or adolescent
Injection drug use 60 109 20.3 1 6 5.9 2 5 11.3 2 3 12.6 2 6 5.1
Heterosexual contactc 213 424 79.1 40 95 92.7 14 37 87.6 12 19 87.4 50 118 94.3
Otherd 169 3 0.6 47 1 1.4 18 0 1.1 5 0 0.0 52 1 0.6
Subtotal 442 536 100 88 102 100 34 42 100 19 22 100 104 125 100
Totale 2,294 2,756 100 397 474 100 296 360 100 240 275 100 815 968 100
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least Jan
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplet
b Entries include persons whose place of birth is not among those listed and persons whose place of birth is unknown.
c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may n
e of birth, 2008—United States and 
Puerto Rico Total
% No.
Est. 
No.a % No.b
Est. 
No.a,b %
74.8 177 268 32.2 2,393 3,958 63.4
6.5 250 362 43.6 599 1,047 16.8
4.7 32 44 5.3 214 342 5.5
13.6 100 152 18.3 529 857 13.7
0.5 85 5 0.6 1,088 38 0.6
00 644 831 100 4,823 6,240 100
7.8 55 88 23.5 203 378 23.3
90.7 178 285 76.3 654 1,211 74.8
1.4 60 1 0.2 418 30 1.8
00 293 374 100 1,275 1,619 100
00 937 1,204 100 6,098 7,860 100
plete reporting.
y not sum to the column total.
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Table 9. AIDS diagnoses among adult and adolescent Hispanics/Latinos, by transmission category and plac
5 U.S. dependent areas
Transmission category
Place of birth
United States Central America South America Cuba Mexico
No.
Est. 
No.a % No.
Est. 
No.a % No.
Est. 
No.a % No.
Est. 
No.a % No.
Est. 
No.a
Male adult or adolescent
Male-to-male sexual contact 925 1,369 66.1 150 350 66.4 129 183 76.7 79 98 65.0 550 955
Injection drug use 200 335 16.2 9 35 6.7 3 14 6.0 7 13 8.8 40 83
Male-to-male sexual contact and 
injection drug use
107 163 7.9 6 16 3.0 5 7 3.0 3 5 3.1 34 60
Heterosexual contactc 129 188 9.1 69 125 23.6 17 32 13.6 19 34 22.7 104 173
Otherd 268 17 0.8 148 1 0.2 32 2 0.7 24 1 0.4 240 6
Subtotal 1,629 2,071 100 382 527 100 186 239 100 132 151 100 968 1,277 1
Female adult or adolescent
Injection drug use 105 170 33.7 2 10 7.4 2 5 14.5 1 1 6.5 6 14
Heterosexual contactc 187 317 62.6 53 124 91.4 12 31 84.3 16 20 93.5 84 164
Otherd 110 19 3.8 51 2 1.2 15 0 1.3 2 0 0.0 48 3
Subtotal 402 506 100 106 136 100 29 37 100 19 21 100 138 181 1
Totale 2,031 2,578 100 488 662 100 215 275 100 151 172 100 1,106 1,458 1
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incom
b Entries include persons whose place of birth is not among those listed and persons whose place of birth is unknown.
c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column ma
Table 10a. Time to an AIDS diagnosis after a diagnosis of HIV infection, by selected characteristics, 2007—37 states 
with confidential name-based HIV infection reporting 
Diagnosis of AIDS after diagnosis of HIV infection
Total<12 Monthsa 12 Monthsb
Est. No. (%) Est. No. (%) Est. No.c
Age at diagnosis (yr)
<13 17 9 163 91 180
13–14 11 33 22 67 34
15–19 272 16 1,439 84 1,711
20–24 879 18 3,898 82 4,777
25–29 1,333 24 4,143 76 5,476
30–34 1,472 30 3,384 70 4,856
35–39 1,968 34 3,790 66 5,758
40–44 2,283 37 3,839 63 6,123
45–49 1,999 41 2,891 59 4,890
50–54 1,290 39 1,977 61 3,267
55–59 806 45 968 55 1,775
60–64 390 45 482 55 872
65 356 48 386 52 742
Race/ethnicity
American Indian/Alaska Native 77 38 128 62 204
Asian 142 33 287 67 429
Black/African American 6,383 32 13,751 68 20,134
Hispanic/Latinod 2,684 37 4,591 63 7,276
Native Hawaiian/Other Pacific Islander 13 34 26 66 39
White 3,614 30 8,347 70 11,961
Multiple races 165 39 253 61 418
Transmission category
Male adult or adolescent
Male-to-male sexual contact 6,605 31 14,808 69 21,413
Injection drug use 1,195 42 1,648 58 2,844
Male-to-male sexual contact and injection drug use 383 31 835 69 1,218
Heterosexual contacte 1,675 39 2,665 61 4,340
Otherf 50 60 34 40 84
Subtotal 9,909 33 19,990 67 29,899
Female adult or adolescent
Injection drug use 604 37 1,030 63 1,634
Heterosexual contacte 2,487 29 6,169 71 8,655
Otherf 62 67 31 33 93
Subtotal 3,153 30 7,230 70 10,382
Child (<13 yrs at diagnosis)
Perinatal 15 10 136 90 151
Otherg 2 5 27 95 29
Subtotal 17 9 163 91 180
Totalh 13,078 32 27,383 68 40,461
Note. Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for 
incomplete reporting.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least 
January 2005.
Data exclude 17 persons whose month of diagnosis of HIV infection is unknown.
a Includes persons whose diagnoses of HIV infection and AIDS were made at the same time.
b Includes persons in whom AIDS has not developed.
c Because row totals were calculated independently of the values for the subpopulations, the values in each row may not sum to the row total.
d Hispanics/Latinos can be of any race.
e Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
g Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
h Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may 
not sum to the column total.
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Table 10b. Time to an AIDS diagnosis after a diagnosis of HIV infection, by selected characteristics, 2007—37 states 
and 5 U.S. dependent areas with confidential name-based HIV infection reporting 
Diagnosis of AIDS after diagnosis of HIV infection
Total<12 Monthsa 12 Monthsb
Est. No. (%) Est. No. (%) Est. No.c
Age at diagnosis (yr)
<13 17 9 175 91 192
13–14 11 32 24 68 35
15–19 276 16 1,464 84 1,740
20–24 892 18 3,990 82 4,882
25–29 1,356 24 4,272 76 5,629
30–34 1,519 30 3,479 70 4,997
35–39 2,018 34 3,897 66 5,915
40–44 2,357 37 3,940 63 6,296
45–49 2,063 41 2,996 59 5,059
50–54 1,341 40 2,036 60 3,377
55–59 835 46 996 54 1,831
60–64 413 45 497 55 910
65 372 48 408 52 781
Race/ethnicity
American Indian/Alaska Native 77 38 128 62 204
Asian 143 33 289 67 433
Black/African American 6,401 32 13,765 68 20,166
Hispanic/Latinod 3,055 36 5,363 64 8,418
Native Hawaiian/Other Pacific Islander 15 35 27 65 42
White 3,614 30 8,350 70 11,963
Multiple races 165 39 253 61 418
Transmission category
Male adult or adolescent
Male-to-male sexual contact 6,706 31 14,993 69 21,699
Injection drug use 1,284 41 1,858 59 3,142
Male-to-male sexual contact and injection drug use 397 32 854 68 1,251
Heterosexual contact  e 1,750 39 2,783 61 4,533
Other  f 50 60 34 40 84
Subtotal 10,187 33 20,522 67 30,708
Female adult or adolescent
Injection drug use 616 37 1,071 63 1,687
Heterosexual contacte 2,587 29 6,376 71 8,962
Otherf 62 66 32 34 94
Subtotal 3,265 30 7,479 70 10,744
Child (<13 yrs at diagnosis)
Perinatal 15 10 141 90 157
Otherg 2 4 33 96 35
Subtotal 17 9 175 91 192
Totalh 13,469 32 28,175 68 41,644
Note. Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for 
incomplete reporting.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least 
January 2005.
Data exclude 17 persons whose month of diagnosis of HIV infection is unknown.
a Includes persons whose diagnoses of HIV infection and AIDS were made at the same time.
b Includes persons in whom AIDS has not developed.
c Because row totals were calculated independently of the values for the subpopulations, the values in each row may not sum to the row total.
d Hispanics/Latinos can be of any race.
e Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
g Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
h Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may 
not sum to the column total.
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2007
No.
Estimateda
No. Rate
6 8 0.0
7 9 0.2
33 43 0.3
137 179 1.2
411 537 3.7
680 889 6.6
1,419 1,883 12.9
2,290 3,016 19.7
2,499 3,295 20.7
2,179 2,868 19.6
1,413 1,857 14.5
764 1,002 9.8
818 1,075 4.0
57 75 4.1
33 43 0.7
6,876 8,951 31.3
1,882 2,513 9.1
5 7 4.9
3,473 4,636 3.2
328 431 16.4
Table 11a. Deaths of persons with a diagnosis of HIV infection, by year of death and selected characteristics, 2005–20
based HIV infection reporting  
2005 2006
No.
Estimateda
No.
Estimateda
No. Rate No. Rate
Age at death (yr)
<13 6 6 0.0 14 15 0.0
13–14 7 8 0.1 7 8 0.1
15–19 34 36 0.2 36 41 0.3
20–24 128 136 0.9 167 187 1.3
25–29 429 456 3.3 398 446 3.1
30–34 902 961 7.0 748 842 6.2
35–39 1,679 1,790 12.4 1,550 1,740 11.9
40–44 2,607 2,779 17.5 2,452 2,762 17.7
45–49 2,651 2,824 18.1 2,636 2,978 18.8
50–54 2,162 2,307 16.6 2,185 2,461 17.3
55–59 1,306 1,393 11.5 1,363 1,538 12.1
60–64 722 770 8.4 708 804 8.5
65 720 770 3.0 806 910 3.5
Race/ethnicity
American Indian/Alaska Native 60 64 3.6 57 66 3.7
Asianb 37 40 0.7 42 48 0.8
Black/African American 7,235 7,693 27.6 7,169 8,041 28.5
Hispanic/Latinoc 2,012 2,156 8.5 2,021 2,298 8.7
Native Hawaiian/Other Pacific Islander 5 5 4.1 2 2 1.8
White 3,833 4,096 2.9 3,484 3,955 2.8
Multiple races 167 178 7.3 295 321 12.7
2007—37 states with confidential name-
2007
No.
Estimateda
No. Rate
3,618 5,971 —
1,804 2,945 —
729 1,109 —
998 1,810 —
1,902 129 —
9,051 11,964 14.1
1,012 1,683 —
1,535 2,871 —
1,002 68 —
3,549 4,621 5.2
43 57 —
13 17 —
56 74 0.2
12,656 16,659 7.9
V infection may be due to any cause.
 January 2005.
plete reporting. Rates are per 100,000 population. 
ubpopulations, the values in each column may not 
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Table 11a. Deaths of persons with a diagnosis of HIV infection, by year of death and selected characteristics, 2005–
based HIV infection reporting (cont)
2005 2006
No.
Estimateda
No.
Estimateda
No. Rate No. Rate
Transmission category
Male adult or adolescent
Male-to-male sexual contact 3,752 4,954 — 3,578 5,011 —
Injection drug use 2,193 2,816 — 2,004 2,761 —
Male-to-male sexual contact and injection drug use 797 959 — 800 1,018 —
Heterosexual contactd 982 1,432 — 1,088 1,664 —
Othere 1,915 115 — 1,886 105 —
Subtotal 9,639 10,277 12.4 9,356 10,558 12.6
Female adult or adolescent
Injection drug use 1,168 1,550 — 1,060 1,512 —
dHeterosexual contact 1,521 2,282 — 1,573 2,504 —
Othere 972 69 — 1,013 81 —
Subtotal 3,661 3,902 4.5 3,646 4,096 4.7
Child (<13 yrs at diagnosis)
Perinatal 39 42 — 54 61 —
Otherf 14 15 — 14 16 —
Subtotal 53 57 0.2 68 77 0.2
Totalg 13,353 14,236 6.9 13,070 14,732 7.1
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Deaths of persons with a diagnosis of HI
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incom
Rates are not calculated by transmission category because of the lack of denominator data.
b Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c Hispanics/Latinos can be of any race.
d Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
f Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g Includes persons of unknown race/ethnicity. Because column totals for estimated numbers were calculated independently of the values for the s
sum to the column total.
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007—37 states and 5 U.S. dependent 
2007
No.
Estimateda
No. Rate
7 9 0.0
7 9 0.2
35 45 0.3
142 185 1.2
429 559 3.7
709 924 6.7
1,474 1,948 13.0
2,380 3,123 20.1
2,578 3,389 20.9
2,250 2,953 19.8
1,447 1,899 14.5
793 1,037 9.9
853 1,117 4.1
57 75 —
35 46 —
6,886 8,963 —
2,315 3,032 —
6 8 —
3,474 4,638 —
329 433 —
Table 11b. Deaths of persons with a diagnosis of HIV infection, by year of death and selected characteristics, 2005–2
areas with confidential name-based HIV infection reporting  
2005 2006
No.
Estimateda
No.
Estimateda
No. Rate No. Rate
Age at death (yr)
<13 6 6 0.0 14 15 0.0
13–14 7 8 0.1 9 10 0.2
15–19 35 37 0.3 39 44 0.3
20–24 140 149 1.0 178 200 1.3
25–29 450 479 3.4 412 462 3.2
30–34 957 1,021 7.2 783 882 6.4
35–39 1,792 1,915 13.0 1,618 1,818 12.2
40–44 2,723 2,906 18.0 2,572 2,900 18.3
45–49 2,738 2,920 18.4 2,745 3,104 19.2
50–54 2,239 2,392 16.9 2,261 2,548 17.6
55–59 1,339 1,430 11.5 1,398 1,578 12.1
60–64 746 797 8.5 741 842 8.7
65 762 816 3.1 841 950 3.5
Race/ethnicity
American Indian/Alaska Native 60 64 — 57 66 —
Asianb 38 41 — 44 50 —
Black/African American 7,240 7,698 — 7,172 8,045 —
Hispanic/Latinoc 2,584 2,787 — 2,554 2,909 —
Native Hawaiian/Other Pacific Islander 5 5 — 3 4 —
White 3,834 4,097 — 3,485 3,956 —
Multiple races 167 178 — 296 323 —
–2007—37 states and 5 U.S. dependent 
2007
No.
Estimateda
No. Rate
3,670 6,038 —
1,965 3,152 —
760 1,146 —
1,055 1,885 —
1,922 130 —
9,372 12,350 14.3
1,059 1,740 —
1,603 2,960 —
1,010 68 —
3,672 4,767 5.3
47 62 —
13 17 —
60 79 0.2
13,104 17,197 8.0
V infection may be due to any cause.
 January 2005.
plete reporting. Rates are per 100,000 population. 
ission category because of the lack of denominator 
ubpopulations, the values in each column may not 
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Table 11b. Deaths of persons with a diagnosis of HIV infection, by year of death and selected characteristics, 2005
areas with confidential name-based HIV infection reporting (cont)
2005 2006
No.
Estimateda
No.
Estimateda
No. Rate No. Rate
Transmission category
Male adult or adolescent
Male-to-male sexual contact 3,814 5,027 — 3,647 5,091 —
Injection drug use 2,428 3,084 — 2,205 2,994 —
Male-to-male sexual contact and injection drug use 838 1,006 — 845 1,070 —
Heterosexual contactd 1,053 1,517 — 1,156 1,742 —
Othere 1,937 119 — 1,892 106 —
Subtotal 10,070 10,753 12.8 9,745 11,004 12.9
Female adult or adolescent
Injection drug use 1,231 1,622 — 1,115 1,576 —
Heterosexual contactd 1,596 2,370 — 1,653 2,597 —
Othere 980 69 — 1,018 83 —
Subtotal 3,807 4,062 4.6 3,786 4,257 4.7
Child (<13 yrs at diagnosis)
Perinatal 42 45 — 63 71 —
Otherf 15 16 — 17 20 —
Subtotal 57 61 0.2 80 91 0.2
Totalg 13,934 14,876 7.1 13,611 15,353 7.2
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Deaths of persons with a diagnosis of HI
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incom
Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas. Rates are not calculated by transm
data.
b Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c Hispanics/Latinos can be of any race.
d Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
f Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g Includes persons of unknown race/ethnicity. Because column totals for estimated numbers were calculated independently of the values for the s
sum to the column total.
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Cumulativebtimateda
Rate No. Est. No.a
0.0 4,885 4,931
0.1 282 289
0.2 1,129 1,160
0.8 8,847 9,001
2.5 44,164 44,738
4.8 96,464 97,756
9.4 118,954 121,136
14.8 107,396 110,166
15.7 76,116 78,730
14.5 46,853 48,818
10.6 26,679 27,853
7.1 15,161 15,790
2.8 15,338 16,015
3.9 1,782 1,847
0.7 3,099 3,174
24.8 226,390 233,364
6.0 83,104 85,328
2.8 346 355
2.6 244,772 249,373
9.3 2,593 2,758
— 258,353 279,240
— 103,222 115,987
— 39,930 42,946
— 20,722 26,379
— 41,005 9,387
10.6 463,232 473,939
Table 12a. Deaths of persons with an AIDS diagnosis, by year of death and selected characteristics, 2005–2007 and c
2005 2006 2007
No.
Estimateda
No.
Estimateda
No.
Es
No. Rate No. Rate No.
Age at death (yr)
<13 6 7 0.0 13 15 0.0 5 6
13–14 8 8 0.1 3 3 0.0 9 11
15–19 36 39 0.2 43 49 0.2 31 40
20–24 136 146 0.7 162 184 0.9 134 175
25–29 426 457 2.3 412 467 2.3 398 523
30–34 1,024 1,099 5.5 826 941 4.8 713 939
35–39 1,985 2,133 10.2 1,775 2,017 9.6 1,501 1,995
40–44 3,202 3,433 15.1 2,877 3,277 14.6 2,461 3,243
45–49 3,160 3,390 15.1 3,057 3,491 15.3 2,727 3,599
50–54 2,515 2,702 13.5 2,468 2,813 13.7 2,326 3,057
55–59 1,495 1,606 9.3 1,538 1,755 9.6 1,469 1,931
60–64 770 827 6.4 796 912 6.8 786 1,032
65 849 916 2.5 875 1,000 2.7 809 1,068
Race/ethnicity
American Indian/Alaska Native 66 72 3.2 75 87 3.9 68 90
Asianc 74 80 0.7 100 115 0.9 66 87
Black/African American 8,210 8,817 24.4 7,699 8,747 24.0 7,001 9,120
Hispanic/Latinod 2,326 2,487 5.8 2,314 2,634 6.0 2,051 2,736
Native Hawaiian/Other Pacific 
Islander 13 14 3.5 5 6 1.4 9 12
White 4,757 5,115 2.6 4,375 5,027 2.5 3,868 5,172
Multiple races 164 176 4.4 275 305 7.3 305 401
Transmission category
Male adult or adolescent
Male-to-male sexual contact 4,827 6,097 — 4,520 6,081 — 4,123 6,504
Injection drug use 2,728 3,375 — 2,386 3,179 — 2,025 3,170
Male-to-male sexual contact 
and injection drug use 1,154 1,344 — 1,082 1,351 — 920 1,344
Heterosexual contacte 1,057 1,477 — 1,148 1,671 — 1,008 1,728
Otherf 1,818 146 — 1,745 140 — 1,665 147
Subtotal 11,584 12,440 10.5 10,881 12,422 10.3 9,741 12,893
d cumulative—United States (cont)
07
CumulativebEstimateda
. Rate No. Est. No.a
59 — 41,569 48,228
17 — 35,823 44,125
96 — 16,250 4,624
72 3.7 93,642 96,977
46 — 4,823 4,889
8 — 571 578
54 0.1 5,394 5,467
15 8.8 184,141 188,441
32 2.5 55,842 57,321
58 7.9 205,916 212,203
15 3.5 116,369 118,418
19 5.8 562,268 576,384
plete reporting. Rates are per 100,000 population. 
ubpopulations, the values in each column may not 
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Table 12a. Deaths of persons with an AIDS diagnosis, by year of death and selected characteristics, 2005–2007 an
2005 2006 20
No.
Estimateda
No.
Estimateda
No.No. Rate No. Rate No
Female adult or adolescent
Injection drug use 1,461 1,876 — 1,297 1,796 — 1,170 1,8
Heterosexual contacte 1,612 2,318 — 1,653 2,546 — 1,542 2,7
Otherf 922 94 — 962 101 — 874
Subtotal 3,995 4,288 3.4 3,912 4,443 3.5 3,586 4,6
Child (<13 yrs at diagnosis)
Perinatal 31 33 — 45 51 — 36
Otherg 2 2 — 7 8 — 6
Subtotal 33 36 0.1 52 60 0.1 42
Region of Residence
Northeast 4,372 4,640 8.5 4,110 4,615 8.4 3,691 4,8
Midwest 1,358 1,492 2.3 1,347 1,606 2.4 1,229 1,6
South 7,411 7,969 7.4 7,105 8,052 7.4 6,623 8,7
West 2,471 2,662 3.9 2,283 2,651 3.8 1,826 2,4
Totalh 15,612 16,763 5.7 14,845 16,924 5.7 13,369 17,6
Note. Deaths of persons with an AIDS diagnosis may be due to any cause.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incom
Rates are not calculated by transmission category because of the lack of denominator data.
b From the beginning of the epidemic through 2007.
c Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d Hispanics/Latinos can be of any race.
e Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
g Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
h Includes persons of unknown race/ethnicity. Because column totals for estimated numbers were calculated independently of the values for the s
sum to the column total.
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Cumulativebtimateda
Rate No. Est. No.a
0.0 5,126 5,178
0.1 291 298
0.2 1,180 1,213
0.9 9,308 9,477
2.5 46,146 46,775
4.9 100,137 101,544
9.6 123,360 125,707
15.0 111,075 114,012
15.9 78,543 81,281
14.7 48,266 50,314
10.6 27,450 28,667
7.3 15,667 16,327
2.9 15,991 16,705
— 1,782 1,847
— 3,129 3,205
— 226,639 233,624
— 103,022 106,074
— 348 357
— 244,841 249,443
— 2,595 2,760
— 261,511 282,542
— 111,889 125,129
— 41,571 44,660
— 22,595 28,373
— 41,308 9,514
10.7 478,874 490,217
Table 12b. Deaths of persons with an AIDS diagnosis, by year of death and selected characteristics, 2005–2007 and c
dependent areas  
2005 2006 2007
No.
Estimateda
No.
Estimateda
No.
Es
No. Rate No. Rate No.
Age at death (yr)
<13 6 7 0.0 13 15 0.0 6 8
13–14 8 8 0.1 5 6 0.1 9 11
15–19 37 40 0.2 46 53 0.2 33 42
20–24 146 158 0.7 172 196 0.9 139 181
25–29 444 477 2.4 422 479 2.3 412 539
30–34 1,073 1,154 5.7 857 976 4.9 737 967
35–39 2,083 2,243 10.6 1,837 2,089 9.8 1,547 2,049
40–44 3,301 3,543 15.3 2,988 3,406 15.0 2,541 3,338
45–49 3,244 3,483 15.3 3,157 3,607 15.7 2,796 3,681
50–54 2,584 2,779 13.7 2,537 2,892 14.0 2,391 3,134
55–59 1,523 1,637 9.3 1,570 1,792 9.7 1,499 1,968
60–64 793 853 6.5 825 946 7.0 815 1,067
65 884 955 2.6 902 1,031 2.7 838 1,103
Race/ethnicity
American Indian/Alaska Native 66 72 — 75 87 — 68 90
Asianc 74 80 — 101 116 — 68 89
Black/African American 8,214 8,822 — 7,702 8,751 — 7,008 9,129
Hispanic/Latinod 2,833 3,052 — 2,794 3,191 — 2,434 3,193
Native Hawaiian/Other Pacific 
Islander 13 14 — 6 7 — 10 13
White 4,758 5,116 — 4,375 5,027 — 3,869 5,173
Multiple races 164 176 — 276 306 — 305 401
Transmission category
Male adult or adolescent
Male-to-male sexual contact 4,886 6,165 — 4,584 6,155 — 4,170 6,562
Injection drug use 2,940 3,618 — 2,570 3,392 — 2,166 3,348
Male-to-male sexual contact 
and injection drug use 1,192 1,387 — 1,126 1,402 — 947 1,375
Heterosexual contacte 1,121 1,553 — 1,205 1,737 — 1,061 1,796
Otherf 1,830 147 — 1,750 146 — 1,677 147
Subtotal 11,969 12,869 10.7 11,235 12,832 10.5 10,021 13,228
d cumulative—United States and 5 U.S. 
07
CumulativebEstimateda
. Rate No. Est. No.a
12 — 43,340 50,102
94 — 38,250 46,700
96 — 16,414 4,736
02 3.7 98,004 101,538
50 — 5,072 5,146
8 — 590 598
59 0.1 5,662 5,743
15 8.8 184,141 188,441
32 2.5 55,842 57,321
58 7.9 205,916 212,203
15 3.5 116,369 118,418
70 10.8 20,272 21,115
89 5.9 582,540 597,499
plete reporting. Rates are per 100,000 population. 
ission category because of the lack of denominator 
ubpopulations, the values in each column may not 
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Table 12b. Deaths of persons with an AIDS diagnosis, by year of death and selected characteristics, 2005–2007 an
dependent areas (cont)
2005 2006 20
No.
Estimateda
No.
Estimateda
No.No. Rate No. Rate No
Female adult or adolescent
Injection drug use 1,513 1,937 — 1,347 1,855 — 1,214 1,9
Heterosexual contacte 1,680 2,397 — 1,724 2,629 — 1,605 2,7
Otherf 927 94 — 968 106 — 877
Subtotal 4,120 4,428 3.5 4,039 4,590 3.6 3,696 4,8
Child (<13 yrs at diagnosis)
Perinatal 34 37 — 50 57 — 40
Otherg 3 3 — 7 8 — 6
Subtotal 37 40 0.1 57 65 0.1 46
Region of Residence
Northeast 4,372 4,640 8.5 4,110 4,615 8.4 3,691 4,8
Midwest 1,358 1,492 2.3 1,347 1,606 2.4 1,229 1,6
South 7,411 7,969 7.4 7,105 8,052 7.4 6,623 8,7
West 2,471 2,662 3.9 2,283 2,651 3.8 1,826 2,4
U.S. dependent areas 514 573 13.3 486 564 13.0 394 4
Totalh 16,126 17,337 5.8 15,331 17,488 5.8 13,763 18,0
Note. Deaths of persons with an AIDS diagnosis may be due to any cause.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incom
Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas. Rates are not calculated by transm
data.
b From the beginning of the epidemic through 2007.
c Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d Hispanics/Latinos can be of any race.
e Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
g Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
h Includes persons of unknown race/ethnicity. Because column totals for estimated numbers were calculated independently of the values for the s
sum to the column total.
Table 13a. Survival for more than 12, 24, and 36 months after a diagnosis of HIV infection during 2000–2004, by 
selected characteristics—37 states with confidential name-based HIV infection reporting
No. of persons
Proportion survived 
(in months)
>12 >24 >36
Age at diagnosis (yr)
<13 1,252 0.97 0.97 0.97
13–14 218 0.99 0.98 0.98
15–19 4,850 0.99 0.99 0.98
20–24 15,656 0.99 0.98 0.97
25–29 20,830 0.97 0.96 0.95
30–34 27,931 0.96 0.95 0.94
35–39 33,866 0.95 0.93 0.91
40–44 28,889 0.93 0.91 0.89
45–49 20,055 0.90 0.87 0.85
50–54 11,935 0.88 0.84 0.81
55–59 6,250 0.84 0.81 0.77
60–64 3,312 0.81 0.75 0.72
65 2,914 0.71 0.66 0.61
Race/ethnicity
American Indian/Alaska Native 818 0.91 0.89 0.87
Asiana 1,163 0.95 0.93 0.93
Black/African American 91,158 0.93 0.91 0.89
Hispanic/Latinob 30,986 0.94 0.92 0.91
Native Hawaiian/Other Pacific Islander 102 0.97 0.95 0.94
White 51,936 0.94 0.92 0.91
Multiple races 1,686 0.95 0.92 0.90
Transmission category
Male adult or adolescent
Male-to-male sexual contact 62,840 0.95 0.94 0.93
Injection drug use 12,547 0.91 0.87 0.84
Male-to-male sexual contact and injection drug use 5,783 0.96 0.94 0.92
Heterosexual contactc 14,402 0.94 0.92 0.90
Otherd 30,144 0.88 0.86 0.84
Subtotal 125,716 0.93 0.91 0.89
Female adult or adolescent
Injection drug use 6,897 0.93 0.90 0.87
Heterosexual contactc 25,088 0.96 0.94 0.93
Otherd 19,005 0.93 0.91 0.89
Subtotal 50,990 0.94 0.92 0.91
Child (<13 yrs at diagnosis)
Perinatal 1,102 0.97 0.97 0.97
Othere 150 0.98 0.97 0.97
Subtotal 1,252 0.97 0.97 0.97
Year of diagnosis
2000 29,074 0.93 0.91 0.89
2001 39,369 0.93 0.91 0.89
2002 37,569 0.94 0.92 0.90
2003 35,002 0.94 0.92 0.90
2004 36,944 0.94 0.92 0.91
Totalf 177,958 0.94 0.92 0.90
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Excludes persons whose month of diagnosis 
or month of death is unknown.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least 
January 2005.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
f Includes persons of unknown race/ethnicity.
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Table 13b. Survival for more than 12, 24, and 36 months after a diagnosis of HIV infection during 2000–2004, by 
selected characteristics—37 states and 5 U.S. dependent areas with confidential name-based HIV infection 
reporting
No. of persons
Proportion survived 
(in months)
>12 >24 >36
Age at diagnosis (yr)
<13 1,296 0.97 0.97 0.96
13–14 227 0.99 0.98 0.98
15–19 4,983 0.99 0.99 0.98
20–24 16,205 0.98 0.98 0.97
25–29 21,619 0.97 0.96 0.95
30–34 28,871 0.96 0.95 0.94
35–39 35,040 0.94 0.93 0.91
40–44 29,933 0.93 0.91 0.89
45–49 20,806 0.90 0.87 0.85
50–54 12,403 0.87 0.84 0.81
55–59 6,561 0.84 0.80 0.77
60–64 3,479 0.80 0.75 0.71
65 3,099 0.71 0.66 0.61
Race/ethnicity
American Indian/Alaska Native 820 0.91 0.89 0.87
Asiana 1,181 0.95 0.93 0.93
Black/African American 91,303 0.93 0.91 0.89
Hispanic/Latinob 37,357 0.92 0.91 0.89
Native Hawaiian/Other Pacific Islander 104 0.97 0.95 0.94
White 51,960 0.94 0.92 0.91
Multiple races 1,688 0.95 0.92 0.90
Transmission category
Male adult or adolescent
Male-to-male sexual contact 63,870 0.95 0.94 0.93
Injection drug use 14,562 0.90 0.86 0.84
Male-to-male sexual contact and injection drug use 6,035 0.95 0.94 0.91
Heterosexual contactc 15,407 0.93 0.91 0.89
Otherd 30,398 0.88 0.86 0.84
Subtotal 130,272 0.93 0.91 0.89
Female adult or adolescent
Injection drug use 7,413 0.93 0.90 0.87
Heterosexual contactc 26,395 0.96 0.94 0.92
Otherd 19,146 0.93 0.91 0.89
Subtotal 52,954 0.94 0.92 0.90
Child (<13 yrs at diagnosis)
Perinatal 1,141 0.97 0.97 0.96
Othere 155 0.97 0.96 0.96
Subtotal 1,296 0.97 0.97 0.96
Year of diagnosis
2000 30,482 0.93 0.90 0.88
2001 40,669 0.93 0.91 0.89
2002 38,937 0.93 0.91 0.90
2003 36,323 0.93 0.92 0.90
2004 38,111 0.94 0.92 0.90
Totalf 184,522 0.93 0.91 0.90
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Excludes persons whose month of diagnosis 
or month of death is unknown.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least 
January 2005.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
f Includes persons of unknown race/ethnicity.
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Table 14a. Survival for more than 12, 24, and 36 months after an AIDS diagnosis during 2000–2004, by selected 
characteristics—United States
No. of persons
Proportion survived 
(in months)
>12 >24 >36
Age at diagnosis (yr)
<13 493 0.93 0.92 0.91
13–14 331 0.97 0.96 0.93
15–19 1,477 0.97 0.95 0.93
20–24 7,227 0.94 0.92 0.90
25–29 15,906 0.93 0.91 0.88
30–34 28,882 0.92 0.89 0.87
35–39 40,611 0.91 0.87 0.85
40–44 37,486 0.89 0.85 0.82
45–49 26,886 0.86 0.82 0.78
50–54 16,151 0.83 0.78 0.74
55–59 8,081 0.79 0.74 0.71
60–64 4,222 0.75 0.69 0.65
65 3,660 0.66 0.59 0.54
Race/ethnicity
American Indian/Alaska Native 862 0.86 0.81 0.77
Asiana 1,791 0.90 0.88 0.87
Black/African American 96,366 0.87 0.83 0.80
Hispanic/Latinob 34,749 0.90 0.87 0.85
Native Hawaiian/Other Pacific Islander 191 0.90 0.85 0.83
White 55,627 0.89 0.86 0.83
Multiple races 1,792 0.92 0.88 0.84
Transmission category
Male adult or adolescent
Male-to-male sexual contact 67,968 0.91 0.88 0.86
Injection drug use 21,834 0.85 0.80 0.76
Male-to-male sexual contact and injection drug use 9,551 0.92 0.88 0.84
Heterosexual contactc 15,632 0.89 0.85 0.82
Otherd 25,549 0.82 0.78 0.75
Subtotal 140,534 0.88 0.85 0.82
Female adult or adolescent
Injection drug use 11,597 0.87 0.81 0.76
Heterosexual contactc 24,521 0.91 0.87 0.84
Otherd 14,268 0.86 0.81 0.79
Subtotal 50,386 0.89 0.84 0.81
Child (<13 yrs at diagnosis)
Perinatal 462 0.93 0.92 0.92
Othere 31 0.87 0.84 0.84
Subtotal 493 0.93 0.92 0.91
Region of residence
Northeast 53,076 0.89 0.86 0.83
Midwest 20,313 0.89 0.86 0.84
South 85,701 0.87 0.83 0.79
West 32,323 0.90 0.87 0.85
Year of diagnosis
2000 39,145 0.87 0.83 0.80
2001 38,092 0.88 0.84 0.81
2002 38,128 0.88 0.84 0.81
2003 38,679 0.89 0.86 0.83
2004 37,369 0.89 0.86 0.83
Totalf 191,413 0.88 0.85 0.82
Note. Data exclude persons whose month of diagnosis or month of death is unknown.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
f Includes persons of unknown race/ethnicity.
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Table 14b. Survival for more than 12, 24, and 36 months after an AIDS diagnosis during 2000–2004, by selected 
characteristics—United States and 5 U.S. dependent areas
No. of persons
Proportion survived 
(in months)
>12 >24 >36
Age at diagnosis (yr)
<13 507 0.92 0.91 0.90
13–14 346 0.97 0.96 0.93
15–19 1,507 0.97 0.94 0.93
20–24 7,390 0.94 0.92 0.89
25–29 16,293 0.93 0.90 0.88
30–34 29,603 0.92 0.89 0.86
35–39 41,736 0.90 0.87 0.84
40–44 38,513 0.88 0.84 0.81
45–49 27,669 0.85 0.81 0.78
50–54 16,626 0.82 0.78 0.74
55–59 8,383 0.78 0.74 0.70
60–64 4,373 0.74 0.69 0.65
65 3,842 0.65 0.59 0.54
Race/ethnicity
American Indian/Alaska Native 864 0.86 0.81 0.78
Asiana 1,808 0.90 0.88 0.87
Black/African American 96,469 0.87 0.83 0.80
Hispanic/Latinob 39,984 0.87 0.84 0.82
Native Hawaiian/Other Pacific Islander 192 0.90 0.85 0.83
White 55,641 0.89 0.86 0.83
Multiple races 1,795 0.92 0.88 0.84
Transmission category
Male adult or adolescent
Male-to-male sexual contact 68,841 0.91 0.88 0.86
Injection drug use 23,580 0.84 0.79 0.75
Male-to-male sexual contact and injection drug use 9,839 0.91 0.87 0.84
Heterosexual contactc 16,471 0.88 0.85 0.82
Other  d 25,642 0.81 0.78 0.75
Subtotal 144,373 0.88 0.84 0.82
Female adult or adolescent
Injection drug use 12,039 0.86 0.80 0.75
Heterosexual contactc 25,540 0.90 0.87 0.84
Otherd 14,329 0.86 0.81 0.79
Subtotal 51,908 0.88 0.84 0.80
Child (<13 yrs at diagnosis)
Perinatal 475 0.92 0.91 0.91
Othere 32 0.88 0.81 0.81
Subtotal 507 0.92 0.91 0.90
Region of residence
Midwest 20,313 0.89 0.86 0.84
Northeast 53,076 0.89 0.86 0.83
South 85,701 0.87 0.83 0.79
West 32,323 0.90 0.87 0.85
U.S. dependent areas 5,375 0.71 0.68 0.65
Year of diagnosis
2000 40,317 0.87 0.83 0.79
2001 39,276 0.87 0.83 0.80
2002 39,178 0.88 0.84 0.81
2003 39,749 0.89 0.85 0.83
2004 38,268 0.89 0.86 0.83
Totalf 196,788 0.88 0.84 0.81
Note. Data exclude persons whose month of diagnosis or month of death is unknown.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
f Includes persons of unknown race/ethnicity.
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2007
No.
Estimateda
No. Rate
2,791 2,919 7.9
1,215 1,248 21.6
5,320 5,624 37.9
16,244 17,486 120.3
33,099 35,154 239.4
47,215 49,547 367.1
77,128 80,086 546.9
110,241 113,613 743.9
106,855 109,553 687.5
77,265 78,963 538.5
45,454 46,347 362.0
21,594 22,027 215.2
17,465 17,803 66.4
2,225 2,306 126.7
3,119 3,315 55.4
267,795 276,464 967.5
96,483 100,304 364.0
230 245 173.6
186,382 191,953 133.3
4,799 4,918 187.2
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T
s Living with a Diagnosis of HIV Infection or AI
able 15a.
DS
Persons living with a diagnosis of HIV infection, by year and selected characteristics, 2005–2007—37 state
infection reporting  
2005 2006
No.
Estimateda
No.
Estimateda
No. Rate No. Rate
Age at end of year
<13 3,686 3,814 10.5 3,205 3,332 9.1
13–14 1,347 1,380 23.3 1,291 1,324 22.6
15–19 4,373 4,543 31.3 4,852 5,070 34.5
20–24 14,525 15,278 105.0 15,240 16,174 111.3
25–29 30,688 32,085 231.8 31,802 33,475 233.7
30–34 49,276 51,185 370.6 47,598 49,680 367.1
35–39 83,272 86,029 596.7 80,067 82,967 569.7
40–44 110,697 113,910 719.3 111,780 115,214 739.6
45–49 93,249 95,785 613.6 99,670 102,410 646.2
50–54 62,955 64,614 464.6 70,069 71,883 504.3
55–59 34,575 35,521 292.5 39,861 40,884 320.3
60–64 15,903 16,370 178.1 18,339 18,837 199.4
65 12,809 13,233 51.1 14,861 15,301 58.2
Race/ethnicity
American Indian/Alaska Native 2,004 2,074 117.3 2,100 2,177 121.3
Asianb 2,519 2,644 47.3 2,778 2,928 50.6
Black/African American 246,715 254,470 912.2 256,815 265,268 940.3
Hispanic/Latinoc 87,801 91,044 357.2 91,948 95,539 360.4
Native Hawaiian/Other Pacific Islander 162 172 131.9 200 213 156.9
White 172,563 177,573 124.3 179,178 184,627 128.8
Multiple races 4,736 4,902 201.3 4,761 4,932 195.0
ates with confidential name-based HIV 
2007
No.
Estimateda
e No. Rate
214,621 265,330 —
51,419 68,532 —
24,743 30,037 —
36,239 51,150 —
77,524 2,748 —
.5 404,546 417,797 492.8
27,665 40,197 —
72,683 111,629 —
48,449 1,989 —
.3 148,797 153,814 173.0
7,563 7,757 —
978 1,000 —
.6 8,541 8,757 23.6
.1 561,886 580,371 275.4
 January 2005.
plete reporting. Rates are per 100,000 population. 
ubpopulations, the values in each column may not 
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Table 15a. Persons living with a diagnosis of HIV infection, by year and selected characteristics, 2005–2007—37 st
infection reporting (cont)
2005 2006
No.
Estimateda
No.
Estimateda
No. Rate No. Rat
Transmission category
Male adult or adolescent
Male-to-male sexual contact 193,456 235,655 — 203,758 249,876 —
Injection drug use 52,306 68,609 — 51,812 68,632 —
Male-to-male sexual contact and injection drug use 24,678 29,691 — 24,730 29,928 —
Heterosexual contactd 33,816 46,229 — 35,045 48,616 —
Othere 67,054 2,770 — 71,725 2,794 —
Subtotal 371,310 382,954 463.2 387,070 399,847 477
Female adult or adolescent
Injection drug use 28,192 40,082 — 27,952 40,245 —
Heterosexual contactd 67,920 100,206 — 70,359 105,842 —
Othere 41,590 1,955 — 44,815 1,963 —
Subtotal 137,702 142,242 163.5 143,126 148,051 168
Child (<13 yrs at diagnosis)
Perinatal 7,390 7,577 — 7,471 7,664 —
Otherf 951 972 — 966 988 —
Subtotal 8,341 8,549 23.5 8,437 8,651 23
Totalg 517,355 533,747 259.0 538,635 556,552 267
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incom
Rates are not calculated by transmission category because of the lack of denominator data.
b Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c Hispanics/Latinos can be of any race.
d Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
f Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g Includes persons of unknown race/ethnicity. Because column totals for estimated numbers were calculated independently of the values for the s
sum to the column total.
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2007
No.
Estimateda
No. Rate
2,856 2,989 7.9
1,254 1,289 21.8
5,512 5,825 38.4
16,649 17,922 120.8
34,093 36,227 241.5
48,816 51,247 371.6
79,538 82,604 553.1
113,889 117,365 753.8
110,396 113,164 697.7
79,857 81,601 546.6
47,056 47,974 367.6
22,440 22,886 218.8
18,374 18,727 68.5
2,227 2,308 —
3,200 3,399 —
268,128 276,814 —
114,815 119,217 —
236 251 —
186,461 192,036 —
4,801 4,920 —
Table 15b. Persons living with a diagnosis of HIV infection, by year and selected characteristics, 2005–2007—37 state
confidential name-based HIV infection reporting  
2005 2006
No.
Estimateda
No.
Estimateda
No. Rate No. Rate
Age at end of year
<13 3,775 3,907 10.5 3,277 3,408 9.1
13–14 1,403 1,438 23.7 1,343 1,378 23.0
15–19 4,559 4,735 31.8 5,032 5,257 35.0
20–24 14,958 15,737 105.8 15,659 16,619 111.9
25–29 31,673 33,129 234.0 32,804 34,547 236.0
30–34 50,936 52,922 375.1 49,224 51,394 371.7
35–39 86,043 88,890 604.2 82,662 85,660 576.7
40–44 114,402 117,701 729.6 115,504 119,030 749.8
45–49 96,373 98,963 622.8 102,941 105,738 655.5
50–54 65,032 66,719 471.1 72,462 74,315 512.0
55–59 35,838 36,804 297.0 41,265 42,310 325.1
60–64 16,569 17,047 181.4 19,104 19,615 203.1
65 13,478 13,912 52.7 15,631 16,083 60.0
Race/ethnicity
American Indian/Alaska Native 2,006 2,077 — 2,102 2,179 —
Asianb 2,599 2,727 — 2,858 3,011 —
Black/African American 247,012 254,779 — 257,131 265,598 —
Hispanic/Latinoc 105,010 108,708 — 109,728 113,829 —
Native Hawaiian/Other Pacific Islander 167 177 — 205 218 —
White 172,641 177,654 — 179,256 184,709 —
Multiple races 4,740 4,906 — 4,764 4,935 —
ates and 5 U.S. dependent areas with 
2007
No.
Estimateda
e No. Rate
— 217,639 268,692 —
— 57,135 74,692 —
— 25,705 31,036 —
— 38,490 53,687 —
— 78,288 2,785 —
.0 417,257 430,892 498.3
— 29,227 41,869 —
76,488 115,925 —
48,862 2,014 —
.3 154,577 159,808 176.0
7,851 8,049 —
1,043 1,067 —
.0 8,894 9,116 24.1
.5 580,730 599,819 278.9
 January 2005.
plete reporting. Rates are per 100,000 population. 
ission category because of the lack of denominator 
ubpopulations, the values in each column may not 
P
ersons Living w
ith a D
iagnosis of H
IV
 Infection or A
ID
S
79
Table 15b. Persons living with a diagnosis of HIV infection, by year and selected characteristics, 2005–2007—37 st
confidential name-based HIV infection reporting (cont)
2005 2006
No.
Estimateda
No.
Estimateda
No. Rate No. Rat
Transmission category
Male adult or adolescent
Male-to-male sexual contact 196,199 238,613 — 206,632 253,019
Injection drug use 57,934 74,562 — 57,498 74,701
Male-to-male sexual contact and injection drug use 25,666 30,711 — 25,701 30,931
Heterosexual contactd 35,901 48,497 — 37,234 51,036
Othere 67,545 2,806 — 72,339 2,831
Subtotal 383,245 395,189 468.6 399,404 412,519 483
Female adult or adolescent
Injection drug use 29,755 41,740 — 29,525 41,922
Heterosexual contactd 71,456
1,981
— 74,028 109,921 —
Othere 41,886
104,083
— 45,165 1,987 —
Subtotal 143,097 147,804 166.4 148,718 153,830 171
Child (<13 yrs at diagnosis)
Perinatal 7,682 7,874 — 7,758 7,955 —
Otherf 1,013 1,036 — 1,026 1,049 —
Subtotal 8,695 8,909 23.9 8,784 9,004 24
Totalg 535,039 551,904 262.3 556,908 575,355 270
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incom
Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas. Rates are not calculated by transm
data.
b Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c Hispanics/Latinos can be of any race.
d Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
f Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g Includes persons of unknown race/ethnicity. Because column totals for estimated numbers were calculated independently of the values for the s
sum to the column total.
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No.
Estimateda
No. Rate
890 908 1.7
655 664 8.0
2,617 2,693 12.6
5,558 5,900 28.1
14,430 15,200 72.5
27,537 28,619 147.2
56,110 57,600 272.7
92,967 94,504 430.4
97,135 98,026 428.9
73,276 73,440 349.4
44,379 44,240 242.5
21,268 21,106 145.7
17,021 16,695 44.0
1,684 1,696 73.7
4,391 4,554 35.3
198,551 201,223 546.7
86,242 87,690 192.8
412 424 99.4
158,543 159,963 80.4
3,838 3,862 89.5
Table 16a. Persons living with an AIDS diagnosis, by year and selected characteristics, 2005–2007—United States  
2005 2006
No.
Estimateda
No.
Estimateda
No. Rate No. Rate
Age at end of year
<13 1,432 1,451 2.8 1,145 1,163 2.2
13–14 772 778 9.1 727 736 8.7
15–19 2,239 2,277 10.8 2,461 2,511 11.8
20–24 5,011 5,188 24.8 5,219 5,446 26.0
25–29 13,465 13,896 69.9 14,020 14,590 71.2
30–34 29,980 30,727 154.0 28,421 29,302 150.0
35–39 62,619 63,789 305.0 59,301 60,644 287.8
40–44 94,852 96,152 421.7 95,091 96,570 430.9
45–49 84,927 85,741 381.9 90,947 91,880 403.8
50–54 59,681 60,011 300.3 66,486 66,838 326.8
55–59 33,613 33,716 194.4 38,893 38,959 214.0
60–64 15,378 15,388 118.4 17,988 17,963 134.5
65 12,328 12,250 33.3 14,425 14,280 38.3
Race/ethnicity
American Indian/Alaska Native 1,542 1,561 69.7 1,611 1,630 71.8
Asianb 3,738 3,825 31.3 4,040 4,153 33.0
Black/African American 181,337 183,779 509.5 189,895 192,625 528.9
Hispanic/Latinoc 77,946 78,994 185.7 82,126 83,403 189.6
Native Hawaiian/Other Pacific Islander 325 330 80.5 370 378 90.4
White 147,662 149,060 75.3 153,182 154,721 77.9
Multiple races 3,562 3,627 89.7 3,717 3,785 90.6
 (cont)
2007
No.
Estimateda
e No. Rate
189,432 216,140 —
52,788 63,509 —
26,790 29,505 —
30,001 37,867 —
47,219 3,470 —
.1 346,230 350,491 288.3
26,319 33,854 —
51,995 68,802 —
25,453 2,604 —
.6 103,767 105,260 82.8
3,654 3,653 —
191 189 —
.4 3,845 3,842 7.3
.8 130,020 131,920 240.9
.5 48,941 49,564 74.7
.0 184,168 185,240 167.9
.7 90,714 92,870 132.9
.8 453,843 459,594 152.5
plete reporting. Rates are per 100,000 population. 
ubpopulations, the values in each column may not 
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Table 16a. Persons living with an AIDS diagnosis, by year and selected characteristics, 2005–2007—United States
2005 2006
No.
Estimateda
No.
Estimateda
No. Rate No. Rat
Transmission category
Male adult or adolescent
Male-to-male sexual contact 173,225 195,037 — 181,398 205,652 —
Injection drug use 52,201 62,230 — 52,487 62,972 —
Male-to-male sexual contact and injection drug use 26,041 28,552 — 26,439 29,090 —
Heterosexual contactd 26,912 33,300 — 28,537 35,634 —
Othere 40,365 3,327 — 43,670 3,418 —
Subtotal 318,744 322,447 271.4 332,531 336,766 280
Female adult or adolescent
Injection drug use 25,890 32,721 — 26,102 33,330 —
Heterosexual contactd 46,607 59,966 — 49,396 64,449 —
Othere 21,181 2,344 — 23,235 2,469 —
Subtotal 93,678 95,030 76.2 98,733 100,249 79
Child (<13 yrs at diagnosis)
Perinatal 3,676 3,686 — 3,665 3,671 —
Otherf 199 199 — 195 194 —
Subtotal 3,875 3,885 7.5 3,860 3,866 7
Region of residence
Northeast 121,495 123,170 225.9 125,830 127,723 233
Midwest 44,160 44,683 67.9 46,631 47,203 71
South 167,109 168,558 157.2 175,627 177,217 163
West 83,533 84,951 124.9 87,036 88,737 128
Totalg 416,297 421,363 142.6 435,124 440,880 147
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incom
Rates are not calculated by transmission category because of the lack of denominator data.
b Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c Hispanics/Latinos can be of any race.
d Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
f Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g Includes persons of unknown race/ethnicity. Because column totals for estimated numbers were calculated independently of the values for the s
sum to the column total.
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2007
No.
Estimateda
No. Rate
911 929 1.7
671 680 8.1
2,701 2,777 12.7
5,700 6,044 28.4
14,699 15,481 72.8
28,152 29,248 148.2
57,366 58,860 274.8
95,337 96,841 435.1
99,558 100,372 433.8
75,145 75,232 353.5
45,594 45,399 245.5
21,899 21,702 147.6
17,708 17,336 45.0
1,686 1,698 —
4,420 4,583 —
198,738 201,404 —
97,562 98,726 —
416 428 —
158,591 160,010 —
3,840 3,864 —
191,417 218,136 —
56,476 67,121 —
27,511 30,196 —
31,462 39,353 —
47,449 3,527 —
354,315 358,332 290.7
Table 16b. Persons living with an AIDS diagnosis, by year and selected characteristics, 2005–2007—United States an
2005 2006
No.
Estimateda
No.
Estimateda
No. Rate No. Rate
Age at end of year
<13 1,467 1,485 2.8 1,175 1,193 2.2
13–14 796 801 9.2 749 757 8.8
15–19 2,335 2,372 11.1 2,544 2,594 12.0
20–24 5,149 5,327 25.1 5,363 5,590 26.3
25–29 13,736 14,172 70.2 14,290 14,867 71.5
30–34 30,699 31,451 155.4 29,073 29,962 151.1
35–39 64,182 65,336 308.1 60,701 62,036 290.4
40–44 97,301 98,549 426.7 97,543 98,973 435.9
45–49 87,117 87,855 386.5 93,194 94,045 408.2
50–54 61,202 61,463 303.7 68,238 68,517 330.7
55–59 34,566 34,625 196.9 39,950 39,965 216.5
60–64 15,874 15,860 120.2 18,553 18,499 136.4
65 12,844 12,733 34.2 15,022 14,839 39.3
Race/ethnicity
American Indian/Alaska Native 1,544 1,563 — 1,613 1,632 —
Asianb 3,770 3,857 — 4,071 4,183 —
Black/African American 181,493 183,930 — 190,068 192,793 —
Hispanic/Latinoc 88,666 89,415 — 93,131 94,100 —
Native Hawaiian/Other Pacific Islander 329 334 — 373 381 —
White 147,710 149,107 — 153,231 154,770 —
Multiple races 3,565 3,630 — 3,719 3,787 —
Transmission category
Male adult or adolescent
Male-to-male sexual contact 175,068 196,868 — 183,302 207,551 —
Injection drug use 55,779 65,716 — 56,116 66,509 —
Male-to-male sexual contact and injection drug use 26,765 29,248 — 27,152 29,771 —
Heterosexual contactd 28,277 34,671 — 29,954 37,065 —
Othere 40,540 3,381 — 43,869 3,474 —
Subtotal 326,429 329,884 273.8 340,393 344,370 282.5
 and 5 U.S. dependent areas (cont)
2007
No.
Estimateda
e No. Rate
— 27,317 34,845 —
— 54,225 71,088 —
— 25,582 2,643 —
.0 107,124 108,576 84.2
— 3,806 3,800 —
— 195 192 —
.6 4,001 3,992 7.5
.8 130,020 131,920 240.9
.5 48,941 49,564 74.7
.0 184,168 185,240 167.9
.7 90,714 92,870 132.9
.0 11,598 11,307 260.1
.3 465,441 470,902 154.1
plete reporting. Rates are per 100,000 population. 
ission category because of the lack of denominator 
ubpopulations, the values in each column may not 
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Table 16b. Persons living with an AIDS diagnosis, by year and selected characteristics, 2005–2007—United States
2005 2006
No.
Estimateda
No.
Estimateda
No. Rate No. Rat
Female adult or adolescent
Injection drug use 26,862 33,684 — 27,094 34,314
Heterosexual contactd 48,656 62,037 — 51,536 66,626
Othere 21,283 2,380 — 23,352 2,506
Subtotal 96,801 98,101 77.6 101,982 103,447 81
Child (<13 yrs at diagnosis)
Perinatal 3,835 3,841 — 3,821 3,822
Otherf 203 203 — 199 198
Subtotal 4,038 4,044 7.6 4,020 4,021 7
Region of residence
Northeast 121,495 123,170 225.9 125,830 127,723 233
Midwest 44,160 44,683 67.9 46,631 47,203 71
South 167,109 168,558 157.2 175,627 177,217 163
West 83,533 84,951 124.9 87,036 88,737 128
U.S. dependent areas 10,971 10,667 246.8 11,271 10,957 253
Totalg 427,268 432,029 144.1 446,395 451,837 149
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incom
Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas. Rates are not calculated by transm
data.
b Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c Hispanics/Latinos can be of any race.
d Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
f Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g Includes persons of unknown race/ethnicity. Because column totals for estimated numbers were calculated independently of the values for the s
sum to the column total.
Table 17a. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 
2007—37 states with confidential name-based HIV infection reporting  
No.
Estimateda
No. Rate
American Indian/Alaska Native
Age at end of year
<13 10 11 2.8
13–14 1 1 1.6
15–19 23 24 14.5
20–24 76 83 52.1
25–29 172 185 132.3
30–34 239 251 210.1
35–39 404 418 347.8
40–44 421 434 343.5
45–49 396 406 316.1
50–54 264 271 240.0
55–59 117 119 127.9
60–64 57 58 85.5
65 45 46 32.3
Transmission category
Male adult or adolescent
Male-to-male sexual contact 909 1,055 —
Injection drug use 184 214 —
Male-to-male sexual contact and injection drug use 209 246 —
Heterosexual contactb 103 125 —
Otherc 188 10 —
Subtotal 1,593 1,650 234.4
Female adult or adolescent
Injection drug use 155 199 —
Heterosexual contactb 305 418 —
Otherc 144 11 —
Subtotal 604 627 85.3
Child (<13 yrs at diagnosis)
Perinatal 23 24 —
Otherd 5 5 —
Subtotal 28 29 7.6
Totale 2,225 2,306 126.7
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Table 17a. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 
2007—37 states with confidential name-based HIV infection reporting (cont)
No.
Estimateda
No. Rate
Asianf
Age at end of year
<13 23 25 2.3
13–14 5 5 3.5
15–19 21 23 6.5
20–24 85 94 24.9
25–29 224 243 47.6
30–34 464 501 83.1
35–39 621 661 110.7
40–44 596 632 124.5
45–49 458 481 108.7
50–54 300 314 81.9
55–59 172 181 56.3
60–64 77 80 35.5
65 73 76 17.4
Transmission category
Male adult or adolescent
Male-to-male sexual contact 1,318 1,954 —
Injection drug use 86 161 —
Male-to-male sexual contact and injection drug use 58 84 —
Heterosexual contactb 239 325 —
Otherc 704 36 —
Subtotal 2,405 2,559 107.4
Female adult or adolescent
Injection drug use 32 75 —
Heterosexual contactb 320 588 —
Otherc 318 47 —
Subtotal 670 710 28.1
Child (<13 yrs at diagnosis)
Perinatal 31 33 —
Otherd 13 13 —
Subtotal 44 46 4.3
Totale 3,119 3,315 55.4
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Table 17a. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 
2007—37 states with confidential name-based HIV infection reporting (cont)
No.
Estimateda
No. Rate
Black/African American
Age at end of year
<13 1,913 1,998 34.8
13–14 817 839 85.5
15–19 3,613 3,824 151.3
20–24 10,391 11,152 481.7
25–29 18,527 19,582 885.8
30–34 24,237 25,310 1,317.4
35–39 35,929 37,192 1,847.6
40–44 48,891 50,318 2,416.9
45–49 47,297 48,506 2,338.0
50–54 36,601 37,396 2,058.5
55–59 21,715 22,134 1,506.2
60–64 9,714 9,908 975.3
65 8,150 8,306 345.8
Transmission category
Male adult or adolescent
Male-to-male sexual contact 65,171 87,446 —
Injection drug use 26,099 37,091 —
Male-to-male sexual contact and injection drug use 8,928 11,902 —
Heterosexual contactb 23,838 35,588 —
Otherc 43,533 909 —
Subtotal 167,569 172,935 1,621.0
Female adult or adolescent
Injection drug use 14,658 22,908 —
Heterosexual contactb 46,123 73,899 —
Otherc 34,009 1,141 —
Subtotal 94,790 97,948 805.4
Child (<13 yrs at diagnosis)
Perinatal 4,967 5,095 —
Otherd 468 484 —
Subtotal 5,435 5,579 97.1
Totale 267,795 276,464 967.5
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Table 17a. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 
2007—37 states with confidential name-based HIV infection reporting (cont)
No.
Estimateda
No. Rate
Hispanic/Latinog
Age at end of year
<13 493 517 7.3
13–14 235 242 26.8
15–19 915 964 45.0
20–24 2,640 2,865 133.6
25–29 6,066 6,517 261.5
30–34 9,340 9,891 412.1
35–39 14,588 15,274 699.2
40–44 19,312 20,007 1,031.8
45–49 17,472 17,967 1,100.0
50–54 12,055 12,373 969.0
55–59 6,986 7,152 724.5
60–64 3,466 3,550 492.3
65 2,915 2,984 180.4
Transmission category
Male adult or adolescent
Male-to-male sexual contact 34,578 43,908 —
Injection drug use 13,493 17,781 —
Male-to-male sexual contact and injection drug use 3,604 4,449 —
Heterosexual contactb 6,448 8,246 —
Otherc 13,704 308 —
Subtotal 71,827 74,691 703.3
Female adult or adolescent
Injection drug use 4,840 6,813 —
Heterosexual contactb 11,594 16,834 —
Otherc 6,536 236 —
Subtotal 22,970 23,883 242.3
Child (<13 yrs at diagnosis)
Perinatal 1,521 1,561 —
Otherd 165 170 —
Subtotal 1,686 1,731 24.5
Totale 96,483 100,304 364.0
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Table 17a. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 
2007—37 states with confidential name-based HIV infection reporting (cont)
No.
Estimateda
No. Rate
Native Hawaiian/Other Pacific Islander
Age at end of year
<13 0 0 0.0
13–14 0 0 0.0
15–19 0 0 0.0
20–24 14 15 133.1
25–29 28 30 214.3
30–34 42 45 349.2
35–39 36 38 340.8
40–44 32 33 330.0
45–49 37 40 452.8
50–54 12 12 167.5
55–59 13 14 235.5
60–64 11 12 294.3
65 5 5 68.7
Transmission category
Male adult or adolescent
Male-to-male sexual contact 131 165 —
Injection drug use 5 7 —
Male-to-male sexual contact and injection drug use 4 5 —
Heterosexual contactb 10 14 —
Otherc 32 2 —
Subtotal 182 194 351.0
Female adult or adolescent
Injection drug use 5 7 —
Heterosexual contactb 24 42 —
Otherc 19 2 —
Subtotal 48 51 95.3
Child (<13 yrs at diagnosis)
Perinatal 0 0 —
Otherd 0 0 —
Subtotal 0 0 0.0
Totale 230 245 173.6
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Table 17a. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 
2007—37 states with confidential name-based HIV infection reporting (cont)
No.
Estimateda
No. Rate
White
Age at end of year
<13 314 328 1.5
13–14 143 147 4.1
15–19 699 736 7.8
20–24 2,860 3,086 33.1
25–29 7,720 8,212 89.9
30–34 12,441 13,078 157.5
35–39 24,758 25,689 267.9
40–44 39,921 41,098 391.8
45–49 40,079 41,019 355.8
50–54 27,267 27,822 253.9
55–59 15,991 16,285 165.5
60–64 8,069 8,218 101.0
65 6,120 6,235 28.3
Transmission category
Male adult or adolescent
Male-to-male sexual contact 110,637 128,290 —
Injection drug use 11,074 12,634 —
Male-to-male sexual contact and injection drug use 11,672 12,983 —
Heterosexual contactb 5,274 6,419 —
Otherc 18,409 1,450 —
Subtotal 157,066 161,776 271.6
Female adult or adolescent
Injection drug use 7,656 9,730 —
Heterosexual contactb 13,520 18,653 —
Otherc 6,891 522 —
Subtotal 28,067 28,905 46.1
Child (<13 yrs at diagnosis)
Perinatal 937 959 —
Otherd 312 313 —
Subtotal 1,249 1,272 5.9
Totale 186,382 191,953 133.3
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Table 17a. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 
2007—37 states with confidential name-based HIV infection reporting (cont)
No.
Estimateda
No. Rate
Multiple races
Age at end of year
<13 34 36 3.6
13–14 13 13 11.9
15–19 49 53 21.5
20–24 174 187 92.5
25–29 349 372 206.6
30–34 424 443 325.2
35–39 697 717 570.1
40–44 896 917 778.1
45–49 942 959 809.4
50–54 612 619 587.6
55–59 344 346 400.2
60–64 153 153 230.0
65 112 105 73.2
Transmission category
Male adult or adolescent
Male-to-male sexual contact 1,729 2,079 —
Injection drug use 447 543 —
Male-to-male sexual contact and injection drug use 262 308 —
Heterosexual contactb 313 388 —
Otherc 511 23 —
Subtotal 3,262 3,341 421.3
Female adult or adolescent
Injection drug use 303 400 —
Heterosexual contactb 758 1,059 —
Otherc 385 26 —
Subtotal 1,446 1,485 175.3
Child (<13 yrs at diagnosis)
Perinatal 80 81 —
Otherd 11 10 —
Subtotal 91 92 9.3
Totale 4,799 4,918 187.2
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Table 17a. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 
2007—37 states with confidential name-based HIV infection reporting (cont)
No.
Estimateda
No.h Rate
Totali
Age at end of year
<13 2,791 2,919 7.9
13–14 1,215 1,248 21.6
15–19 5,320 5,624 37.9
20–24 16,244 17,486 120.3
25–29 33,099 35,154 239.4
30–34 47,215 49,547 367.1
35–39 77,128 80,086 546.9
40–44 110,241 113,613 743.9
45–49 106,855 109,553 687.5
50–54 77,265 78,963 538.5
55–59 45,454 46,347 362.0
60–64 21,594 22,027 215.2
65 17,465 17,803 66.4
Transmission category
Male adult or adolescent
Male-to-male sexual contact 214,621 265,330 —
Injection drug use 51,419 68,532 —
Male-to-male sexual contact and injection drug use 24,743 30,037 —
Heterosexual contactb 36,239 51,150 —
Otherc 77,524 2,748 —
Subtotal 404,546 417,797 492.8
Female adult or adolescent
Injection drug use 27,665 40,197 —
Heterosexual contactb 72,683 111,629 —
Otherc 48,449 1,989 —
Subtotal 148,797 153,814 173.0
Child (<13 yrs at diagnosis)
Perinatal 7,563 7,757 —
Otherd 978 1,000 —
Subtotal 8,541 8,757 23.6
Totale 561,886 580,371 275.4
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least 
January 2005.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete 
reporting. Rates are per 100,000 population. Rates are not calculated by transmission category because of the lack of denominator data.
b Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
c Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
d Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may 
not sum to the column total.
f Includes Asian/Pacific Islander legacy cases (see Technical Notes).
g Hispanics/Latinos can be of any race.
h Because row totals were calculated independently of the values for the subpopulations, the values in each row may not sum to the row total.
i Includes persons of unknown race/ethnicity.
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Table 17b. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 
2007—37 states and 5 U.S. dependent areas with confidential name-based HIV infection reporting  
No. Est. No.a
American Indian/
Alaska Native
Age at end of year
<13 10 11
13–14 1 1
15–19 23 24
20–24 76 83
25–29 172 185
30–34 239 251
35–39 404 418
40–44 422 435
45–49 397 407
50–54 264 271
55–59 117 119
60–64 57 58
65 45 46
Transmission category
Male adult or adolescent
Male-to-male sexual contact 910 1,056
Injection drug use 184 214
Male-to-male sexual contact and injection drug use 209 246
Heterosexual contactb 104 126
Otherc 188 10
Subtotal 1,595 1,652
Female adult or adolescent
Injection drug use 155 199
Heterosexual contactb 305 418
Otherc 144 11
Subtotal 604 627
Child (<13 yrs at diagnosis)
Perinatal 23 24
Otherd 5 5
Subtotal 28 29
Totale 2,227 2,308
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Table 17b. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 
2007—37 states and 5 U.S. dependent areas with confidential name-based HIV infection reporting (cont)
No. Est. No.a
Asianf
Age at end of year
<13 24 26
13–14 5 5
15–19 21 23
20–24 86 95
25–29 232 252
30–34 472 509
35–39 644 685
40–44 610 646
45–49 472 495
50–54 304 318
55–59 176 185
60–64 80 83
65 74 77
Transmission category
Male adult or adolescent
Male-to-male sexual contact 1,354 2,000
Injection drug use 86 169
Male-to-male sexual contact and injection drug use 59 86
Heterosexual contactb 241 332
Otherc 728 37
Subtotal 2,468 2,624
Female adult or adolescent
Injection drug use 32 77
Heterosexual contactb 324 602
Otherc 331 48
Subtotal 687 727
Child (<13 yrs at diagnosis)
Perinatal 32 34
Otherd 13 13
Subtotal 45 47
Totale 3,200 3,399
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Table 17b. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 
2007—37 states and 5 U.S. dependent areas with confidential name-based HIV infection reporting (cont)
No. Est. No.a
Black/African American
Age at end of year
<13 1,918 2,004
13–14 818 840
15–19 3,616 3,827
20–24 10,395 11,156
25–29 18,550 19,607
30–34 24,261 25,336
35–39 35,983 37,249
40–44 48,953 50,383
45–49 47,349 48,560
50–54 36,640 37,436
55–59 21,741 22,160
60–64 9,738 9,933
65 8,166 8,322
Transmission category
Male adult or adolescent
Male-to-male sexual contact 65,227 87,512
Injection drug use 26,119 37,142
Male-to-male sexual contact and injection drug use 8,932 11,909
Heterosexual contactb 23,880 35,661
Otherc 43,601 910
Subtotal 167,759 173,135
Female adult or adolescent
Injection drug use 14,668 22,930
Heterosexual contactb 46,187 74,014
Otherc 34,068 1,144
Subtotal 94,923 98,088
Child (<13 yrs at diagnosis)
Perinatal 4,974 5,103
Otherd 471 487
Subtotal 5,445 5,590
Totale 268,128 276,814
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Table 17b. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 
2007—37 states and 5 U.S. dependent areas with confidential name-based HIV infection reporting (cont)
No. Est. No.a
Hispanic/Latinog
Age at end of year
<13 552 580
13–14 273 282
15–19 1,104 1,162
20–24 3,039 3,295
25–29 7,028 7,556
30–34 10,908 11,556
35–39 16,909 17,699
40–44 22,866 23,661
45–49 20,933 21,495
50–54 14,585 14,947
55–59 8,545 8,733
60–64 4,275 4,371
65 3,798 3,881
Transmission category
Male adult or adolescent
Male-to-male sexual contact 37,454 47,102
Injection drug use 19,183 23,872
Male-to-male sexual contact and injection drug use 4,555 5,431
Heterosexual contactb 8,650 10,696
Otherc 14,368 342
Subtotal 84,210 87,443
Female adult or adolescent
Injection drug use 6,389 8,455
Heterosexual contactb 15,320 20,984
Otherc 6,868 256
Subtotal 28,577 29,695
Child (<13 yrs at diagnosis)
Perinatal 1,801 1,844
Otherd 227 234
Subtotal 2,028 2,078
Totale 114,815 119,217
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Table 17b. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 
2007—37 states and 5 U.S. dependent areas with confidential name-based HIV infection reporting (cont)
No. Est. No.a
Native Hawaiian/Other 
Pacific Islander
Age at end of year
<13 0 0
13–14 0 0
15–19 0 0
20–24 14 15
25–29 28 30
30–34 43 46
35–39 36 38
40–44 34 35
45–49 39 42
50–54 13 13
55–59 13 14
60–64 11 12
65 5 5
Transmission category
Male adult or adolescent
Male-to-male sexual contact 135 170
Injection drug use 5 8
Male-to-male sexual contact and injection drug use 4 5
Heterosexual contactb 10 14
Otherc 33 2
Subtotal 187 199
Female adult or adolescent
Injection drug use 5 7
Heterosexual contactb 25
19Otherc
43
2
Subtotal 49 52
Child (<13 yrs at diagnosis)
Perinatal 0 0
Otherd 0 0
Subtotal 0 0
Totale 236 251
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Table 17b. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 
2007—37 states and 5 U.S. dependent areas with confidential name-based HIV infection reporting (cont)
No. Est. No.a
White
Age at end of year
<13 314 328
13–14 143 147
15–19 699 736
20–24 2,861 3,087
25–29 7,721 8,213
30–34 12,441 13,078
35–39 24,767 25,698
40–44 39,934 41,112
45–49 40,089 41,029
50–54 27,283 27,839
55–59 16,004 16,299
60–64 8,079 8,229
65 6,126 6,241
Transmission category
Male adult or adolescent
Male-to-male sexual contact 110,676 128,334
Injection drug use 11,079 12,643
Male-to-male sexual contact and injection drug use 11,678 12,990
Heterosexual contactb 5,277 6,423
Otherc 18,416 1,450
Subtotal 157,126 161,839
Female adult or adolescent
Injection drug use 7,658 9,735
Heterosexual contactb 13,529 18,668
Otherc 6,899 522
Subtotal 28,086 28,924
Child (<13 yrs at diagnosis)
Perinatal 937 959
Otherd 312 313
Subtotal 1,249 1,272
Totale 186,461 192,036
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Table 17b. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 
2007—37 states and 5 U.S. dependent areas with confidential name-based HIV infection reporting (cont)
No. Est. No.a
Multiple races
Age at end of year
<13 34 36
13–14 13 13
15–19 49 53
20–24 174 187
25–29 349 372
30–34 424 443
35–39 698 718
40–44 897 918
45–49 942 959
50–54 612 619
55–59 344 346
60–64 153 153
65 112 105
Transmission category
Male adult or adolescent
Male-to-male sexual contact 1,729 2,078
Injection drug use 448 544
Male-to-male sexual contact and injection drug use 262 308
Heterosexual contactb 314 389
Otherc 511 23
Subtotal 3,264 3,343
Female adult or adolescent
Injection drug use 303 400
Heterosexual contactb 758 1,059
Otherc 385 26
Subtotal 1,446 1,485
Child (<13 yrs at diagnosis)
Perinatal 80 81
Otherd 11 10
Subtotal 91 92
Totale 4,801 4,920
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Table 17b. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 
2007—37 states and 5 U.S. dependent areas with confidential name-based HIV infection reporting (cont)
No. Est. No.a,h
Totali
Age at end of year
<13 2,856 2,989
13–14 1,254 1,289
15–19 5,512 5,825
20–24 16,649 17,922
25–29 34,093 36,227
30–34 48,816 51,247
35–39 79,538 82,604
40–44 113,889 117,365
45–49 110,396 113,164
50–54 79,857 81,601
55–59 47,056 47,974
60–64 22,440 22,886
65 18,374 18,727
Transmission category
Male adult or adolescent
Male-to-male sexual contact 217,639 268,692
Injection drug use 57,135 74,692
Male-to-male sexual contact and injection drug use 25,705 31,036
Heterosexual contactb 38,490 53,687
Otherc 78,288 2,785
Subtotal 417,257 430,892
Female adult or adolescent
Injection drug use 29,227 41,869
Heterosexual contactb 76,488 115,925
Otherc 48,862 2,014
Subtotal 154,577 159,808
Child (<13 yrs at diagnosis)
Perinatal 7,851 8,049
Otherd 1,043 1,067
Subtotal 8,894 9,116
Totale 580,730 599,819
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least 
January 2005.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete 
reporting.
b Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
c Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
d Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may 
not sum to the column total.
f Includes Asian/Pacific Islander legacy cases (see Technical Notes).
g Hispanics/Latinos can be of any race.
h Because row totals were calculated independently of the values for the subpopulations, the values in each row may not sum to the row total.
i Includes persons of unknown race/ethnicity.
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Table 18a. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2007—
United States  
No.
Estimateda
No. Rate
American Indian/Alaska Native
Age at end of year
<13 3 3 0.6
13–14 0 0 0.0
15–19 10 10 4.9
20–24 21 22 10.9
25–29 68 72 41.2
30–34 133 137 90.9
35–39 276 280 183.2
40–44 382 383 237.5
45–49 345 345 208.1
50–54 235 233 158.6
55–59 113 113 92.9
60–64 56 56 63.3
65 42 41 22.5
Transmission category
Male adult or adolescent
Male-to-male sexual contact 700 755 —
Injection drug use 176 193 —
Male-to-male sexual contact and injection drug use 225 240 —
Heterosexual contactb 73 82 —
Otherc 100 12 —
Subtotal 1,274 1,282 143.0
Female adult or adolescent
Injection drug use 133 159 —
Heterosexual contactb 184 227 —
Otherc 80 14 —
Subtotal 397 400 42.8
Child (<13 yrs at diagnosis)
Perinatal 12 12 —
Otherd 1 1 —
Subtotal 13 13 2.8
Region of residence
Northeast 140 146 111.5
Midwest 199 197 49.7
South 422 434 60.6
West 923 919 87.0
Totale 1,684 1,696 73.7
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Table 18a. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2007—
United States (cont)
No.
Estimateda
No. Rate
Asianf
Age at end of year
<13 5 5 0.2
13–14 2 2 0.6
15–19 12 13 1.6
20–24 46 51 6.1
25–29 153 165 16.1
30–34 407 435 36.2
35–39 779 819 66.9
40–44 883 915 85.3
45–49 780 804 82.8
50–54 597 607 69.7
55–59 382 390 52.7
60–64 184 187 35.7
65 161 162 13.3
Transmission category
Male adult or adolescent
Male-to-male sexual contact 2,298 2,895 —
Injection drug use 159 234 —
Male-to-male sexual contact and injection drug use 159 186 —
Heterosexual contactb 301 375 —
Otherc 725 86 —
Subtotal 3,642 3,776 72.9
Female adult or adolescent
Injection drug use 51 84 —
Heterosexual contactb 436 589 —
Otherc 247 90 —
Subtotal 734 764 13.6
Child (<13 yrs at diagnosis)
Perinatal 11 11 —
Otherd 4 4 —
Subtotal 15 15 0.7
Region of residence
Northeast 1,030 1,068 39.0
Midwest 312 326 21.2
South 577 595 22.3
West 2,472 2,565 43.0
Totale 4,391 4,554 35.3
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Table 18a. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2007—
United States (cont)
No.
Estimateda
No. Rate
Black/African American
Age at end of year
<13 614 628 8.6
13–14 465 472 37.4
15–19 1,788 1,842 56.6
20–24 3,414 3,619 122.0
25–29 7,794 8,176 290.4
30–34 13,456 13,942 565.2
35–39 24,533 25,135 961.8
40–44 38,545 39,208 1,447.6
45–49 40,111 40,537 1,499.9
50–54 32,372 32,478 1,381.6
55–59 19,553 19,488 1,023.3
60–64 8,759 8,698 658.3
65 7,147 7,000 222.4
Transmission category
Male adult or adolescent
Male-to-male sexual contact 50,915 62,080 —
Injection drug use 27,807 34,578 —
Male-to-male sexual contact and injection drug use 9,460 10,943 —
Heterosexual contactb 18,799 24,824 —
Otherc 24,771 1,054 —
Subtotal 131,752 133,479 965.6
Female adult or adolescent
Injection drug use 14,867 19,865 —
Heterosexual contactb 32,079 43,952 —
Otherc 17,310 1,381 —
Subtotal 64,256 65,198 415.5
Child (<13 yrs at diagnosis)
Perinatal 2,459 2,460 —
Otherd 83 84 —
Subtotal 2,542 2,544 34.9
Region of residence
Northeast 58,153 59,056 971.9
Midwest 21,940 22,295 331.1
South 103,108 104,074 501.2
West 15,350 15,797 488.7
Totale 198,551 201,223 546.7
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Table 18a. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2007—
United States (cont)
No.
Estimateda
No. Rate
Hispanic/Latinog
Age at end of year
<13 157 160 1.4
13–14 109 111 7.1
15–19 449 461 12.4
20–24 1,220 1,306 36.0
25–29 3,486 3,707 90.3
30–34 6,925 7,232 183.3
35–39 12,779 13,174 364.5
40–44 18,546 18,886 593.3
45–49 17,241 17,398 652.7
50–54 12,007 12,028 581.1
55–59 6,914 6,891 440.0
60–64 3,448 3,420 305.0
65 2,961 2,915 115.7
Transmission category
Male adult or adolescent
Male-to-male sexual contact 34,595 40,922 —
Injection drug use 12,876 15,712 —
Male-to-male sexual contact and injection drug use 4,222 4,786 —
Heterosexual contactb 5,967 7,092 —
Otherc 10,269 567 —
Subtotal 67,929 69,079 395.3
Female adult or adolescent
Injection drug use 4,293 5,502 —
Heterosexual contactb 9,318 11,927 —
Otherc 4,006 489 —
Subtotal 17,617 17,918 110.3
Child (<13 yrs at diagnosis)
Perinatal 650 647 —
Otherd 46 46 —
Subtotal 696 693 5.9
Region of residence
Northeast 34,927 35,378 565.3
Midwest 4,716 4,835 117.3
South 22,349 22,337 140.5
West 24,250 25,139 131.0
Totale 86,242 87,690 192.8
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Table 18a. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2007—
United States (cont)
No.
Estimateda
No. Rate
Native Hawaiian/Other Pacific Islander
Age at end of year
<13 3 3 3.6
13–14 1 1 7.4
15–19 1 1 2.8
20–24 6 6 17.7
25–29 30 32 83.3
30–34 41 43 123.9
35–39 58 61 185.1
40–44 88 90 285.2
45–49 85 87 290.9
50–54 46 46 186.7
55–59 33 33 164.8
60–64 11 11 76.9
65 9 9 30.6
Transmission category
Male adult or adolescent
Male-to-male sexual contact 250 285 —
Injection drug use 12 14 —
Male-to-male sexual contact and injection drug use 19 20 —
Heterosexual contactb 19 21 —
Otherc 33 2 —
Subtotal 333 343 200.9
Female adult or adolescent
Injection drug use 8 11 —
Heterosexual contactb 45 59 —
Otherc 21 6 —
Subtotal 74 76 44.9
Child (<13 yrs at diagnosis)
Perinatal 5 5 —
Otherd 0 0 —
Subtotal 5 5 5.9
Region of residence
Northeast 21 23 109.7
Midwest 14 15 61.6
South 64 67 113.2
West 313 319 99.1
Totale 412 424 99.4
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Table 18a. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2007—
United States (cont)
No.
Estimateda
No. Rate
White
Age at end of year
<13 101 102 0.3
13–14 70 70 1.4
15–19 331 339 2.6
20–24 775 818 6.3
25–29 2,736 2,876 23.0
30–34 6,306 6,554 57.4
35–39 17,147 17,585 132.5
40–44 33,713 34,204 234.2
45–49 37,697 37,975 235.6
50–54 27,412 27,441 178.5
55–59 17,011 16,952 123.3
60–64 8,652 8,578 75.9
65 6,592 6,468 21.1
Transmission category
Male adult or adolescent
Male-to-male sexual contact 99,206 107,516 —
Injection drug use 11,295 12,233 —
Male-to-male sexual contact and injection drug use 12,418 13,008 —
Heterosexual contactb 4,581 5,164 —
Otherc 10,922 1,717 —
Subtotal 138,422 139,639 168.9
Female adult or adolescent
Injection drug use 6,673 7,859 —
Heterosexual contactb 9,398 11,340 —
Otherc 3,509 586 —
Subtotal 19,580 19,786 22.7
Child (<13 yrs at diagnosis)
Perinatal 486 486 —
Otherd 55 52 —
Subtotal 541 538 1.8
Region of residence
Northeast 33,980 34,454 88.5
Midwest 21,326 21,456 40.7
South 56,315 56,412 81.9
West 46,922 47,641 123.6
Totale 158,543 159,963 80.4
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Table 18a. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2007—
United States (cont)
No.
Estimateda
No. Rate
Multiple races
Age at end of year
<13 7 7 0.5
13–14 7 7 3.8
15–19 26 28 6.5
20–24 75 77 21.6
25–29 163 171 57.0
30–34 266 272 118.5
35–39 520 528 245.1
40–44 783 791 395.1
45–49 843 847 421.4
50–54 558 556 314.3
55–59 345 344 241.2
60–64 149 146 135.6
65 96 87 38.2
Transmission category
Male adult or adolescent
Male-to-male sexual contact 1,391 1,589 —
Injection drug use 448 518 —
Male-to-male sexual contact and injection drug use 282 315 —
Heterosexual contactb 256 299 —
Otherc 356 29 —
Subtotal 2,733 2,749 205.1
Female adult or adolescent
Injection drug use 286 360 —
Heterosexual contactb 524 689 —
Otherc 264 34 —
Subtotal 1,074 1,082 75.8
Child (<13 yrs at diagnosis)
Perinatal 29 29 —
Otherd 2 1 —
Subtotal 31 30 2.0
Region of residence
Northeast 1,663 1,687 278.3
Midwest 430 436 53.8
South 1,302 1,290 96.9
West 443 449 28.7
Totale 3,838 3,862 89.5
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Table 18a. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2007—
United States (cont)
No.
Estimateda
No.h Rate
Totali
Age at end of year
<13 890 908 1.7
13–14 655 664 8.0
15–19 2,617 2,693 12.6
20–24 5,558 5,900 28.1
25–29 14,430 15,200 72.5
30–34 27,537 28,619 147.2
35–39 56,110 57,600 272.7
40–44 92,967 94,504 430.4
45–49 97,135 98,026 428.9
50–54 73,276 73,440 349.4
55–59 44,379 44,240 242.5
60–64 21,268 21,106 145.7
65 17,021 16,695 44.0
Transmission category
Male adult or adolescent
Male-to-male sexual contact 189,432 216,140 —
Injection drug use 52,788 63,509 —
Male-to-male sexual contact and injection drug use 26,790 29,505 —
Heterosexual contactb 30,001 37,867 —
Otherc 47,219 3,470 —
Subtotal 346,230 350,491 288.3
Female adult or adolescent
Injection drug use 26,319 33,854 —
Heterosexual contactb 51,995 68,802 —
Otherc 25,453 2,604 —
Subtotal 103,767 105,260 82.8
Child (<13 yrs at diagnosis)
Perinatal 3,654 3,653 —
Otherd 191 189 —
Subtotal 3,845 3,842 7.3
Region of residence
Northeast 130,020 131,920 240.9
Midwest 48,941 49,564 74.7
South 184,168 185,240 167.9
West 90,714 92,870 132.9
Totale 453,843 459,594 152.5
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete 
reporting. Rates are per 100,000 population. Rates are not calculated by transmission category because of the lack of denominator data.
b Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
c Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
d Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may 
not sum to the column total.
f Includes Asian/Pacific Islander legacy cases (see Technical Notes).
g Hispanics/Latinos can be of any race.
h Because row totals were calculated independently of the values for the subpopulations, the values in each row may not sum to the row total.
i Includes persons of unknown race/ethnicity.
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Table 18b. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2007—
United States and 5 U.S. dependent areas  
No. Est. No.a
American Indian/
Alaska Native
Age at end of year
<13 3 3
13–14 0 0
15–19 10 10
20–24 21 22
25–29 68 72
30–34 133 137
35–39 276 280
40–44 383 384
45–49 346 346
50–54 235 233
55–59 113 113
60–64 56 56
65 42 41
Transmission category
Male adult or adolescent
Male-to-male sexual contact 701 756
Injection drug use 176 193
Male-to-male sexual contact and injection drug use 225 240
Heterosexual contactb 74 83
Otherc 100 12
Subtotal 1,276 1,284
Female adult or adolescent
Injection drug use 133 159
Heterosexual contactb 184 227
Otherc 80 14
Subtotal 397 400
Child (<13 yrs at diagnosis)
Perinatal 12 12
Otherd 1 1
Subtotal 13 13
Region of residence
Northeast 140 146
Midwest 199 197
South 422 434
West 923 919
U.S. dependent areas 2 2
Totale 1,686 1,698
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Table 18b. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2007—
United States and 5 U.S. dependent areas (cont)
No. Est. No.a
Asianf
Age at end of year
<13 5 5
13–14 2 2
15–19 12 13
20–24 46 51
25–29 156 169
30–34 410 438
35–39 787 827
40–44 888 920
45–49 785 808
50–54 598 608
55–59 384 392
60–64 185 188
65 162 163
Transmission category
Male adult or adolescent
Male-to-male sexual contact 2,314 2,912
Injection drug use 159 235
Male-to-male sexual contact and injection drug use 159 186
Heterosexual contactb 302 377
Otherc 731 87
Subtotal 3,665 3,798
Female adult or adolescent
Injection drug use 51 85
Heterosexual contactb 438 594
Otherc 251 91
Subtotal 740 770
Child (<13 yrs at diagnosis)
Perinatal 11 11
Otherd 4 4
Subtotal 15 15
Region of residence
Northeast 1,030 1,068
Midwest 312 326
South 577 595
West 2,472 2,565
U.S. dependent areas 29 28
Totale 4,420 4,583
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Table 18b. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2007—
United States and 5 U.S. dependent areas (cont)
No. Est. No.a
Black/African American
Age at end of year
<13 615 628
13–14 466 473
15–19 1,789 1,843
20–24 3,414 3,619
25–29 7,796 8,178
30–34 13,468 13,954
35–39 24,565 25,168
40–44 38,589 39,252
45–49 40,142 40,567
50–54 32,398 32,502
55–59 19,573 19,507
60–64 8,771 8,709
65 7,152 7,004
Transmission category
Male adult or adolescent
Male-to-male sexual contact 50,957 62,124
Injection drug use 27,822 34,603
Male-to-male sexual contact and injection drug use 9,463 10,946
Heterosexual contactb 18,828 24,861
Otherc 24,795 1,054
Subtotal 131,865 133,588
Female adult or adolescent
Injection drug use 14,874 19,877
Heterosexual contactb 32,116 44,007
Otherc 17,336 1,382
Subtotal 64,326 65,267
Child (<13 yrs at diagnosis)
Perinatal 2,462 2,463
Otherd 84 85
Subtotal 2,546 2,548
Region of residence
Northeast 58,153 59,056
Midwest 21,940 22,295
South 103,108 104,074
West 15,350 15,797
U.S. dependent areas 187 182
Totale 198,738 201,404
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Table 18b. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2007—
United States and 5 U.S. dependent areas (cont)
No. Est. No.a
Hispanic/Latinog
Age at end of year
<13 177 180
13–14 124 126
15–19 532 544
20–24 1,362 1,450
25–29 3,750 3,983
30–34 7,525 7,846
35–39 13,989 14,388
40–44 20,857 21,164
45–49 19,620 19,702
50–54 13,836 13,783
55–59 8,099 8,021
60–64 4,058 3,996
65 3,633 3,543
Transmission category
Male adult or adolescent
Male-to-male sexual contact 36,488 42,821
Injection drug use 16,547 19,293
Male-to-male sexual contact and injection drug use 4,935 5,467
Heterosexual contactb 7,395 8,536
Otherc 10,464 623
Subtotal 75,829 76,740
Female adult or adolescent
Injection drug use 5,281 6,474
Heterosexual contactb 11,502 14,145
Otherc 4,102 527
Subtotal 20,885 21,146
Child (<13 yrs at diagnosis)
Perinatal 799 791
Otherd 49 49
Subtotal 848 840
Region of residence
Northeast 34,927 35,378
Midwest 4,716 4,835
South 22,349 22,337
West 24,250 25,139
U.S. dependent areas 11,320 11,036
Totale 97,562 98,726
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Table 18b. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2007—
United States and 5 U.S. dependent areas (cont)
No. Est. No.a
Native Hawaiian/Other 
Pacific Islander
Age at end of year
<13 3 3
13–14 1 1
15–19 1 1
20–24 6 6
25–29 30 32
30–34 41 43
35–39 58 61
40–44 90 92
45–49 86 88
50–54 47 47
55–59 33 33
60–64 11 11
65 9 9
Transmission category
Male adult or adolescent
Male-to-male sexual contact 252 288
Injection drug use 12 14
Male-to-male sexual contact and injection drug use 19 20
Heterosexual contactb 19 21
Otherc 34 2
Subtotal 336 346
Female adult or adolescent
Injection drug use 8 11
Heterosexual contactb 46 60
Otherc 21 6
Subtotal 75 77
Child (<13 yrs at diagnosis)
Perinatal 5 5
Otherd 0 0
Subtotal 5 5
Region of residence
Northeast 21 23
Midwest 14 15
South 64 67
West 313 319
U.S. dependent areas 4 4
Totale 416 428
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Table 18b. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2007—
United States and 5 U.S. dependent areas (cont)
No. Est. No.a
White
Age at end of year
<13 101 102
13–14 70 70
15–19 331 339
20–24 775 818
25–29 2,736 2,876
30–34 6,306 6,554
35–39 17,152 17,590
40–44 33,718 34,209
45–49 37,702 37,980
50–54 27,423 27,452
55–59 17,019 16,960
60–64 8,660 8,585
65 6,598 6,473
Transmission category
Male adult or adolescent
Male-to-male sexual contact 99,233 107,544
Injection drug use 11,296 12,236
Male-to-male sexual contact and injection drug use 12,423 13,013
Heterosexual contactb 4,582 5,165
Otherc 10,926 1,717
Subtotal 138,460 139,676
Female adult or adolescent
Injection drug use 6,675 7,863
Heterosexual contactb 9,403 11,347
Otherc 3,512 586
Subtotal 19,590 19,796
Child (<13 yrs at diagnosis)
Perinatal 486 486
Otherd 55 52
Subtotal 541 538
Region of residence
Northeast 33,980 34,454
Midwest 21,326 21,456
South 56,315 56,412
West 46,922 47,641
U.S. dependent areas 48 47
Totale 158,591 160,010
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Table 18b. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2007—
United States and 5 U.S. dependent areas (cont)
No. Est. No.a
Multiple races
Age at end of year
<13 7 7
13–14 7 7
15–19 26 28
20–24 75 77
25–29 163 171
30–34 266 272
35–39 521 529
40–44 784 792
45–49 843 847
50–54 558 556
55–59 345 344
60–64 149 146
65 96 87
Transmission category
Male adult or adolescent
Male-to-male sexual contact 1,391 1,589
Injection drug use 449 519
Male-to-male sexual contact and injection drug use 282 315
Heterosexual contactb 257 300
Otherc 356 29
Subtotal 2,735 2,751
Female adult or adolescent
Injection drug use 286 360
Heterosexual contactb 524 689
Otherc 264 34
Subtotal 1,074 1,082
Child (<13 yrs at diagnosis)
Perinatal 29 29
Otherd 2 1
Subtotal 31 30
Region of residence
Northeast 1,663 1,687
Midwest 430 436
South 1,302 1,290
West 443 449
U.S. dependent areas 2 2
Totale 3,840 3,864
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Table 18b. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2007—
United States and 5 U.S. dependent areas (cont)
No. Est. No.a,h
Totali
Age at end of year
<13 911 929
13–14 671 680
15–19 2,701 2,777
20–24 5,700 6,044
25–29 14,699 15,481
30–34 28,152 29,248
35–39 57,366 58,860
40–44 95,337 96,841
45–49 99,558 100,372
50–54 75,145 75,232
55–59 45,594 45,399
60–64 21,899 21,702
65 17,708 17,336
Transmission category
Male adult or adolescent
Male-to-male sexual contact 191,417 218,136
Injection drug use 56,476 67,121
Male-to-male sexual contact and injection drug use 27,511 30,196
Heterosexual contactb 31,462 39,353
Otherc 47,449 3,527
Subtotal 354,315 358,332
Female adult or adolescent
Injection drug use 27,317 34,845
Heterosexual contactb 54,225 71,088
Otherc 25,582 2,643
Subtotal 107,124 108,576
Child (<13 yrs at diagnosis)
Perinatal 3,806 3,800
Otherd 195 192
Subtotal 4,001 3,992
Region of residence
Northeast 130,020 131,920
Midwest 48,941 49,564
South 184,168 185,240
West 90,714 92,870
U.S. dependent areas 11,598 11,307
Totale 465,441 470,902
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete 
reporting.
b Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
c Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
d Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may 
not sum to the column total.
f Includes Asian/Pacific Islander legacy cases (see Technical Notes).
g Hispanics/Latinos can be of any race.
h Because row totals were calculated independently of the values for the subpopulations, the values in each row may not sum to the row total.
i Includes persons of unknown race/ethnicity.
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Area of residence (date confidential name-based HIV infection reporting initiated) No.b
Estimateda
No. Rate
Alabama (January 1988) 718 820 17.6
Alaska (February 1999) 40 46 6.7
Arizona (January 1987) 743 928 14.3
Arkansas (July 1989) 222 261 9.1
California (April 2006) 5,161 — —
Colorado (November 1985) 472 540 10.9
Connecticut (January 2005) 369 484 13.8
Delaware (February 2006) 168 — —
District of Columbia (November 2006) 950 — —
Florida (July 1997) 6,878 7,825 42.7
Georgia (December 2003) 2,436 3,703 38.2
Hawaii (March 2008) 62 — —
Idaho (June 1986) 50 60 3.9
Illinois (January 2006) 1,961 — —
Indiana (July 1988) 479 548 8.6
Iowa (July 1998) 108 123 4.1
Kansas (July 1999) 146 167 5.9
Kentucky (October 2004) 379 435 10.2
Louisiana (February 1993) 1,156 1,277 29.0
Maine (January 2006) 46 — —
Maryland (April 2007) 2,579 — —
Massachusetts (January 2007) 540 — —
Michigan (April 1992) 789 868 8.7
Minnesota (October 1985) 339 386 7.4
Mississippi (August 1988) 568 653 22.2
Missouri (October 1987) 587 677 11.5
Montana (September 2006) 22 — —
Nebraska (September 1995) 91 108 6.1
Nevada (February 1992) 433 491 18.9
New Hampshire (January 2005) 46 60 4.6
New Jersey (January 1992) 1,172 1,818 20.9
New Mexico (January 1998) 153 175 8.8
New York (June 2000) 5,061 6,538 33.5
North Carolina (February 1990) 1,991 2,276 24.7
North Dakota (January 1988) 14 16 2.5
Ohio (June 1990) 949 1,057 9.2
Oklahoma (June 1988) 268 305 8.4
Oregon (April 2006)
2,123
— —
Pennsylvania (October 2002)c
267
— —
Rhode Island (July 2006) 123 — —
South Carolina (February 1986) 733 839 18.7
South Dakota (January 1988) 34 38 4.8
Tennessee (January 1992) 1,062 1,216 19.6
Texas (January 1999) 4,181 4,751 19.5
Utah (April 1989) 126 143 5.2
Vermont (April 2008) 12 — —
Virginia (July 1989) 1,036 1,222 15.7
Washington (March 2006) 537 — —
West Virginia (January 1989) 92 111 6.1
Wisconsin (November 1985) 241 274 4.9
Wyoming (June 1989) 26 30 5.7
Subtotal 48,739 41,269 19.4
U.S. dependent areas
American Samoa (August 2001) 0 0 —
Guam (March 2000) 4 5 3.0
Northern Mariana Islands (October 2001) 0 0 —
Puerto Rico (January 2003) 875 1,133 28.7
U.S. Virgin Islands (December 1998) 24 31 28.6
Subtotal 903 1,170 26.8
Totald 49,642 42,439 19.5
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
a Includes data from areas with confidential name-based HIV infection reporting since at least January 2005. Estimated numbers resulted from 
statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000 population.
b Includes data from areas with confidential name-based HIV infection reporting as of December 2008.
c Pennsylvania implemented confidential name-based HIV infection reporting in October 2002 in all areas except Philadelphia, where confidential 
name-based HIV infection reporting was not implemented until October 2005.
d Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may 
not sum to the column total.
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 Table 20. AIDS diagnoses, by area of residence, 2008 and cumulative—United States and 5 U.S. dependent areas
Area of residence 
2008 Cumulativea
No.
Estimatedb Estimatedb
No. Rate Adults or adolescents Children Total
Alabama 362 406 8.7 9,662 76 9,738
Alaska 20 22 3.2 723 7 730
Arizona 535 589 9.1 11,700 47 11,747
Arkansas 120 151 5.3 4,399 37 4,436
California 3,073 4,835 13.2 159,606 687 160,293
Colorado 338 369 7.5 9,607 32 9,639
Connecticut 286 354 10.1 15,943 184 16,127
Delaware 116 146 16.8 4,001 27 4,028
District of Columbia 389 552 93.3 19,672 192 19,864
Florida 4,331 4,766 26.0 116,041 1,571 117,612
Georgia 1,243 1,908 19.7 38,054 245 38,300
Hawaii 36 39 3.0 3,172 17 3,189
Idaho 28 33 2.1 674 2 676
Illinois 951 1,305 10.1 37,592 288 37,880
Indiana 376 416 6.5 9,129 57 9,186
Iowa 64 75 2.5 1,923 13 1,936
Kansas 95 110 3.9 3,106 15 3,121
Kentucky 262 294 6.9 5,307 37 5,344
Louisiana 862 1,060 24.0 20,184 135 20,319
Maine 29 36 2.7 1,220 8 1,228
Maryland 1,122 1,557 27.6 35,395 330 35,725
Massachusetts 278 380 5.8 21,089 226 21,314
Michigan 563 699 7.0 16,749 117 16,866
Minnesota 187 210 4.0 5,394 28 5,422
Mississippi 330 370 12.6 7,498 59 7,557
Missouri 394 500 8.5 12,385 62 12,447
Montana 24 29 3.0 463 3 466
Nebraska 64 76 4.3 1,667 12 1,679
Nevada 286 321 12.4 6,518 29 6,547
New Hampshire 22 27 2.1 1,188 10 1,199
New Jersey 806 1,527 17.6 53,756 801 54,557
New Mexico 91 100 5.1 2,894 9 2,903
New York 3,632 4,571 23.5 190,363 2,390 192,753
North Carolina 983 1,157 12.5 19,412 126 19,539
North Dakota 11 16 2.4 171 2 173
Ohio 528 667 5.8 16,980 149 17,129
Oklahoma 142 172 4.7 5,410 27 5,437
Oregon 191 211 5.6 6,535 19 6,554
Pennsylvania 1,108 1,402 11.3 37,842 375 38,217
Rhode Island 63 78 7.4 2,818 28 2,846
South Carolina 623 696 15.5 15,068 109 15,176
South Dakota 10 11 1.4 291 6 297
Tennessee 541 597 9.6 13,961 59 14,021
Texas 2,662 2,924 12.0 76,674 396 77,070
Utah 67 75 2.7 2,474 20 2,494
Vermont 9 11 1.8 499 6 505
Virginia 498 634 8.2 18,844 186 19,029
Washington 367 405 6.2 12,791 35 12,826
West Virginia 62 81 4.5 1,706 12 1,718
Wisconsin 152 167 3.0 4,965 34 4,999
Wyoming 14 15 2.9 264 2 266
Subtotal 29,346 37,151 12.2 1,063,779 9,349 1,073,128
U.S. dependent areas
American Samoa 0 0 0.0 1 0 1
Guam 5 5 3.1 83 1 84
Northern Mariana Islands 1 1 1.9 4 0 4
Puerto Rico 626 819 20.7 32,057 406 32,463
U.S. Virgin Islands 13 14 12.7 691 19 710
Subtotal 645 840 19.3 32,836 427 33,262
Totalc 29,991 37,991 12.3 1,096,615 9,776 1,106,391
a From the beginning of the epidemic through 2008.
b Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000 
population.
c Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may 
not sum to the column total.
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Table 21. Adults and adolescents living with a diagnosis of HIV infection, by race/ethnicity and area of residence, 
year-end 2007—United States and 5 U.S. dependent areas  
No.
Estimateda
No. Rate
American Indian/Alaska Native
Area of residence
Alabama 11 11 59.0
Alaska 144 147 185.5
Arizona 377 394 193.3
Arkansas 8 8 51.2
California 466 — —
Colorado 80 82 278.9
Connecticut 11 11 178.0
Delaware 5 — —
District of Columbia 12 — —
Florida 78 82 182.3
Georgia 40 44 226.7
Hawaiib — — —
Idaho 14 15 101.4
Illinois 50 — —
Indiana 12 13 99.6
Iowa 3 3 42.3
Kansas 22 22 117.5
Kentucky 12 13 158.4
Louisiana 19 19 93.0
Maine 8 — —
Maryland 41 — —
Massachusetts 16 — —
Michigan 39 39 87.3
Minnesota 108 110 252.5
Mississippi 13 13 130.0
Missouri 26 27 123.8
Montana 22 — —
Nebraska 28 29 257.9
Nevada 50 51 236.3
New Hampshire 1 1 38.2
New Jersey 28 30 262.4
New Mexico 145 148 110.9
New York 149 158 314.3
North Carolina 199 208 248.7
North Dakota 11 11 45.1
Ohio 26 26 126.1
Oklahoma 288 298 136.4
Oregon 55 — —
Pennsylvania 35 — —
Rhode Island 9 — —
South Carolina 11 12 92.9
South Dakota 58 60 128.6
Tennessee 8 8 54.9
Texas 98 102 136.7
Utah 29 29 126.8
Vermontb — — —
Virginia 21 23 123.3
Washington 164 — —
West Virginia 3 3 93.9
Wisconsin 36 36 95.9
Wyoming 9 10 107.4
Subtotal 3,098 2,296 159.5
U.S. dependent areasc
American Samoa 0 0 —
Guam 0 0 —
Northern Mariana Islands 0 0 —
Puerto Rico 1 1 —
U.S. Virgin Islands 0 0 —
Subtotal 1 1 —
Totald 3,099 2,297 —
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Table 21. Adults and adolescents living with a diagnosis of HIV infection, by race/ethnicity and area of residence, 
year-end 2007—United States and 5 U.S. dependent areas (cont)
No.
Estimateda
No. Rate
Asiane
Area of residence
Alabama 13 14 40.6
Alaska 8 8 32.6
Arizona 46 50 41.9
Arkansas 11 12 49.9
California 2,983 — —
Colorado 56 59 58.9
Connecticut 31 34 36.6
Delaware 6 — —
District of Columbia 42 — —
Florida 181 191 58.6
Georgia 86 92 43.5
Hawaiib — — —
Idaho 3 3 24.9
Illinois 251 — —
Indiana 42 45 66.9
Iowa 13 14 37.7
Kansas 12 13 26.1
Kentucky 19 20 62.5
Louisiana 30 31 61.3
Maine 2 — —
Maryland 117 — —
Massachusetts 158 — —
Michigan 51 52 28.0
Minnesota 63 65 48.0
Mississippi 11 12 64.2
Missouri 43 45 66.8
Montana 0 — —
Nebraska 19 20 87.0
Nevada 96 99 77.2
New Hampshire 8 9 45.6
New Jersey 162 176 33.8
New Mexico 11 12 58.8
New York 1,218 1,310 118.4
North Carolina 87 92 70.0
North Dakota 1 1 29.5
Ohio 60 61 42.6
Oklahoma 17 18 36.4
Oregon 53 — —
Pennsylvania 141 — —
Rhode Island 23 — —
South Carolina 13 14 33.5
South Dakota 2 2 48.3
Tennessee 14 15 23.1
Texas 439 458 72.3
Utah 13 14 34.0
Vermontb — — —
Virginia 180 193 64.6
Washington 253 — —
West Virginia 0 0 0.6
Wisconsin 37 39 46.7
Wyoming 0 0 0.0
Subtotal 7,125 3,290 67.0
U.S. dependent areasc
American Samoa 2 2 —
Guam 66 68 —
Northern Mariana Islands 11 12 —
Puerto Rico 1 1 —
U.S. Virgin Islands 0 0 —
Subtotal 80 83 —
Totald 7,205 3,373 —
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Table 21. Adults and adolescents living with a diagnosis of HIV infection, by race/ethnicity and area of residence, 
year-end 2007—United States and 5 U.S. dependent areas (cont)
No.
Estimateda
No. Rate
Black/African American
Area of residence
Alabama 6,349 6,496 668.3
Alaska 63 66 329.7
Arizona 1,132 1,193 710.5
Arkansas 2,056 2,133 619.2
California 18,195 — —
Colorado 1,424 1,457 996.6
Connecticut 3,315 3,520 1,349.3
Delaware 1,924 — —
District of Columbia 10,625 — —
Florida 43,501 44,604 2,078.0
Georgia 21,528 22,552 1,010.9
Hawaiib — — —
Idaho 34 35 573.7
Illinois 15,134 — —
Indiana 2,699 2,783 638.9
Iowa 281 292 538.6
Kansas 632 655 521.7
Kentucky 1,387 1,436 566.2
Louisiana 10,585 10,598 977.4
Maine 76 — —
Maryland 21,550 — —
Massachusetts 3,590 — —
Michigan 7,771 7,783 686.6
Minnesota 1,923 1,987 1,202.5
Mississippi 5,783 5,939 705.7
Missouri 4,630 4,762 901.3
Montana
381
— —
Nebraska
12
394 694.9
Nevada 1,487 1,522 1,026.9
New Hampshire 142 151 1,577.3
New Jersey 18,117 18,522 2,000.8
New Mexico 118 122 381.4
New York 54,127 56,742 2,395.8
North Carolina 14,691 15,287 984.8
North Dakota 23 24 544.5
Ohio 6,712 6,742 626.6
Oklahoma 1,024 1,061 487.6
Oregon 308 — —
Pennsylvania 15,439 — —
Rhode Island 441 — —
South Carolina 9,713 10,048 997.1
South Dakota 70 74 1,329.2
Tennessee 7,857 8,094 1,001.0
Texas 22,175 22,846 1,058.1
Utah 188 194 1,131.5bVermont — — —
Virginia 11,759 12,083 989.1
Washington 1,384 — —
West Virginia 401 416 833.3
Wisconsin 1,793 1,842 741.5
Wyoming 11 11 302.6
Subtotal 354,560 274,466 1,202.2
U.S. dependent areasc
American Samoa 0 0 —
Guam 4 4 —
Northern Mariana Islands 0 0 —
Puerto Rico 3 3 —
U.S. Virgin Islands 321 337 —
Subtotal 328 344 —
Totald 354,888 274,810 —
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Table 21. Adults and adolescents living with a diagnosis of HIV infection, by race/ethnicity and area of residence, 
year-end 2007—United States and 5 U.S. dependent areas (cont)
No.
Estimateda
No. Rate
Hispanic/Latinof
Area of residence
Alabama 205 215 254.1
Alaska 50 51 181.6
Arizona 2,809 2,978 221.7
Arkansas 155 163 159.7
California 28,488 — —
Colorado 1,748 1,794 255.7
Connecticut 3,381 3,573 1,171.0
Delaware 189 — —
District of Columbia 685 — —
Florida 16,818 17,382 579.0
Georgia 1,203 1,277 251.1
Hawaiib — — —
Idaho 89 92 91.0
Illinois 4,407 — —
Indiana 510 529 239.7
Iowa 125 130 158.7
Kansas 300 312 181.5
Kentucky 192 203 304.6
Louisiana 460 466 428.3
Maine 47 — —
Maryland 884 — —
Massachusetts 3,075 — —
Michigan 533 538 184.0
Minnesota 488 504 358.1
Mississippi 128 135 305.2
Missouri 422 440 347.2
Montana 6 — —
Nebraska 189 196 215.8
Nevada 1,216 1,261 276.4
New Hampshire 110 116 483.5
New Jersey 7,274 7,457 697.3
New Mexico 966 996 147.2
New York 37,106 38,751 1,540.6
North Carolina 1,094 1,157 267.6
North Dakota 5 5 55.8
Ohio 681 685 331.1
Oklahoma 301 315 172.5
Oregon 484 — —
Pennsylvania 4,044 — —
Rhode Island 365 — —
South Carolina 348 366 311.0
South Dakota 12 13 99.9
Tennessee 357 374 254.3
Texas 14,653 15,154 240.9
Utah 354 366 173.2bVermont — — —
Virginia 1,142 1,209 324.9
Washington 968 — —
West Virginia 29 30 204.3
Wisconsin 519 537 280.5
Wyoming 18 19 67.8
Subtotal 139,632 99,787 487.3
U.S. dependent areasc
American Samoa 0 0 —
Guam 4 4 —
Northern Mariana Islands 0 0 —
Puerto Rico 18,096 18,664 —
U.S. Virgin Islands 173 182 —
Subtotal 18,273 18,850 —
Totald 157,905 118,637 —
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Table 21. Adults and adolescents living with a diagnosis of HIV infection, by race/ethnicity and area of residence, 
year-end 2007—United States and 5 U.S. dependent areas (cont)
No.
Estimateda
No. Rate
Native Hawaiian/Other Pacific Islander
Area of residence
Alabama 4 4 387.5
Alaska 5 5 165.5
Arizona 8 9 135.6
Arkansas 5 5 297.8
California 190 — —
Colorado 5 4 109.6
Connecticut 0 0 0.0
Delaware 0 — —
District of Columbia 7 — —
Florida 27 29 347.6
Georgia 7 7 197.6
Hawaiib — — —
Idaho 0 0 0.0
Illinois 19 — —
Indiana 3 3 204.5
Iowa 1 1 119.3
Kansas 2 2 191.4
Kentucky 2 2 183.0
Louisiana 0 0 0.0
Maine 0 — —
Maryland 21 — —
Massachusetts 2 — —
Michigan 5 5 244.2
Minnesota 3 3 170.4
Mississippi 3 3 513.4
Missouri 3 3 107.7
Montana 0 — —
Nebraska 1 1 146.1
Nevada 20 21 235.0
New Hampshire 0 0 0.0
New Jersey 13 14 527.8
New Mexico 1 1 104.6
New York 26 29 410.3
North Carolina 13 14 418.6
North Dakota 0 0 0.0
Ohio 3 2 105.1
Oklahoma 5 5 242.1
Oregon 12 — —
Pennsylvania 21 — —
Rhode Island 1 — —
South Carolina 2 2 149.3
South Dakota 1 1 457.5
Tennessee 8 8 432.7
Texas 41 44 353.3
Utah 3 3 23.1
Vermontb — — —
Virginia 10 11 295.6
Washington 30 — —
West Virginia 0 0 0.0
Wisconsin 0 0 0.0
Wyoming 0 0 0.0
Subtotal 533 245 225.0
U.S. dependent areasc
American Samoa 0 0 —
Guam 5 5 —
Northern Mariana Islands 1 1 —
Puerto Rico 1 1 —
U.S. Virgin Islands 0 0 —
Subtotal 7 7 —
Totald 540 252 —
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Table 21. Adults and adolescents living with a diagnosis of HIV infection, by race/ethnicity and area of residence, 
year-end 2007—United States and 5 U.S. dependent areas (cont)
No.
Estimateda
No. Rate
White
Area of residence
Alabama 3,137 3,201 119.0
Alaska 323 332 87.7
Arizona 6,481 6,780 209.7
Arkansas 2,458 2,529 139.1
California 47,024 — —
Colorado 6,800 6,931 235.0
Connecticut 3,691 3,909 175.6
Delaware 817 — —
District of Columbia 2,201 — —
Florida 27,334 28,142 290.6
Georgia 7,308 7,574 162.5
Hawaiib — — —
Idaho 553 571 54.3
Illinois 9,795 — —
Indiana 4,551 4,660 105.2
Iowa 1,041 1,073 47.0
Kansas 1,475 1,519 80.7
Kentucky 2,631 2,709 86.5
Louisiana 4,491 4,518 196.3
Maine 832 — —
Maryland 4,652 — —
Massachusetts 5,328 — —
Michigan 4,690 4,714 71.3
Minnesota 3,134 3,207 85.3
Mississippi 1,747 1,787 123.5
Missouri 5,577 5,717 140.3
Montana 272 — —
Nebraska 827 852 67.8
Nevada 3,592 3,681 289.2
New Hampshire 788 830 79.5
New Jersey 7,876 8,096 175.8
New Mexico 921 939 129.3
New York 26,900 28,030 277.1
North Carolina 5,756 6,011 115.8
North Dakota 115 119 24.2
Ohio 7,722 7,752 96.8
Oklahoma 2,757 2,844 129.8
Oregon 3,665 — —
Pennsylvania 10,275 — —
Rhode Island 783 — —
South Carolina 3,270 3,385 138.3
South Dakota 223 229 39.5
Tennessee 5,497 5,645 140.2
Texas 21,535 22,117 228.5
Utah 1,511 1,548 89.9
Vermontb — — —
Virginia 6,053 6,268 142.2
Washington 6,861 — —
West Virginia 935 976 67.3
Wisconsin 2,225 2,278 55.9
Wyoming 143 147 38.1
Subtotal 278,573 191,625 156.7
U.S. dependent areasc
American Samoa 0 0 —
Guam 15 16 —
Northern Mariana Islands 0 0 —
Puerto Rico 15 16 —
U.S. Virgin Islands 49 51 —
Subtotal 79 83 —
Totald 278,652 191,708 —
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Table 21. Adults and adolescents living with a diagnosis of HIV infection, by race/ethnicity and area of residence, 
year-end 2007—United States and 5 U.S. dependent areas (cont)
No.
Estimateda
No. Rate
Multiple races
Area of residence
Alabama 93 97 329.8
Alaska 9 9 48.4
Arizona 117 121 222.3
Arkansas 22 21 92.3
California 418 — —
Colorado 34 34 68.5
Connecticut 56 59 224.8
Delaware 7 — —
District of Columbia 77 — —
Florida 1,086 1,096 822.3
Georgia 235 247 388.8
Hawaiib — — —
Idaho 3 3 24.5
Illinois 276 — —
Indiana 111 114 283.9
Iowa 12 12 77.4
Kansas 36 37 133.7
Kentucky 11 12 46.9
Louisiana 51 50 199.0
Maine 2 — —
Maryland 192 — —
Massachusetts 16 — —
Michigan 138 137 149.8
Minnesota 27 28 65.6
Mississippi 28 29 214.2
Missouri 45 48 95.8
Montana 2 — —
Nebraska 7 7 61.5
Nevada 23 24 64.6
New Hampshire 11 11 139.7
New Jersey 323 322 531.4
New Mexico 3 3 17.1
New York 1,679 1,738 1,122.4
North Carolina 54 55 97.8
North Dakota 0 0 0.0
Ohio 71 72 84.7
Oklahoma 84 87 88.6
Oregon 20 — —
Pennsylvania 603 — —
Rhode Island 7 — —
South Carolina 65 67 268.9
South Dakota 0 0 0.6
Tennessee 75 77 199.5
Texas 86 91 58.9
Utah 11 11 50.8
Vermontb — — —
Virginia 111 115 157.2
Washington 71 — —
West Virginia 5 5 50.7
Wisconsin 38 39 114.6
Wyoming 5 5 125.2
Subtotal 6,456 4,882 297.6
U.S. dependent areasc
American Samoa 0 0 —
Guam 2 2 —
Northern Mariana Islands 0 0 —
Puerto Rico 0 0 —
U.S. Virgin Islands 0 0 —
Subtotal 2 2 —
Totald 6,458 4,884 —
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Table 21. Adults and adolescents living with a diagnosis of HIV infection, by race/ethnicity and area of residence, 
year-end 2007—United States and 5 U.S. dependent areas (cont)
No.
Estimateda
No.g Rate
Totalh
Area of residence
Alabama 9,866 10,093 263.5
Alaska 602 618 111.8
Arizona 11,026 11,581 225.8
Arkansas 4,735 4,892 210.1
California 97,803 — —
Colorado 10,213 10,428 262.0
Connecticut 10,486 11,107 380.5
Delaware 2,948 — —
District of Columbia 13,657 — —
Florida 89,028 91,529 596.4
Georgia 30,420 31,806 413.2
Hawaiib — — —
Idaho 696 720 59.9
Illinois 29,936 — —
Indiana 7,928 8,147 156.5
Iowa 1,476 1,526 61.5
Kansas 2,491 2,572 113.0
Kentucky 4,255 4,396 124.9
Louisiana 15,645 15,691 437.0
Maine 968 — —
Maryland 27,466 — —
Massachusetts 12,195 — —
Michigan 13,254 13,295 159.1
Minnesota 5,752 5,910 137.7
Mississippi 7,749 7,955 335.0
Missouri 10,762 11,058 227.0
Montana 314 — —
Nebraska 1,454 1,501 103.5
Nevada 6,490 6,665 321.5
New Hampshire 1,060 1,118 101.0
New Jersey 33,940 34,766 483.1
New Mexico 2,166 2,222 138.4
New York 121,294 126,849 777.4
North Carolina 21,965 22,896 307.4
North Dakota 155 160 29.8
Ohio 15,405 15,471 162.2
Oklahoma 4,476 4,628 156.4
Oregon 4,598 — —
Pennsylvania 30,558 — —
Rhode Island 1,629 — —
South Carolina 13,433 13,905 380.5
South Dakota 366 378 57.7
Tennessee 13,817 14,222 278.9
Texas 59,040 60,825 320.0
Utah 2,113 2,169 105.8
Vermontb — — —
Virginia 19,325 19,951 311.9
Washington 9,741 — —
West Virginia 1,377 1,435 93.3
Wisconsin 4,649 4,773 102.2
Wyoming 186 193 44.4
Subtotal 790,908 577,452 332.5
U.S. dependent areasc
American Samoa 2 2 4.7
Guam 96 99 76.2
Northern Mariana Islands 12 13 28.5
Puerto Rico 18,122 18,691 576.5
U.S. Virgin Islands 547 574 641.3
Subtotal 18,779 19,379 545.6
Totald 809,687 596,831 336.7
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
a Includes data from areas with confidential name-based HIV infection reporting since at least January 2005. Estimated numbers resulted from 
statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000 population. 
b Data not available because confidential name-based HIV infection reporting was not implemented until 2008.
c Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.
d Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may 
not sum to the column total. 
e Includes Asian/Pacific Islander legacy cases (see Technical Notes).
f Hispanics/Latinos can be of any race.
g Because row totals were calculated independently of the values for the subpopulations, the values in each row may not sum to the row total.
h Includes persons of unknown race/ethnicity.
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Table 22. Adults and adolescents living with an AIDS diagnosis, by race/ethnicity and area of residence, year-end 
2007—United States and 5 U.S. dependent areas  
No.
Estimateda
No. Rate
American Indian/Alaska Native
Area of residence
Alabama 1 1 5.3
Alaska 88 85 107.7
Arizona 192 190 93.2
Arkansas 3 3 19.2
California 302 308 189.5
Colorado 35 35 117.8
Connecticut 8 8 126.6
Delaware 3 3 138.4
District of Columbia 6 6 432.3
Florida 27 26 58.3
Georgia 22 24 124.8
Hawaii 7 7 168.9
Idaho 8 8 56.6
Illinois 26 27 147.4
Indiana 2 2 15.0
Iowa 1 1 13.7
Kansas 11 11 56.2
Kentucky 6 6 77.0
Louisiana 11 11 54.8
Maine 3 3 52.5
Maryland 13 13 108.6
Massachusetts 11 11 105.4
Michigan 17 18 39.2
Minnesota 59 58 132.9
Mississippi 6 6 57.4
Missouri 18 18 83.3
Montana 19 20 44.2
Nebraska 11 11 95.5
Nevada 24 24 108.9
New Hampshire 1 1 37.8
New Jersey 15 16 144.7
New Mexico 81 78 58.6
New York 83 86 171.3
North Carolina 87 93 111.7
North Dakota 6 6 22.7
Ohio 9 9 42.4
Oklahoma 169 174 79.6
Oregon 38 38 107.3
Pennsylvania 11 12 77.5
Rhode Island 7 7 211.9
South Carolina 4 4 32.5
South Dakota 24 24 51.1
Tennessee 5 4 31.5
Texas 51 50 67.3
Utah 18 17 75.2
Vermont 1 1 48.3
Virginia 7 7 40.0
Washington 102 99 131.8
West Virginia 1 1 30.1
Wisconsin 14 13 34.8
Wyoming 7 7 80.1
Subtotal 1,681 1,693 92.4
U.S. dependent areasb
American Samoa 0 0 —
Guam 0 0 —
Northern Mariana Islands 0 0 —
Puerto Rico 1 1 —
U.S. Virgin Islands 0 0 —
Subtotal 1 1 —
Totalc 1,682 1,694 —
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Table 22. Adults and adolescents living with an AIDS diagnosis, by race/ethnicity and area of residence, year-end 
2007—United States and 5 U.S. dependent areas (cont)
No.
Estimateda
No. Rate
Asiand
Area of residence
Alabama 6 6 17.7
Alaska 5 5 19.4
Arizona 11 11 9.1
Arkansas 4 4 18.2
California 1,965 2,060 55.3
Colorado 30 31 30.5
Connecticut 11 12 12.4
Delaware 2 2 11.6
District of Columbia 18 20 115.0
Florida 76 77 23.5
Georgia 40 43 20.4
Hawaii 201 199 44.9
Idaho 0 0 0.0
Illinois 134 144 32.3
Indiana 23 23 35.1
Iowa 8 8 22.2
Kansas 9 9 18.9
Kentucky 9 9 27.6
Louisiana 20 20 40.8
Maine 2 2 24.3
Maryland 42 45 19.6
Massachusetts 120 126 49.4
Michigan 27 28 15.3
Minnesota 33 33 24.2
Mississippi 6 6 33.5
Missouri 17 17 26.0
Montana 0 0 0.0
Nebraska 12 12 53.2
Nevada 58 57 44.2
New Hampshire 4 4 22.4
New Jersey 72 78 14.9
New Mexico 8 8 41.4
New York 715 736 66.5
North Carolina 27 30 22.5
North Dakota 1 1 28.2
Ohio 25 25 17.8
Oklahoma 11 12 23.2
Oregon 38 38 34.7
Pennsylvania 85 89 37.7
Rhode Island 19 20 86.2
South Carolina 7 7 17.4
South Dakota 1 1 23.5
Tennessee 7 7 11.2
Texas 212 212 33.4
Utah 8 8 20.1
Vermont 0 0 0.0
Virginia 89 95 31.7
Washington 145 146 41.5
West Virginia 1 1 12.3
Wisconsin 22 23 28.0
Wyoming 0 0 0.0
Subtotal 4,386 4,549 42.2
U.S. dependent areasb
American Samoa 1 1 —
Guam 26 25 —
Northern Mariana Islands 2 2 —
Puerto Rico 0 0 —
U.S. Virgin Islands 0 0 —
Subtotal 29 28 —
Totalc 4,415 4,577 —
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Table 22. Adults and adolescents living with an AIDS diagnosis, by race/ethnicity and area of residence, year-end 
2007—United States and 5 U.S. dependent areas (cont)
No.
Estimateda
No. Rate
Black/African American
Area of residence
Alabama 2,629 2,552 262.6
Alaska 43 44 219.0
Arizona 493 484 288.1
Arkansas 947 985 286.0
California 12,177 12,654 691.4
Colorado 646 644 440.8
Connecticut 2,354 2,418 926.8
Delaware 1,214 1,256 896.2
District of Columbia 7,232 7,271 2,709.9
Florida 24,241 23,522 1,095.8
Georgia 12,671 13,481 604.3
Hawaii 64 63 248.4
Idaho 15 17 270.1
Illinois 8,467 8,715 584.7
Indiana 1,312 1,296 297.6
Iowa 175 175 322.8
Kansas 323 322 256.7
Kentucky 809 798 314.8
Louisiana 5,389 5,508 508.0
Maine 36 38 453.9
Maryland 12,681 13,080 990.4
Massachusetts 2,700 2,821 923.2
Michigan 4,085 4,128 364.2
Minnesota 859 860 520.8
Mississippi 2,505 2,458 292.1
Missouri 2,398 2,433 460.6
Montana 10 10 295.1
Nebraska 199 198 348.2
Nevada 685 668 450.6
New Hampshire 84 88 915.7
New Jersey 9,696 10,105 1,091.5
New Mexico 65 66 205.3
New York 33,408 33,483 1,413.7
North Carolina 5,866 6,275 404.3
North Dakota 10 10 229.2
Ohio 3,129 3,177 295.2
Oklahoma 499 518 238.1
Oregon 199 199 395.8
Pennsylvania 9,315 9,527 931.6
Rhode Island 361 375 902.7
South Carolina 5,189 5,226 518.7
South Dakota 32 33 590.9
Tennessee 3,670 3,596 444.7
Texas 11,874 11,664 540.2
Utah 95 95 553.7
Vermont 24 24 696.7
Virginia 5,184 5,361 438.8
Washington 820 816 471.8
West Virginia 186 194 388.0
Wisconsin 866 860 346.3
Wyoming 6 6 159.2
Subtotal 197,937 200,595 679.7
U.S. dependent areasb
American Samoa 0 0 —
Guam 0 0 —
Northern Mariana Islands 0 0 —
Puerto Rico 1 1 —
U.S. Virgin Islands 185 180 —
Subtotal 186 181 —
Totalc 198,123 200,776 —
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Table 22. Adults and adolescents living with an AIDS diagnosis, by race/ethnicity and area of residence, year-end 
2007—United States and 5 U.S. dependent areas (cont)
No.
Estimateda
No. Rate
Hispanic/Latinoe
Area of residence
Alabama 102 103 121.7
Alaska 35 35 123.1
Arizona 1,359 1,348 100.3
Arkansas 76 80 78.7
California 19,436 20,351 208.0
Colorado 868 862 122.8
Connecticut 2,256 2,322 761.2
Delaware 111 115 296.0
District of Columbia 472 486 1,217.0
Florida 9,158 9,020 300.5
Georgia 769 832 163.7
Hawaii 115 113 147.8
Idaho 33 32 31.8
Illinois 2,603 2,704 193.7
Indiana 280 279 126.2
Iowa 84 84 102.8
Kansas 178 178 103.9
Kentucky 143 147 221.4
Louisiana 250 260 238.7
Maine 26 27 233.1
Maryland 546 579 219.8
Massachusetts 2,230 2,326 575.0
Michigan 299 305 104.4
Minnesota 259 259 184.2
Mississippi 72 73 164.6
Missouri 221 225 177.6
Montana 5 5 25.4
Nebraska 120 119 131.5
Nevada 622 619 135.7
New Hampshire 64 66 274.1
New Jersey 3,893 4,052 378.8
New Mexico 591 586 86.6
New York 23,657 23,737 943.7
North Carolina 500 535 123.7
North Dakota 3 3 31.9
Ohio 374 381 184.3
Oklahoma 161 171 93.6
Oregon 326 327 118.8
Pennsylvania 2,439 2,475 609.3
Rhode Island 301 311 356.8
South Carolina 194 198 168.0
South Dakota 4 4 32.0
Tennessee 188 189 128.7
Texas 8,967 8,879 141.1
Utah 203 202 95.6
Vermont 11 11 177.0
Virginia 584 613 164.7
Washington 596 597 140.9
West Virginia 11 11 77.4
Wisconsin 278 280 146.3
Wyoming 12 13 45.0
Subtotal 86,085 87,530 259.6
U.S. dependent areasb
American Samoa 0 0 —
Guam 0 0 —
Northern Mariana Islands 0 0 —
Puerto Rico 11,196 10,912 —
U.S. Virgin Islands 104 104 —
Subtotal 11,300 11,016 —
Totalc 97,385 98,546 —
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Table 22. Adults and adolescents living with an AIDS diagnosis, by race/ethnicity and area of residence, year-end 
2007—United States and 5 U.S. dependent areas (cont)
No.
Estimateda
No. Rate
Native Hawaiian/Other Pacific Islander
Area of residence
Alabama 2 2 187.8
Alaska 3 3 89.9
Arizona 4 4 61.5
Arkansas 4 4 240.2
California 115 123 124.4
Colorado 4 4 92.1
Connecticut 0 0 0.0
Delaware 0 0 0.0
District of Columbia 4 4 1,254.3
Florida 11 11 137.4
Georgia 3 3 85.4
Hawaii 149 147 162.4
Idaho 0 0 0.0
Illinois 6 7 194.2
Indiana 2 2 132.2
Iowa 0 0 0.0
Kansas 0 0 0.0
Kentucky 1 1 87.1
Louisiana 0 0 0.0
Maine 0 0 0.0
Maryland 11 11 526.1
Massachusetts 0 0 0.0
Michigan 2 2 97.1
Minnesota 0 0 0.0
Mississippi 1 1 164.7
Missouri 2 2 72.3
Montana 0 0 0.0
Nebraska 1 1 140.7
Nevada 8 8 89.9
New Hampshire 0 0 0.0
New Jersey 4 4 161.9
New Mexico 1 1 101.4
New York 8 9 124.1
North Carolina 5 5 161.5
North Dakota 0 0 0.0
Ohio 1 1 40.7
Oklahoma 1 1 46.6
Oregon 8 8 103.9
Pennsylvania 7 8 291.2
Rhode Island 1 1 220.1
South Carolina 2 2 145.6
South Dakota 0 0 0.0
Tennessee 1 1 52.2
Texas 15 15 125.3
Utah 1 1 7.5
Vermont 1 1 786.4
Virginia 3 3 86.9
Washington 17 17 78.9
West Virginia 0 0 0.0
Wisconsin 0 0 0.0
Wyoming 0 0 0.0
Subtotal 409 421 123.6
U.S. dependent areasb
American Samoa 0 0 —
Guam 4 4 —
Northern Mariana Islands 1 1 —
Puerto Rico 0 0 —
U.S. Virgin Islands 0 0 —
Subtotal 5 5 —
Totalc 414 426 —
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Table 22. Adults and adolescents living with an AIDS diagnosis, by race/ethnicity and area of residence, year-end 
2007—United States and 5 U.S. dependent areas (cont)
No.
Estimateda
No. Rate
White
Area of residence
Alabama 1,326 1,292 48.0
Alaska 173 172 45.4
Arizona 2,947 2,904 89.8
Arkansas 1,238 1,271 69.9
California 30,517 31,435 230.9
Colorado 2,669 2,645 89.7
Connecticut 2,534 2,605 117.0
Delaware 478 495 97.3
District of Columbia 1,206 1,191 683.6
Florida 15,519 15,216 157.1
Georgia 4,564 4,782 102.6
Hawaii 750 744 268.9
Idaho 260 261 24.8
Illinois 5,151 5,290 74.3
Indiana 2,367 2,319 52.4
Iowa 638 634 27.8
Kansas 862 857 45.5
Kentucky 1,604 1,587 50.7
Louisiana 2,462 2,519 109.5
Maine 462 475 43.9
Maryland 2,584 2,655 95.3
Massachusetts 3,994 4,150 93.5
Michigan 2,522 2,556 38.7
Minnesota 1,323 1,307 34.8
Mississippi 813 800 55.3
Missouri 3,027 3,034 74.5
Montana 169 166 23.1
Nebraska 445 440 35.1
Nevada 1,663 1,636 128.5
New Hampshire 431 441 42.2
New Jersey 4,304 4,492 97.5
New Mexico 573 566 77.9
New York 15,450 15,366 151.9
North Carolina 2,300 2,460 47.4
North Dakota 54 55 11.1
Ohio 3,740 3,783 47.2
Oklahoma 1,404 1,446 66.0
Oregon 2,323 2,297 88.7
Pennsylvania 5,929 6,024 68.9
Rhode Island 651 671 92.1
South Carolina 1,687 1,706 69.7
South Dakota 86 85 14.7
Tennessee 2,943 2,905 72.1
Texas 12,590 12,374 127.8
Utah 876 866 50.3
Vermont 207 213 41.8
Virginia 2,981 3,075 69.7
Washington 3,907 3,855 91.7
West Virginia 570 590 40.7
Wisconsin 1,092 1,076 26.4
Wyoming 77 76 19.8
Subtotal 158,442 159,860 94.2
U.S. dependent areasb
American Samoa 0 0 —
Guam 3 3 —
Northern Mariana Islands 0 0 —
Puerto Rico 13 13 —
U.S. Virgin Islands 32 32 —
Subtotal 48 47 —
Totalc 158,490 159,908 —
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Table 22. Adults and adolescents living with an AIDS diagnosis, by race/ethnicity and area of residence, year-end 
2007—United States and 5 U.S. dependent areas (cont)
No.
Estimateda
No. Rate
Multiple races
Area of residence
Alabama 47 47 158.4
Alaska 5 5 26.3
Arizona 56 55 100.8
Arkansas 7 6 25.5
California 235 245 48.4
Colorado 20 19 38.6
Connecticut 41 42 160.3
Delaware 2 2 32.4
District of Columbia 50 51 872.9
Florida 648 619 464.2
Georgia 132 142 223.7
Hawaii 47 48 30.5
Idaho 2 2 14.4
Illinois 176 183 223.2
Indiana 52 51 125.8
Iowa 7 7 44.3
Kansas 15 15 52.7
Kentucky 4 4 16.2
Louisiana 29 28 112.5
Maine 3 3 39.4
Maryland 118 122 245.3
Massachusetts 11 12 25.5
Michigan 85 85 93.1
Minnesota 13 13 30.1
Mississippi 13 13 97.0
Missouri 25 25 50.9
Montana 2 2 17.1
Nebraska 4 4 31.6
Nevada 11 11 30.0
New Hampshire 6 6 76.1
New Jersey 181 187 307.9
New Mexico 1 1 4.7
New York 1,038 1,042 672.7
North Carolina 19 19 34.7
North Dakota 0 0 0.0
Ohio 33 34 39.8
Oklahoma 50 51 52.2
Oregon 10 9 16.5
Pennsylvania 376 388 563.4
Rhode Island 5 5 61.6
South Carolina 37 37 150.6
South Dakota 0 0 0.0
Tennessee 41 40 104.3
Texas 40 41 26.4
Utah 9 8 40.7
Vermont 0 0 0.3
Virginia 63 65 89.2
Washington 41 41 34.9
West Virginia 1 1 10.5
Wisconsin 18 18 52.5
Wyoming 2 2 48.0
Subtotal 3,831 3,854 139.2
U.S. dependent areasb
American Samoa 0 0 —
Guam 2 2 —
Northern Mariana Islands 0 0 —
Puerto Rico 0 0 —
U.S. Virgin Islands 0 0 —
Subtotal 2 2 —
Totalc 3,833 3,856 —
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Table 22. Adults and adolescents living with an AIDS diagnosis, by race/ethnicity and area of residence, year-end 
2007—United States and 5 U.S. dependent areas (cont)
No.
Estimateda
No.f Rate
Totalg
Area of residence
Alabama 4,114 4,004 104.5
Alaska 352 348 62.9
Arizona 5,063 4,996 97.4
Arkansas 2,283 2,358 101.3
California 64,779 67,208 226.1
Colorado 4,272 4,238 106.5
Connecticut 7,204 7,407 253.7
Delaware 1,810 1,874 261.6
District of Columbia 8,990 9,030 1,781.1
Florida 49,681 48,492 316.0
Georgia 18,204 19,310 250.8
Hawaii 1,333 1,320 123.1
Idaho 318 320 26.6
Illinois 16,564 17,070 161.7
Indiana 4,038 3,972 76.3
Iowa 913 910 36.7
Kansas 1,400 1,394 61.2
Kentucky 2,576 2,553 72.5
Louisiana 8,164 8,349 232.5
Maine 532 548 48.7
Maryland 15,998 16,510 353.8
Massachusetts 9,075 9,455 173.1
Michigan 7,037 7,123 85.2
Minnesota 2,546 2,530 59.0
Mississippi 3,416 3,357 141.4
Missouri 5,709 5,756 118.2
Montana 205 203 25.2
Nebraska 792 785 54.1
Nevada 3,071 3,022 145.8
New Hampshire 590 606 54.7
New Jersey 18,175 18,943 263.2
New Mexico 1,320 1,306 81.3
New York 74,446 74,544 456.9
North Carolina 8,811 9,425 126.6
North Dakota 74 74 13.8
Ohio 7,311 7,410 77.7
Oklahoma 2,295 2,373 80.2
Oregon 2,942 2,916 93.3
Pennsylvania 18,162 18,523 176.5
Rhode Island 1,345 1,390 155.7
South Carolina 7,120 7,181 196.5
South Dakota 147 147 22.4
Tennessee 6,855 6,743 132.2
Texas 33,752 33,238 174.9
Utah 1,210 1,198 58.5
Vermont 244 251 47.1
Virginia 8,915 9,223 144.2
Washington 5,636 5,578 104.0
West Virginia 770 799 52.0
Wisconsin 2,290 2,271 48.6
Wyoming 104 104 24.0
Subtotal 452,953 458,686 184.4
U.S. dependent areasb
American Samoa 1 1 2.3
Guam 35 34 26.1
Northern Mariana Islands 3 3 6.8
Puerto Rico 11,216 10,932 337.2
U.S. Virgin Islands 322 316 353.7
Subtotal 11,577 11,286 317.8
Totalc 464,530 469,972 186.3
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000 
population.
b Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.
c Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may 
not sum to the column total. 
d Includes Asian/Pacific Islander legacy cases (see Technical Notes).
e Hispanics/Latinos can be of any race.
f Because row totals were calculated independently of the values for the subpopulations, the values in each row may not sum to the row total.
g Includes persons of unknown race/ethnicity.
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Table 23. Diagnoses of HIV infection, 2008, and persons living with a diagnosis of HIV infection, year-end 2007, 
by metropolitan statistical area of residence—United States and Puerto Rico  
Area of residence
2008 Living with HIV infection, year-end 2007
No.
Estimateda
Rankb No.
Estimateda
No. Rate No. Rate
Akron, OH 28 30 4.4 74 704 707 101.1
Albany–Schenectady–Troy, NY 97 128 15.0 42 1,949 1,999 234.7
Albuquerque, NM 80 91 10.7 57 1,097 1,127 135.3
Allentown–Bethlehem–Easton, PA–NJ 81 — — — 1,363 123 112.6
Atlanta–Sandy Springs–Marietta, GA 1,678 2,529 47.0 2 19,962 20,852 396.3
Augusta–Richmond County, GA–SC 77 114 21.3 24 1,900 1,989 376.6
Austin–Round Rock, TX 272 309 18.7 29 4,021 4,112 258.2
Bakersfield, CA 133 — — — 1,615 — —
Baltimore–Towson, MD 1,354 — — — 17,364 — —
Baton Rouge, LA 308 341 44.0 5 3,597 3,593 467.0
Birmingham–Hoover, AL 207 238 21.3 25 3,069 3,135 282.8
Boise City–Nampa, ID 10 12 2.0 77 380 392 66.8
Boston, Mass–NHc 396 11 2.7 76 8,294 295 70.7
 Boston Division 220 — — — 4,965 — —
 Cambridge Division 114 — — — 2,031 — —
 Essex Division 53 — — — 1,018 — —
Bradenton–Sarasota–Venice, FL 123 139 20.2 26 1,569 1,611 235.2
Bridgeport–Stamford–Norwalk, CT 108 142 15.9 38 2,731 2,900 325.6
Buffalo–Niagara Falls, NY 120 159 14.1 43 1,996 2,040 181.1
Cape Coral–Fort Myers, FL 123 139 23.5 20 1,483 1,526 259.4
Charleston–North Charleston, SC 109 123 19.1 28 1,940 2,001 317.3
Charlotte–Gastonia–Concord, NC–SC 544 622 36.6 9 5,124 5,340 324.3
Chattanooga, TN–GA 76 92 17.8 30 982 1,015 197.5
Chicago, IL–IN–WI 1,743 88 10.2 60 26,365 1,178 136.9
 Chicago Division 1,620 — — — 24,687 — —
 Gary Division 69 81 11.6 — 1,017 1,047 150.1
 Lake Division 54 7 4.1 — 661 131 80.2
Cincinnati–Middletown, OH–KY–IN 201 227 10.5 58 2,753 2,782 129.8
Cleveland–Elyria–Mentor, OH 238 265 12.7 50 4,017 4,020 191.9
Colorado Springs, CO 32 37 5.9 72 691 705 115.9
Columbia, SC 184 209 28.7 15 3,543 3,663 511.9
Columbus, OH 271 302 17.0 33 3,885 3,909 223.0
Dallas, TX 1,246 1,414 22.4 21 18,325 18,974 308.3
Dallas Division 974 1,104 26.1 — 14,639 15,210 368.4
Fort Worth Division 272 310 15.0 — 3,686 3,764 185.9
Dayton, OH 69 76 9.1 64 1,171 1,176 140.3
Denver–Aurora, CO 367 418 16.7 36 7,991 8,158 332.5
Des Moines, IA 37 42 7.6 68 440 456 83.5
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Table 23. Diagnoses of HIV infection, 2008, and persons living with a diagnosis of HIV infection, year-end 2007, 
by metropolitan statistical area of residence—United States and Puerto Rico (cont)
Area of residence
2008 Living with HIV infection, year-end 2007
No.
Estimateda
Rankb No.
Estimateda
No. Rate No. Rate
Detroit, MI 537 590 13.3 48 8,725 8,741 196.1
Detroit Division 380 418 21.4 — 6,638 6,641 335.1
Warren Division 157 172 7.0 — 2,087 2,100 84.8
El Paso, TX 80 91 12.2 53 1,484 1,531 209.8
Fresno, CA 102 — — — 887 — —
Grand Rapids–Wyoming, MI 42 46 5.9 73 743 751 96.9
Greensboro–High Point, NC 188 214 30.3 13 1,918 2,000 287.4
Greenville, SC 59 67 10.7 56 1,130 1,166 190.4
Harrisburg–Carlisle, PA 53 — — — 1,272 — —
Hartford–West Hartford–East Hartford, CT 119 155 13.0 49 3,598 3,811 321.2
Honolulu, HI 47 — — — — — —
Houston–Baytown–Sugar Land, TX 1,458 1,655 28.9 14 19,660 20,289 362.4
Indianapolis, IN 236 269 15.7 39 3,711 3,816 225.5
Jackson, MS 160 182 33.9 10 2,931 3,004 562.8
Jacksonville, FL 508 579 44.1 4 5,298 5,443 419.4
Kansas City, MO–KS 256 301 15.0 41 4,188 4,303 217.2
Knoxville, TN 74 84 12.2 52 947 972 142.7
Lakeland, FL 139 158 27.2 16 1,525 1,566 273.4
Lancaster, PA 44 — — — 713 — —
Las Vegas–Paradise, NV 390 442 23.7 18 5,262 5,405 295.7
Little Rock–North Little Rock, AR 68 76 11.3 54 1,716 1,770 265.9
Los Angeles, CA 2,367 — — — 41,747 — —
Los Angeles Division 2,045 — — — 35,774 — —
Santa Ana Division 322 — — — 5,973 — —
Louisville, KY–IN 195 220 17.7 31 2,183 2,244 182.1
Madison, WI 34 39 6.9 71 563 583 105.1
McAllen–Edinburg–Pharr, TX 64 72 9.9 61 750 777 110.2
Memphis, TN–MS–AR 499 580 45.1 3 6,134 6,339 495.6
Miami, FL 3,355 3,807 70.3 1 46,562 47,880 888.0
Fort Lauderdale Division 1,169 1,329 75.9 — 14,999 15,473 884.8
Miami Division 1,673 1,896 79.1 — 24,148 24,801 1,040.8
West Palm Beach Division 513 582 46.0 — 7,415 7,605 603.4
Milwaukee–Waukesha–West Allis, WI 142 162 10.4 59 2,645 2,708 175.5
Minneapolis–St. Paul–Bloomington, MN–WI 312 356 11.0 55 5,094 5,239 163.8
Modesto, CA 36 — — — 466 — —
Nashville–Davidson–Murfreesboro, TN 297 336 21.7 23 4,270 4,384 288.4
New Haven–Milford, CT 110 143 16.9 35 3,184 3,367 398.8
New Orleans–Metairie–Kenner, LA 422 465 41.0 7 7,268 7,297 657.7
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Table 23. Diagnoses of HIV infection, 2008, and persons living with a diagnosis of HIV infection, year-end 2007, 
by metropolitan statistical area of residence—United States and Puerto Rico (cont)
Area of residence
2008 Living with HIV infection, year-end 2007
No.
Estimateda
Rankb No.
Estimateda
No. Rate No. Rate
New York, NY–NJ–PA 5,235 6,961 36.7 8 128,015 133,661 708.5
Edison Division 183 281 12.1 — 4,482 4,574 197.9
Nassau Division 306 401 14.0 — 5,326 5,439 189.9
Newark Division 440 663 32.2 — 13,258 13,477 654.1
New York–White Plains—Wayne Division 4,306 5,615 48.0 — 104,949 110,170 947.5
Ogden–Clearfield, UT 19 22 4.1 75 217 223 43.1
Oklahoma City, OK 143 163 13.5 47 2,063 2,138 179.8
Omaha–Council Bluffs, NE–IA 51 59 7.1 69 1,047 1,080 130.5
Orlando, FL 743 843 41.0 6 8,797 9,054 446.3
Oxnard–Thousand Oaks–Ventura, CA 39 — — — 715 — —
Palm Bay–Melbourne–Titusville, FL 76 87 16.2 37 1,126 1,148 214.5
Philadelphia, PA–NJ–DE–MD 1,634 178 13.5 46 25,228 2,990 227.4
Camden Division 113 172 13.7 — 2,758 2,837 227.1
Philadelphia Division 1,396 — — — 20,017 — —
Wilmington Division 125 6 9.3 — 2,453 153 231.9
Phoenix–Mesa–Scottsdale, AZ 581 747 17.4 32 8,263 8,806 211.4
Pittsburgh, PA 196 — — — 2,628 — —
Portland–South Portland, ME 27 — — — 498 — —
Portland–Vancouver–Beaverton, OR–WA 220 — — — 3,766 — —
Poughkeepsie–Newburgh–Middletown, NY 70 93 13.9 45 2,190 2,244 335.6
Providence–New Bedford–Fall River, RI–MA 147 — — — 2,412 — —
Provo–Orem, UT 8 9 1.7 78 110 113 21.6
Raleigh–Cary, NC 257 291 26.7 17 2,696 2,812 269.4
Richmond, VA 247 273 22.2 22 4,041 4,100 338.5
Riverside–San Bernardino–Ontario, CA 330 — — — 7,251 — —
Rochester, NY 152 202 19.5 27 2,864 2,928 283.6
Sacramento–Arden-Arcade–Roseville, CA 205 — — — 2,954 — —
St. Louis, MO–IL 351 301 14.0 44 6,073 5,452 255.0
Salt Lake City, UT 92 105 9.4 62 1,645 1,689 154.2
San Antonio, TX 305 346 17.0 34 4,210 4,306 216.9
San Diego–Carlsbad–San Marcos, CA 502 — — — 10,297 — —
San Francisco, CA 924 — — — 22,194 — —
Oakland Division 327 — — — 5,873 — —
San Francisco Division 597 — — — 16,321 — —
San Jose–Sunnyvale–Santa Clara, CA 157 — — — 2,636 — —
San Juan–Caguas–Guaynabo, PR 672 870 33.3 11 7,101 7,546 290.3
Scranton–Wilkes-Barre, PA 39 — — — 525 — —
Seattle, WA 410 — — — 7,546 — —
Seattle Division 346 — — — 6,684 — —
Tacoma Division 64 — — — 862 — —
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Table 23. Diagnoses of HIV infection, 2008, and persons living with a diagnosis of HIV infection, year-end 2007, 
by metropolitan statistical area of residence—United States and Puerto Rico (cont)
Area of residence
2008 Living with HIV infection, year-end 2007
No.
Estimateda
Rankb No.
Estimateda
No. Rate No. Rate
Springfield, MA 49 — — — 1,524 — —
Stockton, CA 71 — — — 990 — —
Syracuse, NY 61 81 12.6 51 1,023 1,037 161.1
Tampa–St. Petersburg–Clearwater, FL 775 881 32.2 12 9,447 9,706 357.5
Toledo, OH 49 55 8.5 66 874 879 135.1
Tucson, AZ 85 94 9.2 63 1,836 1,838 184.5
Tulsa, OK 71 80 8.8 65 1,365 1,410 155.9
Virginia Beach–Norfolk–Newport News, VA–NC 353 390 23.5 19 5,963 6,048 364.4
Washington, DC–VA–MD–WV 2,277 387 15.2 40 28,131 6,524 261.5
Bethesda Division 405 — — — 2,993 — —
Washington Division 1,872 387 15.2 — 25,138 6,524 261.5
Wichita, KS 37 42 6.9 70 708 727 122.2
Worcester, MA 45 — — — 1,334 — —
Youngstown–Warren–Boardman, OH–PA 37 36 8.1 67 614 550 121.3
Subtotal for MSAs (population 500,000) 40,447 32,984 25.0 — 659,812 464,176 355.6
Metropolitan areas (population of 50,000–
499,999) 5,603 5,725 13.2 — 83,862 71,984 168.0
Nonmetropolitan areas 3,243 3,436 8.3 — 59,093 54,300 131.6
Totald 49,614 42,402 19.6 — 812,820 599,125 279.1
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Because of the lack of U.S. census 
information for all U.S. dependent areas, includes data for only the 50 states, the District of Columbia, and Puerto Rico.
MSA, metropolitan statistical area.
MSA definitions for this report can be found at http://www.census.gov/population/www/metroareas/metrodef.html.
a Includes data from areas with confidential name-based HIV infection reporting since at least January 2005. Estimated numbers resulted from 
statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000 population.
b Based on estimated rate.
c Counts of diagnoses of HIV infection for the metropolitan divisions do not sum to the MSA total. MSA total includes data from 1 metropolitan division 
with population of <500,000.
d Includes persons whose county of residence is unknown. Because column totals for estimated numbers were calculated independently of the values 
for the subpopulations, the values in each column may not sum to the column total. 
HIV Infection and AIDS Data for States and Metropolitan Statistical Areas 137
138
H
IV
 Infection and A
ID
S
 D
ata for S
tates and M
etropolitan S
tatistical A
reas
 metropolitan statistical area of 
Living with AIDS, year-end 
2007tal
No.
Estimatedb
o. No. Rate
833 378 382 54.6
2,509 1,139 1,131 132.8
1,565 674 667 80.1
1,541 797 801 99.8
6,404 12,366 13,105 249.1
2,133 993 1,042 197.2
5,318 2,416 2,359 148.1
1,989 1,154 1,192 151.4
3,571 10,064 10,301 386.7
4,476 1,812 1,850 240.5
2,890 1,174 1,142 103.0
311 148 149 25.4
4,827 6,301 6,548 145.8
9,255 3,785 3,930 209.9
3,467 1,575 1,643 111.8
1,756 784 814 111.1
2,230 969 949 138.5
4,119 1,865 1,923 215.9
2,789 1,159 1,136 100.8
1,954 814 797 135.6
2,308 1,026 1,035 164.1
3,975 1,793 1,915 116.3
1,112 533 532 103.5
3,901 14,690 15,119 159.2
1,825 13,752 14,175 178.8
1,189 490 484 69.3
887 448 460 52.9
3,145 1,380 1,396 65.1
4,697 2,055 2,072 98.9
Table 24. AIDS diagnoses, 2008 and cumulative, and persons living with an AIDS diagnosis, year-end 2007, by
residence—United States and Puerto Rico  
Area of residence
2008
Cumulativea
Adults or 
adolescents Children To
No.
Estimatedb
Rankc
Estimatedb
No. Rate No. No. N
Akron, OH 18 22 3.2 98 831 2
Albany–Schenectady–Troy, NY 61 84 9.8 53 2,485 24
Albuquerque, NM 48 52 6.1 77 1,562 3
Allentown–Bethlehem–Easton, PA–NJ 43 51 6.4 75 1,523 17
Atlanta–Sandy Springs–Marietta, GA 886 1,359 25.3 8 26,263 140 2
Augusta–Richmond County, GA–SC 49 74 13.9 29 2,110 23
Austin–Round Rock, TX 184 204 12.3 34 5,292 26
Bakersfield, CA 94 129 16.1 21 1,980 9
Baltimore–Towson, MD 631 862 32.3 4 23,348 223 2
Baton Rouge, LA 254 310 40.0 2 4,456 20
Birmingham–Hoover, AL 79 92 8.2 63 2,865 25
Boise City–Nampa, ID 10 13 2.1 100 311 0
Boston, Mass–NHd 178 240 5.3 81 14,671 155 1
 Boston Division 93 125 6.6 — 9,159 96
 Cambridge Division 53 72 4.9 — 3,431 36
 Essex Division 27 37 5.0 — 1,734 22
Bradenton–Sarasota–Venice, FL 82 90 13.0 32 2,201 29
Bridgeport–Stamford–Norwalk, CT 83 104 11.6 39 4,061 57
Buffalo–Niagara Falls, NY 83 115 10.2 46 2,768 21
Cape Coral–Fort Myers, FL 76 82 13.9 27 1,929 24
Charleston–North Charleston, SC 97 106 16.5 20 2,290 18
Charlotte–Gastonia–Concord, NC–SC 226 266 15.6 23 3,954 21
Chattanooga, TN–GA 44 51 9.8 51 1,109 3
Chicago, IL–IN–WI 846 1,141 11.9 37 33,635 267 3
 Chicago Division 754 1,032 12.9 — 31,572 253 3
 Gary Division 55 61 8.7 — 1,181 8
 Lake Division 37 48 5.5 — 882 5
Cincinnati–Middletown, OH–KY–IN 131 167 7.7 65 3,125 20
Cleveland–Elyria–Mentor, OH 130 163 7.8 64 4,648 50
by metropolitan statistical area of 
Living with AIDS, year-end 
2007Total
No.
Estimatedb
No. No. Rate
632 277 275 45.2
3,728 1,921 1,940 271.0
3,636 1,471 1,490 85.0
22,220 10,087 9,992 162.4
17,624 8,027 7,993 193.6
4,596 2,060 1,999 98.8
1,404 623 634 75.6
7,585 3,255 3,224 131.4
597 272 270 49.5
11,684 4,741 4,788 107.4
9,227 3,630 3,656 184.5
2,457 1,111 1,132 45.7
1,719 913 901 123.4
1,720 722 743 83.1
924 428 437 56.4
1,497 615 657 94.4
1,430 641 644 105.1
1,403 698 696 131.8
5,623 2,485 2,555 215.4
2,305 903 891 98.9
28,563 11,397 11,277 201.4
4,227 1,911 1,881 111.1
2,744 1,282 1,252 234.6
6,910 3,019 2,931 225.8
5,357 2,375 2,355 118.8
1,006 457 448 65.8
2,097 894 869 151.7
837 404 404 81.1
5,318 2,521 2,475 135.4
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Table 24. AIDS diagnoses, 2008 and cumulative, and persons living with an AIDS diagnosis, year-end 2007, 
residence—United States and Puerto Rico (cont)
Area of residence
2008
Cumulativea
Adults or 
adolescents Children
No.
Estimatedb
Rankc
Estimatedb
No. Rate No. No.
Colorado Springs, CO 20 21 3.5 96 627 5
Columbia, SC 170 186 25.6 7 3,703 24
Columbus, OH 105 130 7.3 67 3,615 21
Dallas, TX 840 915 14.5 26 22,158 62
Dallas Division 680 740 17.5 — 17,587 37
Fort Worth Division 160 174 8.4 — 4,571 25
Dayton, OH 56 70 8.4 61 1,389 15
Denver–Aurora, CO 264 289 11.5 40 7,563 22
Des Moines, IA 21 25 4.5 90 593 4
Detroit, MI 391 483 10.9 42 11,608 76
Detroit Division 289 355 18.2 — 9,169 58
Warren Division 102 127 5.1 — 2,440 17
El Paso, TX 60 67 9.0 56 1,709 10
Fresno, CA 63 85 9.4 54 1,709 11
Grand Rapids–Wyoming, MI 31 39 5.0 84 918 6
Greensboro–High Point, NC 79 94 13.3 31 1,481 15
Greenville, SC 51 58 9.3 55 1,426 4
Harrisburg–Carlisle, PA 47 53 9.9 50 1,395 8
Hartford–West Hartford–East Hartford, CT 105 128 10.8 43 5,576 46
Honolulu, HI 23 25 2.7 99 2,291 14
Houston–Baytown–Sugar Land, TX 895 979 17.1 19 28,389 173
Indianapolis, IN 190 211 12.3 35 4,202 25
Jackson, MS 112 123 23.0 11 2,714 30
Jacksonville, FL 320 353 26.9 5 6,831 79
Kansas City, MO–KS 202 238 11.9 38 5,340 16
Knoxville, TN 55 62 8.9 57 1,001 5
Lakeland, FL 102 111 19.1 15 2,076 21
Lancaster, PA 23 25 5.0 85 816 21
Las Vegas–Paradise, NV 257 289 15.5 24 5,290 28
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1,576 848 875 131.4
6,005 26,945 28,375 221.9
8,291 23,380 24,727 252.1
7,714 3,565 3,648 122.5
2,689 1,268 1,246 101.2
582 284 284 51.2
748 441 438 62.0
5,718 2,691 2,644 206.7
2,414 25,471 24,824 460.4
8,746 7,894 7,722 441.6
2,880 13,086 12,732 534.3
0,788 4,491 4,370 346.7
2,772 1,260 1,243 80.6
4,783 2,258 2,243 70.1
776 351 361 71.0
4,364 2,225 2,195 144.4
4,987 2,235 2,293 271.6
9,860 3,844 3,928 354.0
4,870 78,984 79,768 421.5
7,484 2,589 2,689 116.3
9,083 3,436 3,356 117.2
2,265 7,008 7,297 344.4
6,037 65,951 66,426 571.3
287 133 131 25.2
2,533 1,068 1,105 92.9
1,170 571 568 68.6
9,929 4,643 4,554 224.5
1,116 476 486 61.3
1,660 742 724 135.2 Table 24. AIDS diagnoses, 2008 and cumulative, and persons living with an AIDS diagnosis, year-end 2007, by
residence—United States and Puerto Rico (cont)
Area of residence
2008
Cumulativea
Adults or 
adolescents Children To
No.
Estimatedb
Rankc
Estimatedb
No. Rate No. No. N
Little Rock–North Little Rock, AR 35 42 6.3 76 1,562 14
Los Angeles, CA 1,263 2,333 18.1 17 65,707 298 6
Los Angeles Division 1,063 2,057 20.9 — 58,037 254 5
Santa Ana Division 200 276 9.2 — 7,669 45
Louisville, KY–IN 139 150 12.1 36 2,662 27
Madison, WI 17 18 3.3 97 577 5
McAllen–Edinburg–Pharr, TX 32 34 4.7 88 736 12
Memphis, TN–MS–AR 178 203 15.8 22 5,699 19
Miami, FL 2,111 2,316 42.8 1 61,401 1,012 6
Fort Lauderdale Division 804 883 50.4 — 18,479 267 1
Miami Division 977 1,071 44.7 — 32,360 520 3
West Palm Beach Division 330 361 28.5 — 10,562 226 1
Milwaukee–Waukesha–West Allis, WI 81 88 5.7 79 2,754 18
Minneapolis–St. Paul–Bloomington, MN–WI 163 178 5.5 80 4,761 22
Modesto, CA 29 39 7.6 66 770 6
Nashville–Davidson–Murfreesboro, TN 185 201 12.9 33 4,344 20
New Haven–Milford, CT 73 91 10.8 44 4,914 73
New Orleans–Metairie–Kenner, LA 297 367 32.4 3 9,789 71
New York, NY–NJ–PA 3,461 4,672 24.6 10 211,912 2,958 21
Edison Division 109 211 9.1 — 7,342 142
Nassau Division 233 325 11.3 — 8,967 116
Newark Division 340 644 30.4 — 21,916 350 2
New York–White Plains–Wayne Division 2,779 3,492 29.9 — 173,687 2,350 17
Ogden–Clearfield, UT 6 7 1.2 101 283 4
Oklahoma City, OK 67 80 6.6 71 2,528 5
Omaha–Council Bluffs, NE–IA 35 43 5.1 83 1,166 4
Orlando, FL 377 421 20.5 13 9,833 97
Oxnard–Thousand Oaks–Ventura, CA 23 33 4.1 93 1,113 3
Palm Bay–Melbourne–Titusville, FL 46 53 9.8 52 1,649 11
by metropolitan statistical area of 
Living with AIDS, year-end 
2007Total
No.
Estimatedb
No. No. Rate
32,402 15,011 15,482 265.9
3,549 1,429 1,490 119.3
25,481 12,109 12,469 321.1
3,372 1,473 1,523 220.2
8,489 3,693 3,646 87.5
3,480 1,453 1,442 61.2
623 271 278 54.2
5,250 2,337 2,320 107.1
3,432 1,418 1,400 209.4
4,303 1,976 2,047 128.1
137 70 70 13.3
2,559 1,297 1,387 132.8
3,831 1,699 1,756 145.0
9,861 4,785 4,912 120.8
3,507 1,644 1,623 157.2
4,446 1,885 1,933 92.8
6,775 3,142 3,233 114.3
1,881 915 906 82.7
5,597 2,589 2,523 127.1
14,442 6,462 6,628 224.0
44,002 15,088 15,487 367.3
10,893 4,344 4,461 180.7
33,109 10,744 11,026 630.8
4,300 1,915 1,972 110.4
23,658 7,984 7,858 302.3
613 294 297 54.1
9,904 4,297 4,251 128.9
8,787 3,830 3,793 150.2
1,118 467 458 59.2
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Table 24. AIDS diagnoses, 2008 and cumulative, and persons living with an AIDS diagnosis, year-end 2007, 
residence—United States and Puerto Rico (cont)
Area of residence
2008
Cumulativea
Adults or 
adolescents Children
No.
Estimatedb
Rankc
Estimatedb
No. Rate No. No.
Philadelphia, PA–NJ–DE–MD 786 1,097 18.8 16 32,078 323
Camden Division 57 100 8.0 — 3,506 42
Philadelphia Division 639 880 22.6 — 25,222 259
Wilmington Division 90 117 16.8 — 3,350 22
Phoenix–Mesa–Scottsdale, AZ 416 456 10.6 45 8,457 32
Pittsburgh, PA 130 141 6.0 78 3,460 20
Portland–South Portland, ME 17 21 4.1 92 622 1
Portland–Vancouver–Beaverton, OR–WA 144 161 7.3 68 5,240 10
Poughkeepsie–Newburgh–Middletown, NY 67 93 13.9 28 3,408 24
Providence–New Bedford–Fall River, RI–MA 83 105 6.6 73 4,259 44
Provo–Orem, UT 5 5 1.0 102 134 3
Raleigh–Cary, NC 159 188 17.3 18 2,546 13
Richmond, VA 113 136 11.1 41 3,795 36
Riverside–San Bernardino–Ontario, CA 212 292 7.1 70 9,799 62
Rochester, NY 102 141 13.7 30 3,493 14
Sacramento–Arden-Arcade–Roseville, CA 62 83 4.0 94 4,420 26
St. Louis, MO–IL 200 287 10.1 48 6,734 40
Salt Lake City, UT 48 54 4.8 87 1,871 10
San Antonio, TX 185 201 9.9 49 5,566 31
San Diego–Carlsbad–San Marcos, CA 335 462 15.4 25 14,374 67
San Francisco, CA 647 894 20.9 12 43,902 100
Oakland Division 245 333 13.3 — 10,841 52
San Francisco Division 402 561 31.7 — 33,061 49
San Jose–Sunnyvale–Santa Clara, CA 114 157 8.6 59 4,284 15
San Juan–Caguas–Guaynabo, PR 473 648 24.9 9 23,376 283
Scranton–Wilkes-Barre, PA 23 25 4.6 89 607 6
Seattle, WA 258 285 8.5 60 9,876 28
Seattle Division 219 243 9.5 — 8,768 19
Tacoma Division 39 42 5.4 — 1,109 9
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 metropolitan statistical area of 
Living with AIDS, year-end 
2007tal
No.
Estimatedb
o. No. Rate
2,368 960 1,004 146.2
1,289 597 613 91.8
1,469 646 632 98.1
2,668 5,374 5,257 193.6
948 410 417 64.1
2,188 893 875 87.8
1,696 756 782 86.5
5,322 2,464 2,537 152.8
6,328 17,140 17,546 330.9
3,445 1,768 1,849 158.6
2,883 15,372 15,696 379.4
924 424 419 70.4
2,019 946 989 126.5
619 275 282 49.3
3,931 387,860 392,656 196.1
5,524 46,729 47,000 85.2
2,062 28,699 28,920 58.0
5,592 465,079 470,546 154.2
ia, and Puerto Rico.
population.
lation of <500,000.
s for the subpopulations, the values in each  Table 24. AIDS diagnoses, 2008 and cumulative, and persons living with an AIDS diagnosis, year-end 2007, by
residence—United States and Puerto Rico (cont)
Area of residence
2008
Cumulativea
Adults or 
adolescents Children To
No.
Estimatedb
Rankc
Estimatedb
No. Rate No. No. N
Springfield, MA 32 45 6.5 74 2,340 28
Stockton, CA 49 68 10.1 47 1,273 16
Syracuse, NY 42 57 8.8 58 1,460 9
Tampa–St. Petersburg–Clearwater, FL 487 532 19.5 14 12,547 121 1
Toledo, OH 33 43 6.6 72 934 14
Tucson, AZ 66 72 7.2 69 2,178 10
Tulsa, OK 37 45 4.9 86 1,686 10
Virginia Beach–Norfolk–Newport News, VA–NC 110 138 8.3 62 5,259 63
Washington, DC–VA–MD–WV 993 1,388 25.9 6 36,008 320 3
Bethesda Division 141 192 16.3 — 3,422 23
Washington Division 852 1,196 28.6 — 32,586 297 3
Wichita, KS 22 24 3.9 95 922 2
Worcester, MA 31 41 5.3 82 1,998 21
Youngstown–Warren–Boardman, OH–PA 20 25 4.5 91 619 0
Subtotal for MSAs (population 500,000) 23,934 30,618 15.1 — 925,522 8,409 93
Metropolitan areas (population of 50,000 to 499,999) 3,451 4,161 7.5 — 104,692 832 10
Nonmetropolitan areas 2,168 2,576 5.1 — 61,597 465 6
Totale 29,972 37,970 12.3 — 1,095,836 9,756 1,10
Note. Because of the lack of U.S. census information for all U.S. dependent areas, includes data for only the 50 states, the District of Columb
MSA, metropolitan statistical area.
MSA definitions for this report can be found at http://www.census.gov/population/www/metroareas/metrodef.html.
a From the beginning of the epidemic through 2008.
b Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000 
c Based on estimated rate.
d Counts of AIDS diagnoses for the metropolitan divisions do not sum to the MSA total. MSA total includes data from 1 metropolitan division with popu
e Includes persons whose county of residence is unknown. Because column totals for estimated numbers were calculated independently of the value
column may not sum to the column total.
Web Addresses for Reports of State or Local HIV Surveillance
Alabama http://www.adph.org/aids/Default.asp?id=984
Alaska http://www.epi.hss.state.ak.us/bulletins/catlist.jsp?cattype=HIV+(Human+Immunodeficiency+Virus)
Arizona http://www.azdhs.gov/phs/hiv/hiv_epi.htm
Arkansas http://www.healthyarkansas.com/data/data.html#
California http://www.cdph.ca.gov/data/statistics/Pages/OAHIVAIDSStatistics.aspx
Chicago http://egov.cityofchicago.org/city/webportal/portalDeptCategoryAction.do?deptCategoryOID=-536897686&content
Type=COC_EDITORIAL&topChannelName=Dept&entityName=Health&deptMainCategoryOID=-536897682
Colorado http://www.cdphe.state.co.us/dc/HIVandSTD/surveillance.html
Connecticut http://www.ct.gov/dph/cwp/view.asp?a=3135&q=393048
Delaware http://www.dhss.delaware.gov/dhss/dph/epi/disstatshiv.html
District of Columbia http://doh.dc.gov/doh/cwp/view,A,1371,Q,603431.asp
Florida http://www.doh.state.fl.us/Disease_ctrl/aids/trends/trends.html
Georgia http://health.state.ga.us/epi/hivaids/index.asp
Hawaii http://hawaii.gov/health/healthy-lifestyles/std-aids/data-statistics/index.html
Houston http://www.houstontx.gov/health/HIV-STD/
Idaho http://healthandwelfare.idaho.gov/Health/FamilyPlanningSTDHIV/HIVAIDS/tabid/390/Default.aspx
Illinois http://www.idph.state.il.us/aids/stats.htm
Indiana http://www.in.gov/isdh/19092.htm
Iowa http://www.idph.state.ia.us/adper/hiv_aids_programs.asp#surveillance
Kansas http://www.kdheks.gov/hiv/surveillance.html
Kentucky http://chfs.ky.gov/dph/epi/HIV-AIDS+Reporting+and+Statistics.htm
Los Angeles http://publichealth.lacounty.gov/phcommon/public/reports/rptspubdisplay.cfm?unit=hiv&ou=ph&prog=hae
Louisiana http://www.dhh.louisiana.gov/offices/?id=264
Maine http://www.maine.gov/dhhs/boh/ddc/hiv-std/data_statistics_surveillance.shtml
Maryland http://www.dhmh.state.md.us/AIDS/Data&Statistics/statistics.htm
Massachusetts http://www.mass.gov/?pageID=eohhs2subtopic&L=7&L0=Home&L1=Researcher&L2=Physical+Health+and+
Treatment&L3=Diseases+%26+Conditions&L4=HIV%26%2347%3bAIDS&L5=HIV%26%2347%3bAIDS+
Surveillance&L6=Surveillance+Reports&sid=Eeohhs2
Michigan http://www.michigan.gov/mdch/0,1607,7-132-2940_2955_2982_46000_46003---,00.html
Minnesota http://www.health.state.mn.us/divs/idepc/diseases/hiv/hivstatistics.html
Mississippi http://www.msdh.state.ms.us/msdhsite/index.cfm/14,0,150,63,html
Missouri http://www.dhss.mo.gov/HIV_STD_AIDS/Data.html
Montana http://hivdata.hhs.mt.gov/
Nebraska http://www.dhhs.ne.gov/dpc/HIV.htm
Nevada http://health.nv.gov/FP_Publications.htm
New Hampshire http://www.dhhs.nh.gov/DHHS/CDCS/LIBRARY/Data-Statistical+Report/hiv-aids-report.htm
New Jersey http://www.state.nj.us/health/aids/aidsqtr.htm
New Mexico http://www.health.state.nm.us/epi/hiv-aids.html
New York http://www.health.state.ny.us/diseases/aids/statistics/index.htm
New York City http://www.nyc.gov/html/doh/html/dires/epi_reports.shtml
North Carolina http://www.epi.state.nc.us/epi/hiv/surveillance.html
North Dakota http://www.ndhealth.gov/hiv/
Ohio http://www.odh.ohio.gov/healthStats/disease/hivcov.aspx
Oklahoma http://www.ok.gov/health/Disease,_Prevention,_Preparedness/HIV_STD_Service/HIV_STD_Statistics/index.html
Oregon http://www.oregon.gov/DHS/ph/hiv/data/EpiProfile.shtml
Pennsylvania http://www.portal.state.pa.us/portal/server.pt/community/department_of_health_home/17457
Philadelphia http://www.phila.gov/health/units/aaco/HIV_AIDS.html
Rhode Island http://www.health.ri.gov/hiv/data.php
San Francisco http://www.sfdph.org/dph/files/reports/default.asp
South Carolina http://www.dhec.sc.gov/health/disease/stdhiv/surveillance.htm
South Dakota http://doh.sd.gov/Disease/statistics.aspx
Tennessee http://health.state.tn.us/statistics/std.htm
Texas http://www.dshs.state.tx.us/hivstd/default.shtm
Utah http://health.utah.gov/cdc/sp.htm
Vermont http://healthvermont.gov/prevent/aids/quarter/reports.aspx
Virginia http://www.vdh.virginia.gov/epidemiology/DiseasePrevention/Data/
Washington http://www.doh.wa.gov/cfh/hiv/statistics/reporting/default.htm
West Virginia http://www.wvhiv.org/DiseaseSurveillance/tabid/1674/Default.aspx
Wisconsin http://dhfs.wisconsin.gov/aids-hiv/Stats/index.htm
Wyoming http://www.health.wyo.gov/PHSD/hivsurveillance/index.html
Note. Electronic reports were not available for the following areas: American Samoa, Guam, the Northern Mariana Islands, Puerto Rico, and the 
U.S. Virgin Islands. 
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